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ABSTRACT 
An evidence-practice gap is defined as the difference between what we know from the 
best available research evidence and what actually happens in current practice. The highly 
respected ARDSNet low-tidal-volume ventilation trial was published in 2000, however, in 
2016 an observational study conducted in over 50 countries documented that up to one third 
of eligible patients failed to receive the ARDSNet low-tidal-volume ventilation strategy. In 
this thesis, we undertook a sequence of studies to better understand research evidence use in 
intensive care, with the intention of developing a tool that may help close evidence-practice 
gaps. 
To better understand research evidence use, we conducted a self-administered mail-out 
survey of intensive care specialists in Australia and New Zealand, and a self-administered 
online survey of a multinational group of intensive care clinicians. Based on knowledge 
gained from these surveys, we developed a concise evidence summary tool designed to 
overcome 27 explicit barriers to the use of research evidence. To evaluate the evidence 
summary tool, we developed a clinical case-based scenario. 
Ninety-three multinational intensive care clinicians were invited to review the case-
based scenario and then read the evidence summary tool. Reading the evidence summary tool 
led to a significant increase in the belief that the intervention described in the tool would 
benefit the realistic patient in our case-based scenario (mean score change 0.32, 95% CI 0.19 
to 0.46, P<0.001). Interestingly, the group most influenced by the evidence summary tool 
were those who appeared to be less up to date. 
Whilst it is not known whether this success in increasing intensive care clinicians’ 
belief in the benefit of a treatment would translate into a change in clinical practice 
behaviours, these promising results clearly indicate a need for further investigation into the 
use of evidence summary tools as an intervention to help close evidence-practice gaps. 
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INTRODUCTION 
Overview 
It is universally agreed that patient health outcomes are maximised when the practice 
of medicine is guided by objective research evidence. To provide appropriate research 
evidence to guide clinical decision making, societies are making a huge investment in medical 
research. For example, over the 17 year period between 2010 and 2016, the National Health 
and Medical Research Council (NHMRC) provided over $AUD 11 billion in medical research 
funding.
1
 Despite awareness that research evidence should guide clinical decision making, 
even when convincing evidence exists, studies demonstrate that medical care is not always 
provided in line with that evidence.  
The intensive care unit (ICU) is a highly specialised area of the hospital in which the 
most critically ill patients with the highest risk of death are cared for. On average, an ICU 
accounts for ten percent of the total number of patient beds within a hospital, yet caring for 
critically ill patients in the ICU consumes approximately 30% of a hospital’s total budget.2, 3 
Over the past ten years, the number of randomised controlled trials (RCTs) conducted in 
critically ill ICU patient populations each year has increased by more than 50%.
4
 
Unfortunately, studies consistently show that interventions that have been proven by these 
RCTs to reduce the mortality of critically ill patients are frequently underused.
5, 6
  
The purpose of this thesis was to explore attitudes towards the use of published 
research evidence in intensive care medicine and, based on an understanding of factors that 
inhibit and/or facilitate the appropriate use of published research evidence, to develop and 
evaluate an intervention to improve the use of research evidence by intensive care clinicians.  
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Background 
Use of objective research techniques to generate evidence that could be used to guide 
the practice of medicine appear as early as the 18
th
 century. Historically, the first controlled 
clinical trial can be traced back to 1747.
7
 James Lind, a British Naval Surgeon, conducted a 
comparative study of a variety of treatments for scurvy, with the aim of identifying the best 
way to reduce the high rate of deaths from this disease.  
Lind identified 12 sailors with similar presentations of the disease scurvy. Based on 
his clinical experience and knowledge of the disease, he chose sailors with signs and 
symptoms that he believed represented a stage of the disease that was universally fatal. He 
took steps to ensure that all participants were provided with the same basic diet, environment 
and care, apart from the six interventions he had chosen for comparison.  
Lind allocated two sailors to each of his six pre-determined treatment groups. The first 
group received treatment with 1.1 L of cider given daily; the second group received 25 ml of 
elixir vitriol (sulfuric acid) given daily; the third group received 18 ml of vinegar three times 
per day; the fourth group received 284 ml of seawater daily; the fifth group received a 
medicinal paste made up of garlic, mustard seed, dried radish root and gum myrrh plus 284 
ml of barley water; and finally the sixth group received two oranges and one lemon every day 
for six days. Lind found that those sailors treated with the oranges and lemon ‘improved and 
recovered faster’ than those treated with any other intervention.7, 8 
Interestingly enough, this example of what is generally recognised as the first 
controlled trial also provides us with the first example of an evidence-practice gap. An 
evidence-practice gap is defined by the Australian NHMRC as “the difference between what 
we know from the best available research evidence and what actually happens in current 
practice.”9  
18 
As previously outlined, James Lind conducted his controlled trial in 1747 and 
published the results in book form in 1753.
7
 However, British Royal Navy records document 
that it was not until 1795 that it became common for British naval ships to carry citrus fruit on 
board to ensure sailors didn’t develop scurvy.8 During this 42 year evidence-practice gap it 
has been estimated that hundreds of thousands of British sailors lost their lives to scurvy.
8
  
The disconnect between what we know and what we do 
Despite a general awareness that patient benefits are maximised when research 
evidence is used to guide clinical decision making, even when convincing evidence exists, 
medical care is not always provided in line with that evidence.
10
  
Recently, the NHMRC  recognised the potential importance of this issue by 
proclaiming the investigation of methods for reducing evidence-practice gaps as a national 
research priority.
9
 In December 2003, the Australian National Institute of Clinical Studies, a 
national agency tasked specifically with closing the gaps between evidence and practice in 
health care,  published a report which highlighted areas for further research within Australia.
11
 
This report broadly classified evidence-practice gaps into one of two types: 1) When evidence 
for a specific intervention exists, yet that intervention has failed to translate into routine use in 
clinical practice, then this is a situation of underuse or; 2) When evidence exists for a specific 
intervention to be used in a specific condition (e.g. antibiotics for pneumonia), yet the 
intervention is often freely given to patients who do not have the specific condition (e.g. 
instead of pneumonia, antibiotics are given to patients with a head cold) then this is a situation 
of overuse. 
 Evidence-practice gaps in medical practice 
The concept of an evidence-practice gap in medicine is not new. As previously 
outlined, the results of what is generally considered to be the first controlled clinical trial also 
provides an example of the first evidence-practice gap: citrus fruit for the prevention of 
19 
Figure 1. Knowledge of effectiveness vs. recommending 
treatment (from Antman et al.
12
)  
 
Blue line: Approximate time that treatment was known to 
be effective. Red line: approximate time that treatment 
recommendations were being made in the literature. 
scurvy did not gain widespread use until 42 years after publication that demonstrated its 
effectiveness.
7,8
 There are many more recent examples.  
A landmark meta-analysis published in 1992 provides a compelling demonstration of 
an evidence-practice gap with regards to the use of thrombolytics as a primary treatment for 
acute myocardial infarction.
12
 Antman and colleagues conducted a comparative study 
contrasting the knowledge of appropriate treatment, as ascertained from the results of meta-
analyses of RCTs, and the recommendations for appropriate treatment, as ascertained from 
expert review papers and textbooks. Their study demonstrated there was a time delay between 
the appearance of convincing evidence from cumulative meta-analyses and routine treatment 
recommendations made by 
experts (see Figure 1).   
Antman et al. undertook 
a review of 182 RCTs, 43 
review articles and 100 
textbook chapters. They 
documented that 
recommendations for the 
routine use of thrombolytics 
first began to appear in expert 
review papers and textbook 
chapters in 1986. This was 13 
years after their cumulative 
meta-analysis of ten RCTs including 2,544 patients demonstrated a significant mortality 
reduction from primary treatment of acute myocardial infarction with thrombolytics. 
Evidence-practice gaps don’t just exist in the form of a time-lag between knowledge 
20 
and action; they can also be documented by studying the proportion of delivered care that is 
consistent with best evidence. For example, in order to determine the proportion of medical 
care provided to citizens of the United States that was consistent with current evidence, 
McGlynn and colleagues conducted a retrospective study that evaluated the delivery of 
medical care processes to 6,712 people.
13
 This study was conducted between October 1998 
and August 2000, and found that only 54.9% (95% CI, 54.3 to 55.5) of delivered care was 
consistent with the best available evidence.  
The study sample was obtained from a list of households that had previously 
participated in the Community Tracking Study conducted by the Centre for Studying Health 
System Change,
14
 which documented insurance coverage, patterns of usage of health care 
services, and health status of a random sample of the American population.  
McGlynn et al. randomly selected households that had participated in the Community 
Tracking Study and obtained consent for additional information to be collected. Written 
consent was obtained from households willing to participate in the study to access medical 
records, and photocopies of these records were obtained for evaluation. Participants were 
asked to complete a telephone interview regarding their health history and to provide details 
of all health care providers (individual or institutional) who they had seen in the last year.  
At least one medical record was obtained for 6,712 (89%) of the 7,528 eligible people 
who volunteered to participate. Analysis was conducted on the delivery of care for 439 
indicators in 30 conditions. An aggregate score was determined by dividing all instances in 
which the participant received recommended care by the number of times the participant was 
eligible for recommended care.  
Overall the study found that the 6,712 participants received only 54.9% (95% CI, 54.3 
to 55.5) of the care episodes that could have been recommended based on best available 
evidence. The highest rate of recommended care delivery was for the conduct of an annual 
21 
medical check-up for patients with hypertension: Seventy-three percent (95% CI, 71.5 to 
75.3) of patients with hypertension did receive annual check-up visits. The lowest rate of 
recommended care delivery was for smoking cessation advice in patients with chronic 
obstructive pulmonary disease: Only 18.3% (95% CI, 16.7 to 20.0) of smokers with chronic 
obstructive pulmonary disease received smoking cessation advice.  
Underuse of care supported by evidence was documented more often than technical 
overuse evidence-practice gaps. Whilst 45% (95% CI, 45.8 to 46.8) of participants were not 
provided with care that was recommended by research evidence, only 11% (95% CI, 10.2 to 
12.4) of participants were provided with care that was deemed to result from overuse of 
recommended care. 
In a similar study conducted in Australia, Runciman and colleagues classified care as 
inappropriate, based on best evidence recommendations, in 43% (95% CI, 39.9 to 45.7) of 
eligible encounters.
15
 
Runcimen et al. based their methodology primarily on the methods used by McGlynn 
et al.,
13
 with some modifications: Participants were recruited from rural and remote areas in 
addition to metropolitan areas, and onsite medical records were reviewed rather than copied 
records.  
The study evaluated the delivery of care for 22 health conditions against indicators of 
appropriate care developed by clinical experts’ review of the evidence. Potential participants 
(15,292) residing in New South Wales or South Australia were contacted via telephone 
numbers randomly chosen from the White Pages telephone directory. The final study sample 
included 1,154 consenting participants.  
Indicators of care were evaluated during 35,573 eligible encounters between study 
participants and their health care providers, with recommended care delivered appropriately 
57% (95% CI, 54.3 to 60.1) of the time. The highest overall compliance was with the delivery 
22 
of surgery for coronary artery disease, with 90% (95% CI, 85.4 to 93.3) of patients deemed to 
be eligible actually receiving surgery. The highest level of overuse was documented with 
regards to antibiotic prescribing, with only 19% (95% CI, 0.1 to 77.3) of prescriptions deemed 
to be clearly consistent with current recommendations for use. 
Overprescribing: an important evidence-practice gap 
 
The over-prescribing of medications provides a good example of an overuse evidence-
practice gap. Often a medication may have proven effect in a specific patient population or to 
treat a specific disease, yet the medication is prescribed to patients with a disease process for 
which the evidence does not document a treatment effect. 
The first major example of overprescribing comes from a study published in 1963.
16
 
Forsyth et al. conducted an observational study assessing prescribing practices amongst 
general practitioners in the United Kingdom. The study demonstrated that only 9.9% of 
prescriptions were written to treat a condition for which objective research showed the drug 
was proven to be effective.  
The study sample was obtained by requesting participation from active general 
practitioners in a small northern industrial town in England, and collecting prescribing 
information on all of their patient consultations. This information included patient 
demographics, location of the contact with the patient, major diagnostic group, estimated 
severity of illness (trivial, acute ordinary, acute serious, chronic ordinary, chronic serious) and 
therapeutic intent of drugs prescribed to one of five grades (specific, probable, possible, 
hopeful, and placebo).  
During the two week study period, there were a total of 9,405 consultations from the 
combined practice populations of an estimated 45,000 people. Sixty-six percent of 
consultations resulted in at least one prescription being written for a patient, with a total of 
9,575 items prescribed. Forty-three percent of the prescriptions were written for generic 
23 
medications whilst 57% of the prescriptions were for drugs protected by a patent (proprietary 
prescriptions). 
In assessing the prescribing patterns, an analysis was performed on the therapeutic 
intent of proprietary prescriptions and generic prescriptions. This analysis demonstrated that 
in proprietary prescriptions, 9.3% (467/5,039) were written for an indication where the drug 
was proven to be effective by research evidence, with similar results for generic prescriptions 
where 10.6% (432/4,055) were written for an indication where the drug was proven to be 
effective by research evidence.  
In 1987, Chassin and colleagues conducted a study that documents that interventional 
procedures can also be overused.
17
 This project focussed on the performance of three specific 
procedures (coronary angiography, carotid endarterectomy and upper gastrointestinal tract 
endoscopy), and reviewed records of physician claims from Medicare insurance carriers 
located in a broad range of states (Arkansas, Colorado, Iowa, Massachusetts, Montana, 
Pennsylvania, South Carolina and Northern California). 
Ninety percent (819/913) of the physicians approached by the investigators 
participated in the study, with these physicians responsible for performing 4,988 study 
procedures.  A random sample of cases for all three procedures was selected in each study site 
directly from Medicare claims data. 
An expert panel judged that 32.4% (95% CI, 29.8 to 34.0) of the randomly selected 
1,302 carotid endarterectomies were deemed to have been performed for an indication that 
was not supported by current research evidence. For coronary angiographies, 17.4% (95% CI, 
15.6 to 19.3) of 1,677 procedures were performed for an indication that was not consistent 
with current research evidence, and for upper gastrointestinal endoscopies, 17.2% (95% CI, 
15.4 to 19.1) of the 1,585 randomly selected procedures were performed for an indication not 
consistent with research evidence.  
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How much medical practice can be based on objective research evidence? 
In 1995 Ellis and colleagues conducted an observational study to document the 
diagnosis and treatment of patients under their care in order to evaluate how much of their 
medical practice was based on research evidence.
18
 They found that 53% (58/109) of their 
patients received care for their primary diagnosis based upon direct evidence from RCTs. 
The clinical investigative team included seven medical practitioners of various skill 
levels: one professor, one senior registrar, two registrars, one senior house officer, two house 
officers and ten medical students. The study population included every inpatient treated by the 
clinical investigative team during the month of April 1995 at the John Radcliffe Hospital, a 
university affiliated teaching hospital in Oxford.  
At the time of death or discharge, or at the end of the month if the patient was still in 
hospital, the investigators met and by consensus decided on the primary diagnosis of the 
patient and the primary intervention that represented the most important attempt to cure, 
alleviate or care for the patient in respect of his or her primary diagnosis. Primary 
interventions were classified into one of three groups: (1) Intervention with evidence from 
RCTs; (2) Intervention with convincing non-experimental evidence or (3) Intervention 
without substantial evidence. Primary interventions that were classified as either category (1) 
or category (2) were deemed to be evidence based.  
A total of 121 patients were cared for by the clinical investigative team during the data 
collection period. A primary diagnosis was not made for 12 patients that were admitted on the 
last day of the study, resulting in a total of 109 patient diagnoses being evaluated in the study 
sample.  
On evaluation, 53% (58/109) of patients received care for their primary diagnosis 
based upon evidence from RCTs (category 1) with an additional 29% (32/109) receiving care 
for their diagnosis based upon other types of research evidence (category 2). Examples of 
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interventions classified as convincing non-experimental evidence were those that investigators 
believed had face validity so high that it would be unethical to conduct an RCT, for example, 
transfusion in massive haemorrhage.  
In 1990, Dubinsky et al. conducted a similar study to assess the percentage of National 
Institutes of Health recommendations for Medicare item coverage that were based on RCTs or 
other objective research evidence.
19
 In the United States, the National Institutes of Health is 
involved in the conduct of assessments of new medical technologies in order to aid in the 
Medicare coverage decision making process. This study reported that only 20.6% (26/126) of 
the National Institutes of Health recommendations were based on RCTs or other objective 
research evidence. 
This study by Dubinsky et al. involved a retrospective review of the National 
Institutes of Health records of new coverage decision assessments over a six year period, 
between 1981 and 1987. Coverage decisions were classified into one of five categories: 1) 
strong positive recommendations based on RCTs or other objective clinical studies; 2) 
positive recommendations based on RCTs or other objective clinical studies; 3) positive 
recommendations based on consensus of expert opinion; 4) negative recommendations based 
on inconclusive or conflicting expert opinion; and 5) negative recommendations based on 
evidence of ineffectiveness or lack of efficacy based on RCTs or other objective clinical 
studies.  
Table 1 (next page) summarises the category of recommendation made and the 
number and percentage in each category. 
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Table 1. Category of evidence supporting National Institute of Health recommendations.   
Category of recommendation 
Number 
(n/N) 
Percentage 
% 
1 – Strong positive based on RCTs or other clinical trials 2/126 1.6 
2 – Positive based on RCTs or other clinical trials 21/126 16.7 
3 – Positive based on consensus or expert opinion 55/126 43.6 
4 – Negative based on inconclusive or conflicting expert opinion 45/126 35.7 
5 – Negative based on RCTs or other clinical trials 3/126 2.4 
 
During the six year study period, the National Institutes of Health generated 126 
recommendations for Medicare item coverage, with 20.6% (26/126) of these 
recommendations based on RCTs or objective clinical studies. A positive recommendation for 
an item to be covered by Medicare was only supported by RCTs or objective clinical studies 
in 29.5% (23/78) of the cases. The remaining 70.5% (55/78) of items that the National 
Institutes of Health recommended be covered by Medicare relied on expert opinion rather 
than scientific evidence.  
Intensive Care Medicine 
The Intensive Care Unit (ICU) is a highly specialised area of the hospital in which the 
most critically ill patients with the highest risk of death are cared for. On average, an ICU 
accounts for ten percent of the total number of patient beds within a hospital, yet caring for 
critically ill patients in the ICU consumes approximately 30% of a hospital’s total budget.2, 3 
Over the past 10 years, the number of RCTs conducted each year in critically ill ICU patient 
populations has increased by more than 50%,
4
 but formal studies consistently show that even 
interventions that have been proven to reduce mortality by these RCTs are underused.
5, 6
  
In Australia and New Zealand, a well known medical specialist interest group for 
Intensive Care Medicine is the Australian and New Zealand Intensive Care Society 
(ANZICS). In addition to involvement in specialist medical education and ICU research 
activities, the society records information about patients admitted to adult and paediatric ICUs 
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within Australia and New Zealand.  The ANZICS Adult Patient Database currently contains 
data from over 1.6 million individual episodes of care contributed from 165 ICUs across 
Australia and New Zealand.  
During 2015, the ANZICS Adult Patient Database reported that 147,060 critically ill 
patients were admitted to an ICU, with 12,367 (8.41%) of these patients dying before hospital 
discharge.
20
  
Costs of Intensive Care  
In 2010 Halpern and colleagues published a paper describing the patterns of use and 
costs of caring for patients in the ICU in the United States.
3
 The burden of caring for critically 
ill patients is significant. The medical care of a critically ill patient in the ICU costs 
approximately three times more than the provision of medical care for a standard hospital 
patient. Furthermore, the costs of ICU care are also rising out of proportion to the costs of 
caring for the standard hospital patient, by an additional seven percent increase every five 
years.   
This study used the data collected by Medicare and Medicaid in the Hospital Cost 
Reporting Information System to evaluate costs from 2000 to 2005. Over the 5 year study 
period, Halpern et al. reported that the overall daily cost of care for a patient in the ICU rose 
from $USD 2,698 to $USD 3,518 per patient per day, a 30.4% increase. Over the same time 
period, the overall daily cost of care for a standard hospital patient rose from $USD 899 to 
$USD 1,153, representing a 22% increase. At the end of the study period in 2005, caring for 
the ICU patient was three times ($USD 3,518/$USD 1,153) more expensive than caring for 
the standard hospital patient. These cost estimates are similar to estimates reported by 
Australian investigators in publications from the same time period.   
Rechner et al. conducted a retrospective review of data from critically ill patients 
admitted to the ICU at The Royal Brisbane and Women’s Hospital.21 This study was 
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conducted using criteria set by the European Society of Intensive Care Medicine Health 
Services Research and Outcome Working Group on Cost Effectiveness. All key costs were 
identified: staff costs, clinical support services, disposables and capital equipment.  
Data was collected over a 12 month period from July 2002 to June 2003.  During this 
time 1,615 critically ill patients were admitted to the ICU, resulting in 5,692 ICU care days. 
The total ICU based expenditure for the study period was $AUD 15,915,964 resulting in an 
average daily cost of care for a critically ill ICU patient of $AUD 2,670. 
Moran et al.
22
 also conducted a study to estimate the cost of caring for critically ill 
ICU patients in Australia. They evaluated data collected in three South Australian adult ICUs 
for a nine month period in 1991. Cost data was collected relating to all management activities 
and interventions including drug administration, procedural supplies, pathology costs, 
radiology costs, physiotherapy costs, nursing staff costs, medical staff costs, overhead costs 
and other residual costs related to operating the ICU. All costs were indexed to 2002 costs, 
which was the year before publication.  
Over the nine month study period, 1,333 critically ill patients were admitted to the 
study ICUs. These patients required 5,198 days of care in the ICU with a total budget of 
$AUD 12,449,210 which translates to an average daily cost of care for a critically ill ICU 
patient of $AUD 2,395.  
Accounting for the difference in exchange rates between the Australian and US dollar 
from 2002 until 2005, the studies by Halpern, Rechner and Moran demonstrate that the costs 
of caring for a critically ill patient in the ICU are remarkably similar in the two countries.  
Research in Intensive Care 
Because critically ill patients face a high risk of death and require costly care, 
undertaking objective research to guide clinical decision making has become a priority. 
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Figure 2. Cumulative distribution of intensive care RCTs indexed on PubMed 
(from Doig et al.
4
).  
 
PubMed was searched using medical subject headings to identify 
randomized controlled trials published in the field of intensive care or critical 
care medicine. A total of 11,630 publications were indexed by PubMed 
between 1971 and 2013 using the above terms. 
In 2015, Doig et al. published a review identifying the number of RCTs conducted in 
critically ill ICU patients that were indexed on PubMed
4
 (see Figure 2). PubMed is the 
National Library of Medicine’s free web search service that provides access to MEDLINE, 
one of the largest databases of citations and abstracts to medical, nursing, dental, veterinary, 
health care, and preclinical sciences journal articles.  
In their review paper, Doig et al. report that over the last 10 year period of their study, 
there were 515 new RCTs published on intensive care topics in 2003, whilst in 2013 there 
were 763 new RCTs published. This rate of growth represents a doubling in the number of 
new publications every 14 years.
4
 
Evidence-practice gaps in Intensive Care  
Many clinical trials published in critically ill ICU patient populations are accepted to 
define landmark and life saving interventions, yet there is clear evidence these interventions 
are under-used. The Acute Respiratory Distress Syndrome Network (ARDSNet) low-tidal-
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volume trial is accepted to be a landmark trial in critically ill ICU patients and also illustrates 
a key evidence-practice gap.
23,24,6
  
The National Institute of Health funded ARDSNet investigators conducted an 861 
patient RCT in the United States.
23
 This study evaluated the benefits of using a novel 
mechanical ventilation strategy (lower tidal volume and restricted plateau pressure) compared 
to traditional mechanical ventilation in patients with Acute Respiratory Distress Syndrome. 
Acute Respiratory Distress Syndrome arises when inflammation in the lung severely reduces 
gas exchange, resulting in life threatening breathing difficulties. The ARDSNet investigators 
reported that mechanical ventilation of patients with Acute Respiratory Distress Syndrome 
using the ARDSNet low-tidal-volume ventilation strategy significantly reduced mortality by 
22% (relative risk reduction, P=0.007).  
The study was conducted over a three year period, from March 1996 to March 1999 at 
ten University Hospitals in the United States. Intubated and mechanically ventilated patients 
were considered for inclusion in the study if they met the traditional diagnosis of Acute 
Respiratory Distress Syndrome: an acute deterioration in oxygenation status as indicated by a 
drop in the ratio of partial pressure of oxygen in the blood to the fraction of inspired oxygen 
being delivered (PaO2:FiO2 ratio) of 300 or less; bilateral pulmonary infiltrates evident on 
chest x-ray; and no clinical evidence of left atrial hypertension (pulmonary capillary wedge 
pressure less than 18 cm of water if measured).  Patients were excluded if it was more than 36 
hours since they first met the three inclusion criteria above.  
Allocation concealment was maintained by using an interactive centralised voice 
system with patients randomly assigned to receive the ARDSNet mechanical ventilation 
strategy or traditional mechanical ventilation. Traditional mechanical ventilation patients 
received ventilation with an initial tidal volume of 12 ml per kilogram predicted (ideal) body 
weight, whereas the ARDSNet low-tidal-volume ventilation patients received an initial tidal 
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volume of 6 ml per kilogram of predicted (ideal) body weight. Furthermore, traditional 
mechanical ventilations patients were allowed a maximum plateau pressure of 50 cm of water 
whilst ARDSNet low-tidal-volume ventilation patients were allowed a maximum plateau 
pressure of 30 cm of water. All other aspects of mechanical ventilation were similar between 
groups. 
Fewer patients who were randomised to receive the ARDSNet low-tidal-volume 
ventilation strategy died compared to patients who received traditional mechanical ventilation 
(171/429 deaths for traditional mechanical ventilation vs. 134/432 deaths for ARDSNet low-
tidal-volume ventilation, P=0.007).  
Furthermore, of the patients who were alive, fewer patients who received ARDSNet 
low-tidal-volume ventilation required a mechanical ventilator by the end of the 28 day study 
follow-up period (284/432 for traditional mechanical ventilation vs. 236/429 for ARDSNet 
low-tidal-volume ventilation, P < 0.001).  In addition, the severity of illness of the patients 
who received ARDSNet low-tidal-volume ventilation was improved, as represented by more 
days alive without non-pulmonary organ failure (12 days for traditional mechanical 
ventilation vs. 15 days for ARDSNet low-tidal-volume ventilation, P=0.006). 
Universal acceptance of the importance of the results of the ARDSNet low-tidal-
volume ventilation trial is illustrated by clinical recommendations incorporated into major 
international clinical guidelines.
25-28
 In 2004, a major international guideline for the 
management of severe sepsis and septic shock in critically ill ICU patients, the Surviving 
Sepsis Campaign Guideline, was published.
25
 This guideline was developed by 68 recognised 
intensive care experts from 30 major international specialist medical organisations from 
around the world including the European Society of Intensive Care Medicine (ESICM), the 
US based Society of Critical Care Medicine (SCCM) and the Australian and New Zealand 
Intensive Care Society (ANZICS). Committee members were selected and organised into sub 
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groups according to their expertise and allocated to an assigned area of the guideline that 
addressed a clearly defined clinical question. Committee chairs developed search terms for 
each subgroup, and groups then completed a comprehensive electronic search of MEDLINE, 
EMBASE and the Cochrane Library database to identify all articles published relevant to their 
clearly defined clinical question. Using the GRADE system,
29
 a methodological approach to 
rating the quality of evidence, an assessment of quality was conducted for the evidence 
supporting clinical recommendations relevant to each clinical question. Recommendations for 
the implementation of interventions were then made based upon the quality assessment 
conducted.  
Use of the ARDSNet low-tidal-volume ventilation strategy received a Grade 1 
recommendation, which is the strongest level of recommendation, for the ventilation of 
critically ill patients with Acute Respiratory Distress Syndrome.  
Since the initial Surviving Sepsis Campaign Guideline development process was 
published in 2004, the guideline has been updated three times, resulting in publications in 
2008, 2013 and 2017.
24-26, 30
 In each update, the recommendations for mechanical ventilation 
in patient with sepsis induced Acute Respiratory Distress Syndrome have remained 
unchanged. The 2017 publication makes a Strong recommendation (equivalent to Grade 1 in 
previous grading system) for the use of ARDSNet low-tidal-volume ventilation strategy (6 
ml/kg) in adult patients with sepsis induced ARDS, and a Strong recommendation for 
maintenance of plateau pressures less than 30 cm of water in patients with sepsis induced 
severe ARDS.
26
  
Despite universal acceptance of the results of the ARDSNet study, and promotion of 
the results in highly respected international guidelines endorsed by numerous national 
societies, a recently conducted major observational study demonstrate an evidence-practice 
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gap exists resulting in underuse of the ARDSNet low-tidal-volume mechanical ventilation 
strategy.
6
  
Published in 2016, a prospective observational study by Bellani et al. measured the 
adherence to the ARDSNet low-tidal-volume ventilation strategy in patients with the Acute 
Respiratory Distress Syndrome.
6
 The study involved the collection of data for all 
mechanically ventilated patients from 50 different countries. Patients were excluded if they 
were less than 16 years old or if there was an inability to obtain informed consent.  
A total of 459 ICUs from 435 different hospitals in 50 countries throughout the world 
participated in the study, with 2,377 eligible patients admitted to these ICUs during the study 
period. Patients were followed up until hospital discharge, or for a maximum of 90 days if the 
patient was not already discharged by day 90. 
A diagnosis of Acute Respiratory Distress Syndrome was made by the study 
investigators using prospectively collected patient data with a computer algorithm designed to 
recognise the presence of the Berlin criteria (see Table 2).
31
  
In the 915 critically ill patients objectively diagnosed with the Acute Respiratory 
Distress Syndrome, 36.3% (332/915) of eligible patients did not receive the ARDSNet low-
tidal-volume ventilation strategy. With such a clear evidence–practice gap around the 
ARDSNet low-tidal-volume trial which is considered a landmark clinical trial, it is not 
surprising that many other evidence-practice gaps also exist in intensive care.
5,6
 
Table 2. Berlin criteria for the diagnosis of Acute Respiratory Distress Syndrome. 
 
 acute hypoxaemic respiratory failure as indicated by a drop in the ratio of 
partial pressure of oxygen in the blood to the fraction of inspired oxygen 
being delivered (PaO2:FiO2 ratio) to 300 or less 
 onset within one week of known clinical insult, or new worsening 
respiratory symptoms 
 bilateral opacities on chest x-ray not explained by effusions, lobar or 
lung collapse or nodules 
 respiratory failure not of cardiac origin or fluid overload 
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Between 2008 and 2011, Guerin et al. recruited critically ill patients from 27 ICUs 
into an RCT to investigate whether the use of prone positioning early in the treatment of 
patients with severe Acute Respiratory Distress Syndrome may reduce deaths.
5
 Traditionally, 
ICU patients who need mechanical ventilation are cared for whilst lying on their backs 
(supine), generally with the head of the bed slightly raised. The concept of proning means the 
mechanically ventilated patient is positioned face down (prone) for up to 16 hours per day and 
then positioned supine for the remainder of the day.  
The study included adults with severe Acute Respiratory Distress Syndrome who were 
intubated via the endotracheal route and receiving mechanical ventilation for less than 36 
hours in total. Severe Acute Respiratory Distress Syndrome was defined as a PaO2:FiO2 ratio 
of less than 150, with a fraction of inspired oxygen (FiO2) of less than 0.6, a positive end 
expiratory pressure equal to 5 cm of water or more, with a tidal volume of about 6 ml per 
kilogram of predicted (ideal) body weight. If a patient met these inclusion criteria, after a 12 
to 24 hour stabilisation period of mechanical ventilation the criteria were re-confirmed, at 
which point patients were then randomised.  
Over a three and a half year period, 3,449 patients presented with Acute Respiratory 
Distress Syndrome to the 26 French ICUs and one Spanish ICU that participated in the study. 
This resulted in 466 patients with severe Acute Respiratory Distress Syndrome being included 
in the study.  
Allocation concealment was maintained by using a web based server to randomise 
patients to the prone position group or the supine group. Patients randomised to the prone 
group were placed in the prone position within one hour of randomisation and remained prone 
for at least 16 consecutive hours. Patients assigned to the supine group were all nursed with 
the head of the bed slightly raised. Mechanical ventilation was standardised in both groups 
through the use of a guideline delivering a low-tidal-volume and plateau pressure limited 
35 
ventilation strategy based upon the ARDSNet protocol.
23
 Patients were followed up until day 
90 with analysis performed on an intention-to-treat basis. 
The primary outcome of the study was mortality at Day 28, with results indicating a 
significantly lower mortality rate in prone patients than in supine patients (16.0% vs. 32.8%, 
P<0.001). This mortality benefit remained significant at Day 90 follow-up (23.6% vs. 41.0%, 
P<0.001).  
The mortality benefit attributable to proning patients with severe Acute Respiratory 
Distress Syndrome demonstrated by Guerin’s 466 patient RCT has been confirmed by two 
systematic reviews and meta-analyses conducted by independent groups of investigators that 
considered the results of seven additional RCTs.
32, 33
 
In 2014, Sud and colleagues published a systematic review and meta-analyses of 
RCTs investigating the use of prone positioning in patients with severe Acute Respiratory 
Distress Syndrome.
32
 The literature search was comprehensive with a search strategy 
designed to retrieve relevant trials from MEDLINE, EMBASE and CENTRAL. In addition, 
bibliographies and conference proceedings were hand searched and clinical trial registries and 
databases were reviewed for any unpublished clinical trials. No language restrictions were 
applied during the search strategy, with details of the full search strategy readily available as 
an appendix to the publication.  
Eligibility criteria were clearly identified. RCTs and quasi-randomised trials that were 
conducted in adults and children with severe Acute Respiratory Distress Syndrome supported 
by mechanical ventilation were included. The primary outcome of interest was mortality with 
secondary outcomes being changes in oxygenation and adverse events.  
The methodological quality and risk of bias in each trial was assessed with full 
reporting of randomisation methods, allocation concealment, blinding methods and 
completeness of follow up after randomisation. These assessments were performed 
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independently by three of the authors with disagreements resolved by consensus. A table 
outlining the full results of the risk of bias assessment was included in the publication. All 
outcomes were analysed using an intention-to-treat approach.  
Sud et al.’s literature search identified 238 potential studies. After screening of 
abstracts and titles, 22 RCTs were retrieved for detailed review, with 11 RCTs recruiting a 
total of 2,341 patients selected for inclusion. The primary analysis in this publication was 
based on clinical trials where low-tidal-volume ventilation was mandated. Within six trials 
including 1,016 patients where low-tidal-volume ventilation was mandated, the use of prone 
positioning compared to supine positioning significantly reduced mortality (RR 0.74, 95% CI 
0.59-0.95, I
2
 = 29%). An a priori subgroup analyses was conducted to assess whether the 
duration of prone positioning sessions had an impact on mortality. This demonstrated that 
prone positioning led to a significant reduction in mortality when the duration of the session 
was at least 16 hours per day (RR 0.77, 95% CI 0.64-0.92, I
2
=21%).  
In the second systematic review and meta-analyses on this topic, also published in 
2014, the investigators also conducted a thorough search to identify RCTs where the use of 
prone positioning was compared to supine positioning in patients with severe Acute 
Respiratory Distress Syndrome receiving mechanical ventilation.
33
 
A computerised literature search was conducted in databases including MEDLINE, 
EMBASE, Lilacs and the Cochrane Central Register of Controlled trials. Specific medical 
subject heading terms designed to identify RCTs where the use of prone positioning was 
compared to supine positioning in adult patients with Acute Respiratory Distress Syndrome 
during conventional mechanical ventilation were chosen. A clear process was applied for the 
selection of studies by two independent reviewers, with a third reviewer utilised to resolve 
disagreements. Data was extracted independently by two authors using a standardised data 
collection form. The primary outcome of mortality was either collected directly from reported 
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data in individual trials, or determined by enhancing Kaplan-Meier plots for estimation of 
time to 60 day mortality. One corresponding author was approached to provide missing data 
for one included trial where a mortality rate could not be determined. An a priori analysis was 
planned to stratify trials by high-tidal-volume ventilation versus low-tidal-volume ventilation.  
The quality of individual trials was evaluated at a study level by considering the 
method employed to maintain allocation concealment, completeness of follow-up, blinding, 
crossover between study arms, post-hoc exclusions and early trial discontinuation.  
The authors obtained 643 citations from their initial search, from which 336 unique 
abstracts were identified. Following the exclusion of 108 review articles, commentaries, meta-
analyses or abstract only papers, 228 abstracts were reviewed with 217 of these excluded for 
reasons such as not being a study of Acute Respiratory Distress Syndrome, not containing 
proning as a study intervention, or the trial design was not randomised. From 11 full text 
articles that were retrieved and reviewed in detail for eligibility seven RCTs that enrolled 
2,119 patients were included in the final meta-analyses. One trial was stratified at 
randomisation depending on severity of Acute Respiratory Distress Syndrome, the authors 
pre-specified that this trial was treated as two separate trials during analysis.  
The quality assessment of the included studies is reported in the publication, with all 
studies adhering to randomisation method using a centralised or sealed envelope process to 
maintain allocation concealment. Follow up for the primary outcome of mortality was 
complete, with only two patients lost to follow up in two separate trials. The patients enrolled 
in the included studies were critically ill, with Simplified Acute Physiology Scores (SAPS II) 
ranging from 37 to 47 with between 40 and 802 patients enrolled in each trial. Changes in 
ventilation practice can be seen within the studies when reviewed chronologically, with tidal 
volumes reducing over time. Earlier trials published prior to the landmark ARDSNet trial 
used tidal-volumes greater than 8 ml per kilogram predicted (ideal) body weight whereas 
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trials published after the ARDSNet study used lower tidal volumes, between 6 to 8 ml per 
kilogram predicted (ideal) body weight.  
The primary meta-analysis of included studies did not demonstrate a significant 
difference in mortality (risk ratio at 60 days 0.83, 95% CI 0.68-1.02; P=0.073) however when 
the a priori  stratified analysis of high versus low-tidal-volume was performed, there was a 
significant mortality benefit with prone positioning when low-tidal-volume ventilation was 
delivered (risk ratio 0.66, 95% CI 0.50-0.86; P=0.002). Heterogeneity amongst trials was 
reduced when stratified according to tidal volume (I
2
=11% for high volume and I
2
=25% for 
low-tidal-volume strata) whereas when all trials were pooled, there was moderate 
heterogeneity (I
2
=64%).  
Despite the cumulative evidence from the primary RCT by Guerin et al. and the two 
meta-analyses outlined above, a recent major observational study demonstrates that many 
patients in the ICU who would benefit from prone positioning do not receive this intervention. 
In addition to assessing use of the ARDSNet low-tidal-volume ventilation in critically ill ICU 
patients with Acute Respiratory Distress Syndrome, the 2016 study published by Bellani and 
colleagues also measured the implementation of prone positioning in patients with severe 
Acute Respiratory Distress Syndrome.
6
  
During the study period, Bellani et al. screened 29,144 admissions to the 459 
participating ICU’s located in 50 different countries. Of these patients, 729 were diagnosed as 
having severe Acute Respiratory Distress Syndrome. Severe Acute Respiratory Distress 
Syndrome was defined as Acute Respiratory Distress Syndrome with a PaO2:FiO2 ratio of 100 
or less. Using this definition, which was much more severe than the definition applied by 
Guerin et al.,
5
 Bellani et al. reported that only 16.3% (119/729) of eligible patients received 
proning. 
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Understanding the use of research evidence in clinical practice  
Across almost all disciplines of medicine, overuse and underuse evidence-practice 
gaps can be documented.
5-7, 12, 13, 15-18
 There are many possible barriers that prevent clinicians 
incorporating the results of research evidence into their clinical practice. Modifiable barriers 
are barriers that can be targeted for change such as pre-existing attitudes, a lack of time to 
read and appraise primary research evidence, levels of knowledge and understanding of 
principles and key aspects of research evidence.
34-36
  
 Attitudes towards using research evidence 
Change management theories consistently highlight that a positive attitude towards a 
new behaviour (e.g. stopping smoking) is an important and necessary first step towards 
adopting that new behaviour.
37, 38
 Clinicians’ attitudes towards research evidence and its use 
to guide their clinical practice have therefore been studied and reported extensively in medical 
literature.
34-36, 39-45
 These studies universally report that clinicians have positive attitudes 
towards using research evidence to guide clinical practice decisions.
34, 35, 39-45
  
In 1998, McColl and colleagues published a landmark study reporting the attitudes of 
general practitioners towards the use of research evidence in clinical practice.
34
 In order to 
achieve the objectives of the study, the authors developed a self-administered mail out 
questionnaire to assess respondents’ attitudes, knowledge, self-reported use and perceived 
barriers to using research evidence to guide their clinical practice.  
Utilising a National Database of general practitioners, a random sample of 25% 
(452/1,808) of the general practitioners listed in the Wessex region of England was selected 
with computer based random number generation. Only practising general practitioners were 
eligible for inclusion. After the initial invitation to participate, at least two consecutive follow 
up reminders were sent.   
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The questionnaire was mailed out to 450 practising general practitioners. In total, 302 
completed questionnaires were returned resulting in a response rate of 67% (302/450).  
Respondents were asked to indicate their level of agreement using a visual analogue 
scale with responses ranging from 0 (strongly disagree) to 100 (strongly agree) with the 
statement practising evidence based medicine improved patient care. From the 293 general 
practitioners responding to this question, the median score reported was 70 (25
th
 to 75
th
 
percentile; 57 to 80). However when asked to provide an estimated percentage of 
respondent's clinical practice that is evidence based using a visual analogue scale with 
responses ranging from 0% to 100%, the median response was 50% (25
th
 to 75
th
 percentile;  
31% to 62%).  
In 1999, McAlister et al. published a similar paper describing the attitudes of 
Canadian general internists towards research evidence and barriers they face in using research 
evidence.
39
 
The authors developed their study instrument based upon other published 
questionnaires
46-48
 and undertook pilot testing with their intended population to ensure face 
validity. The questionnaire was mailed out to all members of the sampling frame, with two 
follow up mail outs to non-responders.  
The sampling frame for the study was listed physician members of the Canadian 
Society of Internal Medicine. Only members currently involved in active patient care and 
residing in Canada were eligible for inclusion. 
The questionnaire was returned by 56.8% (296/521) of the physicians selected in the 
study sample. Characteristics of responders were compared to general characteristics of all 
members of the Canadian Society of Internal Medicine, with no major differences found.  
Respondents were split into two groups according to the levels of self-reported use of 
research evidence, with those who reported often or always using research evidence being 
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labelled evidence-users and those who reported sometimes, rarely or never being labelled as 
evidence non-users. According to this definition, 70.1% (206/294) of the respondents who 
answered the question how often do you employ EBM in your clinical practice were classified 
evidence-users and 29.9% (88/294) of respondents were evidence non-users.  
Attitudes towards research evidence and barriers to using research evidence were 
collected using five-point Likert scales, with response options specific to individual questions. 
When asked to indicate their level of agreement with the statement EBM helps clinical 
decision making, 90% (186/206) of evidence-users selected agree or strongly agree as 
compared to 76% (67/294) of evidence non-users (P<0.01). Evidence-users were also more 
likely to agree or strongly agree that EBM improves patient outcomes as compared to 
evidence non-users (62% vs. 42%, P<0.01).  
Young and colleagues reported on the attitudes and knowledge of Australian general 
practitioners towards research evidence and the barriers faced in using research evidence to 
guide clinical practice.
35
 Based on the questions of McColl et al.
34
 a self-administered 
questionnaire was developed for use in this study. Face-to-face interviews were also 
conducted to provide additional qualitative data. A convenience sample of 60 general 
practitioners was asked to complete the study questionnaire, with a response rate of 100% 
(60/60).  
When asked to indicate on a visual analogue scale their own attitude towards EBM, on 
a scale of “0” representing extremely cynical to “100” representing extremely positive the 
median score reported was 75. Yet when asked to indicate how they would describe their 
colleagues’ attitudes towards EBM on the same scale, a median score of 50 was reported. In 
response to the question, the day to day management of patients EBM appears to be useful to 
respondents, where the score “0” represented completely useless and “100” represented 
extremely useful, a median score of 70 was reported. When asked to indicate how much of 
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their practice is based on research evidence respondents reported 70% of their practice to be 
based on research evidence.  
Askew and colleagues conducted a study in order to describe attitudes towards 
research among Queensland general practitioners.
40
 They designed a questionnaire mail out 
survey based upon the instruments developed and published by McColl et al. and Young et 
al., with additional questions developed by themselves.
34,35
 
The survey sample was obtained from the registration lists of general practitioners 
practicing in four out of the 20 Queensland Divisions of General Practice. The survey package 
was mailed out to 656 general practitioners with two follow up reminders sent in an attempt to 
maximise response rates. Responses were received from 75% (492/656) of the sample 
population.  
Respondents were asked to indicate their agreement with several attitude statements 
concerning research evidence, with 70% (325/465) agreeing that practising evidence-based 
medicine improves patient care. When asked if research is useful in day-to-day management 
of patients, 84% (389/463) of those who answered this question were in agreement.  
However, despite positive attitudes towards research, clinical expertise was valued 
over research evidence for clinical decision making: 78% (363/464) of respondents agreed 
with the statement that they prefer clinical experience to research evidence when making 
clinical decisions.  
In 2006 Sur and colleagues published a web-based survey, supported by the American 
Urology Association, that explored the attitudes of members of the American Urological 
Association towards research evidence and to document barriers faced in using research 
evidence in practice.
43
 They developed a survey instrument based upon the widely utilised 
survey of McColl and colleagues.
34
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Sur et al. obtained their study sampling frame by contacting all American Urological 
Association members with a listed e-mail address. These members were invited to participate 
in the web-based survey that was open for four weeks for completion. Follow up reminder e-
mails were not sent, however the e-mail invitation did include a cover letter from the Chair of 
the American Urological Association to provide legitimacy for the study. The study was pilot 
tested in print format and then revised to suit a web-based format.  
The sampling frame included 9,319 American Urological Association members who 
were e-mailed the study invitation, 724 responses were received resulting in a response rate of 
7.8% (724/9,319). Characteristics of respondents were compared to characteristics of all 
members of the American Urological Association with no major differences reported.  
The participants responding to the survey reported strong positive attitudes towards 
research evidence. When asked to rank their level of agreement using a visual analogue scale 
from one (completely disagree) to ten (completely agree) a median score of nine was given to 
the statement EBM improves patient care and a median score of eight was given to the 
statement Surgical outcomes are improved by applying EBM. When asked to rank their own 
use of research evidence, there was a higher self-reported level of use with a median score of 
eight given to the statements all your medical decisions incorporate EBM and all your 
surgical therapy decisions incorporate EBM whereas a median score of five was given to the 
statement all urologists in your community utilise EBM.  
Following on from the web-based survey published in 2006 by Sur et al.,
43
 Dahm et 
al. conducted a second study through the American Urology Association Office of Education 
to identify needs for future planning of educational activities surrounding the use of research 
evidence.
44
 This second survey was based on the initial instrument used in the 2006 project 
published by Sur et al., with additional new questions also developed.  
44 
The study sample was obtained by selecting a random sample of 2,000 Urologists 
from the sampling frame of 7,000 American Urological Association members recorded as 
practising in the United States. All participants were mailed a copy of the survey with a pre-
addressed coded envelope to enable tracking of responses. Strategies were employed to 
maximise response rates including follow up e-mail reminders and re-sending of survey 
packages to non-responders. Anonymity of respondents was maintained with responses de-
identified at entry into the study database. A response rate of 44.5% (889/2,000) was achieved 
for this study. Attitudes to research evidence were generally positive amongst the American 
Urology Association members responding to this survey.  
Through the use of a visual analogue scale respondents indicated their level of 
agreement on a scale from one (completely disagree) to ten (completely agree) with a series of 
statements. With a median score of nine, respondents agreed with the statement the use of 
current best evidence guidelines improves the quality of health care and with a median score 
of eight, respondents agreed with the statement practicing EBM improves patient care. The 
statement most of your surgical decisions incorporate EBM also received a median score of 
nine, whilst a median score of eight was given to the statement most of your medical therapy 
decisions incorporate EBM. Agreement with the statement that all urologists in your 
community utilise EBM was low, with a median score of four. 
Surgeons also report positive attitudes towards the use of research evidence to support 
clinical decisions. In 2007 Kitto et al.  published the results of a study that investigated the 
attitudes of Australian surgeons towards the use of research evidence in practice.
41
  
A self-administered mail out questionnaire was developed, and the sampling frame for 
the study was the current list of practicing surgeons within Southern Health in the Victorian 
Metropolitan Health Service. All 50 listed surgeons were sent the questionnaire, with a 
response rate of 50% (25/50).  
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Surgeons were asked to rate their agreement with various statements regarding 
research evidence use. Their responses were captured using a five-point Likert scale, where 
one represented strongly agree and five represented strongly disagree. A mean score below 
2.5 therefore indicated agreement whereas a score above 2.5 indicated disagreement. The 
respondents indicated disagreement with the negative statements, EBM is a form of ‘cook-
book’ medicine and EBM is a fad, registering means scores of 3.0 and 3.1 respectively. 
Surgeons indicated agreement with the positive statement EBM is mainly concerned with 
patient outcomes, with a mean score of 1.9 (SD 0.70).  
Positive attitudes may not correlate with appropriate use behaviours 
The attitudes of Dutch Orthopaedic Surgeons towards research evidence and use of 
research evidence were reported in a paper published by Poolman et al. in 2007.
42
 The authors 
developed a Dutch language questionnaire utilising the instrument developed by McColl and 
colleagues.
34
 Their questionnaire was pre-tested and validated with adjustments made 
following each set of testing.  
The study involved a direct mail out to all listed members of the Dutch Orthopaedic 
Association. Potential respondents were assured their responses would remain confidential 
and anonymous. Response rates were maximised through promotion at Association meetings, 
provision of a pre-paid coded return envelope and repeat mail outs to non-responders.  
Sixty percent (367/611) of the surgeons who were sent the study package returned 
their questionnaire. Characteristics of respondents were compared to a random sample of non-
responding members of the Dutch Orthopaedic Association, with no major differences noted. 
Attitudes towards research evidence were positive amongst the respondents. When 
asked to indicate on a visual analogue scale with scores ranging from zero (strongly disagree) 
to 100 (strongly agree), their level of agreement with the statement practicing evidence-based 
medicine improves patient care scored 75 (25
th
 to 75
th
 percentile, 63 to 84). When 
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respondents were asked to indicate how useful are research findings in your day to day 
management of patients on a visual analogue scale from 0 (extremely useless) to 100 
(extremely useful), a median score of 74 (25
th
 to 75
th
 percentile, 65 to 83) was reported.  
Despite positive attitudes toward improving patient care and usefulness, proportional 
use of research evidence rated lower: When asked to indicate what percentage of your daily 
practice is evidence based on a visual analogue scale from zero to 100%, the median score 
was 52% (25
th
 to 75
th
 percentile, 33%-67%). 
In 2009, De Vito and colleagues conducted a landmark study that also investigated 
this concept of ‘proportional use’.45 These authors investigated knowledge, attitudes and 
appropriate use of RCTs and meta-analyses by Italian physicians. In order to achieve this 
objective, they developed and evaluated a metric of appropriate use that was defined as 
reading and using the results of RCT's and meta-analyses in clinical practice at least 
sometimes. 
The authors developed a self-administered mail out survey to be sent to a group of 
randomly selected Italian physicians, with repeat mail outs and telephone calls to non-
responders. Potential participants were assured that all replies would be anonymous.   
The study sample was obtained through the use of registration lists from the Board of 
Physicians in two regions of Italy, which included a total of 47,137 physicians. Only currently 
practising physicians were eligible for inclusion in the study.   
The survey was pilot tested and revised to ensure it was practical, valid and easily 
interpretable. The authors conducted a sample size calculation to ensure adequate power was 
achieved and serial mail-outs were conducted. 
The survey was mailed out to 933 Italian physicians, with 654 responses giving an 
overall response rate of 70.1% (654/933). The authors addressed the issue of potential bias 
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through identification and comparison of characteristics of responders to non-responders, with 
no differences reported.  
Italian physicians responding to this survey demonstrated positive attitudes towards 
using research evidence to guide clinical decision making, with 58.9% (364/618) agreeing 
that the application of results of RCTs and meta-analyses improve the health status of 
patients. Whilst 62.9% (390/620) of respondents agreed that meta-analysis is a useful tool to 
help physicians to select effective health interventions, 61.1% (379/620) of respondents 
agreed with the statement many decisions in clinical practice cannot be based on the results 
of RCTs and meta-analysis but rather on the individual patient needs.  
Despite generally positive attitudes towards the use of research evidence to guide 
clinical practice decisions, only 32.1% (95% CI, 28.5 to 35.6) of 654 respondents could be 
classified as appropriate users, defined as reading and using the results of RCT's and meta-
analyses in their clinical practice at least sometimes.  
 Attitudes and use amongst intensive care clinicians 
An extensive search of MEDLINE and EMBASE failed to yield any studies that had 
investigated attitudes of intensive care clinicians towards the use of research evidence to 
support clinical decision making. 
 Attitudes towards specific types of research evidence 
The RCT is considered the most scientifically rigorous and objective type of primary 
experimental research design and is held up as the gold standard for comparing the relative 
benefits of competing health care interventions.
49
 Clinicians appear to have a higher level of 
trust in RCTs and often regard them to be more useful than other types of research 
evidence.
35, 36, 44
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In a 2004 publication outlining a survey investigating the attitudes of Swiss surgeons 
towards the use of research evidence in clinical practice, the RCT was found to be trusted 
above all other types of evidence resources.
36
  
The questionnaire instrument utilised in the study was designed by the authors, with 
pre-testing conducted prior to administration. Small gifts were offered as an incentive to 
encourage participation. The sampling frame for the study was all participants attending the 
76
th
 and 77
th
 Annual Arbeitsgemeinschaft für Osteosynthesefragen course in Davos 
Switzerland.  
The survey was delivered to 1,064 attendees at the course, with a response rate of 50. 
Respondents were predominantly male (84%) with a mean age of 44 years. Fifteen percent of 
respondents reported having completed research training in evidence based medicine.  
Using a 5-point Likert scale with response options definitely trust, probably trust, not 
sure, probably not trust and definitely not trust, participants were asked to rate various 
evidence sources. The highest level of trust reported by respondents was with RCTs, with 
90% of respondents reporting definitely or probably trust, compared to meta-analyses of 
randomised controlled trials where 81% reported definitely or probably trust.  
In a survey of Australian general practitioners conducted in 2001, Young and 
colleagues also reported that respondents found original research articles more useful than all 
other evidence resources.
35
  
In Young et al.’s questionnaire, based upon the work of McColl et al.,34 60 
participating general practitioners were provided a list of nine evidence resources and asked to 
rate how useful they found them by selecting from the response options: very useful, 
somewhat useful, not at all useful, or don’t know. The most highly rated resource was original 
research articles published in peer-reviewed journals, with 90% of the 60 responding general 
practitioners rating this resource as very or somewhat useful. Evidence based clinical practice 
49 
guidelines were rated as very or somewhat useful by 87% of respondents, followed by 
journals that summarise recent important research evidence which, was rated as very or 
somewhat useful by 79% of respondents. The lowest rated resource was systematic reviews or 
meta-analyses, such as the Cochrane library with just 48% of respondents rating this resource 
as very or somewhat useful.  
Dahm et al.’s 2009 survey of members of the American Urological Association also 
reported that the most trusted evidence resource amongst respondents was the RCT.
44
 
Respondents were presented with a list of seven evidence resources and asked to rank 
their trust in each using a five point Likert scale, with responses ranging from definitely not 
trust to definitely trust. From the 889 responding urologists, 97% reported that they probably 
or definitely trust RCTs and 85% of respondents also reporting that they probably or definitely 
trust meta-analyses of RCTs. The case report was the least trusted with 17% of respondents 
selecting probably or definitely trust in response to the question concerning this item.  
 Time to read and learn as a barrier 
Clinicians report challenges with regards to keeping up to date when faced by the 
exponentially increasing volume of medical literature, with time to read and learn one the 
most frequently cited barriers to the incorporation of research evidence into clinical 
practice.
34, 35, 40
 A report published by the United States (US) Institute of Medicine highlights 
the overwhelming volume of primary research clinicians are faced with reading in order to 
keep up to date with advances in medicine.
50
 
The authors of the report conducted a search of PubMed for articles indexed in 
MEDLINE during each year from 1970 to 2010. In 1970, approximately 200,000 peer-
reviewed journal publications were indexed. By the year 2010 the same search resulted in 
approximately 750,000 peer-reviewed publications, demonstrating the number of biomedical 
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Figure 3. Number of journal articles published on health care topics per 
year from 1970 to 2010 (from US Institute of Medicine
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). 
 
 
 
 
and clinical research studies being published each year has nearly quadrupled over the last 40 
years (see Figure 3).
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In 1998 McColl and colleagues completed their influential survey of general 
practitioner’s attitudes towards research evidence.34 Their survey was completed by 302 
practicing general practitioners in the Wessex region of England. The investigators included a 
free-text section for respondents to answer the question “what do you think are the major 
barriers to practising EBM in general practice?” One investigator was responsible for 
reviewing the responses which were then coded and grouped according to themes. The item 
response rate to this question was 80% (242/306), with respondents able to indicate more than 
one barrier in their answer.  
Lack of personal time was the most highly cited barrier with 71% of 242 respondents 
indicating this was a major barrier to incorporating the results of research evidence into their 
practice. The next most frequently reported responses were: personal and organisational 
inertia with 14%; attitudes of colleagues with 12%; patients’ expectations with 10% and; lack 
of hard evidence with 8% (20/242).  
In 2001, when Young and colleagues repeated McColl et al.’s34 study in Australia, 
amongst the 60 general practitioners who completed their survey, three of the five most highly 
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ranked barriers to using research evidence in general practice were related to aspects of 
time.
35
 I do not have time to read and appraise research articles was selected as a very 
important barrier by 40% (24/56) of respondents, whilst only 18% (11/56) of respondents 
indicated this was not a barrier. Twenty-eight percent (17/56) of respondents ranked I do not 
have the time to search for evidence as a very important barrier and 25% (15/56) indicated 
that having the time to discuss the implications of available evidence to patients during 
routing consultations was also a very important barrier. 
Time was also reported as a barrier in a study published by Askew and colleagues in 
2002.
40
 The study involved a survey of 492 Queensland general practitioners, which was 
followed up with semi-qualitative interviews to explore barriers to research use with a 
convenience sample of 18 general practitioners selected from the original sample of 492. The 
interviews were transcribed verbatim, with data analysed using qualitative data analysis 
software to identify recurrent patterns and themes. Time as a barrier was noted as a recurring 
theme from the interviews. When prompted to speak of issues related to the use of research 
evidence in their clinical practice, general practitioners spoke of “a major negative and it’s 
tied in with time.” The general practitioners described a “lack of remuneration for anything 
that does not involve patient contact, meaning that reading and incorporating research into 
the day becomes something of a luxury that can not be afforded.”  
Responses from Dutch orthopaedic surgeons suggest that whilst time is a concern for 
some, there is a wide variation in how time pressure is felt. Published in 2007, Poolman and 
colleagues surveyed 367 members of the Dutch orthopaedic association.
42
 Respondents were 
asked to rate on a visual analogue scale (with zero representing strongly disagree and 100 
representing strongly agree) a number of statements regarding evidence use. When asked to 
rate the statement the adoption of EBM, however worthwhile as an ideal, places another 
demand on already overloaded orthopaedic surgeons respondents recorded a median score of 
52 
53 (25
th
 to 75
th
 percentile, 31 to 73). However, with a range in rankings from zero to 100, it 
was apparent that the responding surgeons had widely different opinions regarding this 
statement. 
In a study of Australian and New Zealand radiation oncologists and registrars, from 
the 191 participants who responded to the survey, almost half (49.7%) of the respondents 
reported that the whole medical information explosion is overwhelming.
51
 Doctors with less 
clinical experience were more likely to select this response, with significantly more registrars 
than radiation oncologists agreeing with this statement (62.2% vs 44.9%; 2 = 5.19, P=0.02).  
Interestingly, some groups of doctors do not rank time pressure as a major concern. 
Kito et al.’s 2007 survey of practicing surgeons from Southern Health in Victoria did not find 
time pressure to be an important barrier to using research to guide their clinical decision 
making.
41
 Using a Likert scale graduated from a score of one indicating very important to five 
indicating not very important, respondents ranked a number of potential barriers. For the 
statement I do not have the time to read and appraise, the mean score reported was 3.7 given 
for primary articles, 4.0 for systematic reviews, and 4.0 for clinical practice guidelines. For 
the statement I do not have time to search for resource studies the mean score reported was 
3.5 for primary articles, 3.5 for systematic reviews, and 3.6 for clinical practice guidelines. 
All of the above mean responses to questions related to time pressure barriers higher than the 
Likert scale’s neutral score of 2.5, thus each item response tends towards the not important 
side of the scale. 
Technical knowledge as a barrier 
A lack of knowledge with regards to the technical issues surrounding the conduct and 
appraisal of research evidence has been proposed as a barrier to the appropriate use of 
research evidence in clinical practice. Technical knowledge amongst clinicians has been 
measured within numerous surveys on research use, with extremely variable results.
34-36, 42
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McColl et al.’s 1998 study of general practitioners included a section to determine the 
levels of knowledge amongst the survey participants.
34
 The 302 general practitioners 
responding to this section were asked to indicate their own level of understanding of ten 
technical terms and rate them using the following scale: understand and could explain, some 
understanding, don’t understand but would like to, or it would not be helpful for me to 
understand.  
The highest level of understanding was reported for the term number needed to treat 
with 35% (102/288) of those who answered this question indicating they understand and 
could explain to others. The lowest score was achieved for the term odds ratio with only 11% 
(31/289) indicating that they understand and could explain to others. 
In Young and colleagues 2001 survey of Australian general practitioners,  respondents 
were presented with 14 technical terms.
35
 They were asked to indicate their level of 
understanding of these terms using the same scale used by McColl et al:
34
 I could understand 
and explain to others, I already have some understanding, I don’t understand but would like 
to, and would not be helpful for me to understand.
34
 The term ‘randomised controlled trial’ 
was the most understood, with 38% (23/60) indicating they understand and could explain to 
others and 42% (25/60) indicating they have some understanding of the term. With regards to 
the lowest rated terms ‘systematic review’ and ‘meta-analysis’, only 18% (11/57) of 
respondents reported they understand and could explain to others the term ‘systematic 
review’ and 15% (9/57) of respondents reported they understand and could explain to others 
the term ‘meta-analysis’.  
In Hanson et al.’s 2004 survey of Swiss surgeons, the investigators also measured 
respondents’ level of knowledge of key principles in critical appraisal.36 In this study, whilst 
respondents were able to correctly identify simple technical terms, they were less able to 
correctly identify more complex concepts.  
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Using a five point Likert scale with response options definitely acceptable, probably 
acceptable, not sure, probably not acceptable and definitely not acceptable, participants were 
asked to indicate their understanding of technical issues related to randomisation, allocation 
concealment and blinding. Ninety-five percent (505/532) of respondents were able to 
correctly identify (definitely or probably acceptable) appropriate methods of randomisation 
such as the use of a computerised randomisation schedule or a random numbers table. They 
were also able to correctly identify inappropriate methods of randomisation, with patient 
preference rated as definitely or probably acceptable by only four percent (21/532) of 
respondents.  
When questioned on technical aspects of allocation concealment, respondents were 
able to correctly identify that the use of opaque envelopes containing the next treatment 
allocation is an acceptable method, with 79% (421/532) selecting definitely or probably 
acceptable. However, respondents were not able to correctly identify inappropriate methods 
of allocation concealment. Forty-nine percent (252/532) of respondents incorrectly believed 
that it was acceptable (definitely or probably) or were unsure if it was acceptable to disclose 
the full randomisation schedule and treatment allocation of the next patient before the patient 
was enrolled and consented.  Awareness of other methods of reducing bias in research was 
low, with 21% (114/532) of respondents indicating they had never heard of the term 
‘blinding’. 
In Poolman et al.’s 2007 study involving 367 Dutch orthopaedic surgeons, knowledge 
regarding ten methodological terms was also assessed using the rating scale of McColl et al.
34, 
42
 In this study, the highest rating for understanding was reported for the term ‘systematic 
review’, with 92.8% (333/359) of respondents indicating that they either understand and 
could explain to others or had some understanding. The term with the lowest level of 
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understanding was ‘odds ratio’, with 60.7% (218/359) of respondents indicating that they 
either understand and could explain to others or had some understanding. 
De Vito et al. also attempted to assess knowledge in their 2009 study of Italian 
physicians.
45
 In this study, knowledge was tested with a series of true or false statements 
about RCTs and meta-analyses, with responses collected using three-point Likert scales 
providing the options agree, uncertain or disagree. 
 For the true statement meta-analyses combines the results of different individual 
studies with the purpose of integrating the findings, 71.4% (442/619) of the respondents 
agreed and correctly identified the statement as true. With regards to a more complex true 
statement regarding relative risk and odds ratios (relative risk and odds ratio are measures 
used in RCTs and meta-analyses to quantify the effect of health interventions), 50.8% 
(307/604) of respondents agreed and correctly identified the statement as true. 
Reducing evidence-practice gaps  
Many strategies and interventions have been proposed for reducing the gap between 
medical knowledge and medical practice. Interventions range from formal theoretical 
frameworks that introduce complexity by proposing hierarchies of research evidence,
52-57
 to 
the use of simple summary tools that reduce complexity through the efficient and explicit 
presentation of research evidence.
58
 Other initiatives have resulted in the development of 
unique informatics resources such as the Cochrane Library,
59
 and the production of focussed 
reminder tools, such as pocket cards and posters.
60
 Unfortunately, a recent Cochrane review 
highlights a problem in this area, with their conclusion that the “low quality of the studies in 
this area provides insufficient evidence to determine with certainty which interventions are 
most effective” at closing evidence-practice gaps.61   
The purpose of this section is to provide an overview of key strategies and 
interventions that are often used in clinical medicine. 
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 Hierarchies of evidence 
Various hierarchies of evidence have been proposed by different authoritative bodies 
as a strategy to improve evidence uptake and reduce evidence-practice gaps. A hierarchy of 
evidence ranks different sources of knowledge from most reliable to least reliable and thus 
aids clinicians by encouraging them to make effective use of the best available research 
evidence. Unfortunately there is no one universally accepted hierarchy of evidence.  
Whilst most hierarchies rank systematic reviews of RCTs at the top as the ‘most 
reliable information source, some theoretical frameworks propose that electronic repositories 
of simple evidence summaries should rank even higher than primary research publications.
52-57
  
The Oxford Centre for Evidence Based Medicine 2011 Levels of Evidence document provides 
a hierarchy for best evidence available to clinicians when answering clinical questions.
53
 For 
example, to address the clinical question “does this intervention help patients?”, the 2011 
Levels of Evidence document ranks systematic reviews of RCTs at the top (Level 1), followed 
by four subsequent levels: Level 2) RCTs or observational studies with strong effects; Level 
3) non-randomized controlled cohorts / follow-up studies; Level 4) case-series or case-control 
studies or historically controlled studies and; Level 5) mechanism-based reasoning 
Within Australia, the NHMRC Evidence Hierarchy also classifies systematic reviews 
of RCTs as Level I evidence, however the five subsequent levels of evidence differ from the 
Oxford approach.
52
 The NHMRC defined subsequent levels of evidence are: Level II) an 
RCT; Level III-1) a pseudo-randomised controlled trial; Level III-2) a comparative study with 
concurrent controls; Level III-3) a comparative study with historical controls and; Level IV) a 
case series with either post-test or pre-test/post-test outcomes.   
In 2001 Haynes et al. published the 4S hierarchical model.
54
 With time constraints 
consistently reported by clinicians as a barrier to using research evidence uptake,
34, 35, 40
 
Haynes et al.’s model placed electronic repositories of evidence summaries (e.g. the Database 
57 
Figure 4. The 4S evidence hierarchy (from Haynes et al.
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). 
 
of Abstracts of Reviews of Effects) towards the top of the hierarchy (See Figure 4). 
Interestingly, the 4S hierarchy places original publications of RCTs at the bottom of the 
hierarchy. 
 
   
 
Haynes et al. have updated and extended the 4S model three times, in 2006, 2009, and 
in 2016, with the final update renaming the framework the Evidence Based Healthcare 
Pyramid 5.0.
55-57
 The theoretical framework was modified during these three updates to 
include emerging evidence resources and to more clearly explain the importance of evidence-
summary documents. The purpose of an evidence summary document is to overcome time-
related barriers to the use of primary research studies by presenting key aspects of a 
systematic review in a much briefer format. Each update by Haynes et al. has seen evidence 
summary document resources consistently placed above systematic reviews and RCTs in the 
evidence hierarchy. Interestingly, there have been no formal evaluations of the impact this 
theoretical construct has on evidence-practice gaps.  
 Systematic Reviews and Meta-analyses 
The systematic review is a summary tool that provides clinicians with an objective 
appraisal and assessment of a series of related primary research studies on a focussed clinical 
topic.
49
 In contrast to a traditional narrative review, the systematic review utilises rigorous, 
58 
systematic, and transparent methods to minimize bias in its conclusions.
54-56
 Meta-analysis is 
a statistical procedure for mathematically combining the estimates of treatment effect 
obtained from the individual clinical trials included in a systematic review.
49
 
The conduct of a systematic review requires a significant amount of time and resources 
to identify, retrieve, appraise and integrate all published studies on a focussed clinical 
question.
62
 Systematic reviews are advantageous to the time pressured clinician as they 
provide a pre-appraised summary of the best available evidence on a topic.
56,63
 
The systematic review evolved in the 1970s to become a more formal method of 
summarising the results of clinical trials.
64,65
 Recognising the potential importance of the well 
conducted systematic review, a group of health care researchers from Oxford came together to 
develop a uniform set of methods for conducting systematic reviews. Eventually calling 
themselves The Cochrane Group, this early initiative “to promote evidence-informed health 
decision-making by producing high-quality, relevant, accessible systematic reviews and other 
synthesized research evidence” has met with great success.66 The Cochrane Database 
currently contains over 7,000 systematic reviews with access provided to clinicians via 
government subscriptions in many countries.
67
 
Despite the proposed time saving advantages of systematic reviews and meta-analyses, 
clinicians consistently rank them below RCTs as a preferred evidence source.
34, 35, 39, 45
  
McColl et al.’s 1998 survey of general practitioners questioned participants on their 
awareness and use of various evidence based resources. When asked to indicate whether they 
used the Cochrane Database of Systematic Reviews, 60% (169/284) of the respondents were 
unaware of the Cochrane Database and only 4% (11/284) reported that they actually use 
Cochrane Reviews to help in clinical decision making.
34
 Similarly, in 2001 Young and 
colleagues reported that only 15% (9/60) of Australian general practitioners rated Cochrane 
Library systematic reviews or meta-analyses as very useful.
35
 McAlister et al.’s 1999 survey 
59 
of physician members of the Canadian Society of Internal Medicine produced similar results, 
with only 5% (15/294) of respondents reporting that they frequently used Cochrane 
Collaboration Reviews as an information source. In this survey, clinical experience and the 
opinion of colleagues were both used as an information source more frequently than Cochrane 
Reviews.
39
  
Published in 2006, Sur et al. asked members of the American Urological Association 
about their awareness of various evidence resources.
43
 Of the 700 Urologists who completed 
their survey, 54% reported that they were unaware of the Cochrane Database of Systematic 
Reviews, with only 7% (49/700) of respondents reporting that they used Cochrane reviews 
regularly in their decision making process. In a follow up study published by Dahm et al. in 
2009, American Urology Association members reported a similarly low awareness of the 
Cochrane Database of Systematic Reviews, with 76% (676/889) of respondents reporting they 
were unaware of its existence, whilst just 8% (71/889) reported they had ever used it.
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Similar levels of awareness and frequency of use are reported in a survey of Danish 
doctors published in 2004.
68
 In this study conducted in a Copenhagen hospital, the Cochrane 
Library was the least frequently used information resource, with 49% (90/183) of respondents 
stating they had never used it and just 9.3% (17/183) reporting frequent use. Traditional 
information resources including textbooks and colleagues were the most frequently used, with 
67% (143/213) of respondents reporting using textbooks frequently and 65% (135/208) 
reporting using colleagues’ advice frequently. These patterns of use are similar to the results 
reported by studies conducted in Australia and New Zealand. 
In 2003, Veness et al. published the results of a survey of radiation oncologists 
practicing in Australian and New Zealand.
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  When asked to describe their familiarity with the 
Cochrane Library, 18% of the 189 respondents reported they were unaware of its existence. A 
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further 52.4% (100/189) reported were aware of it but did not use it, whilst 8.4% (16/189) 
reported that they used it to help in clinical decision making.
51
  
 Clinical Practice Guidelines  
An extremely ambitious and forward thinking initiative to improve health care practice 
by disseminating knowledge has arisen from a contractual relationship formed by the US 
government’s Agency for Healthcare Research and Quality with the US Institute of Medicine. 
After a thorough study of the problems arising due to the exponential growth in the number of 
original research papers published each year in the field of medicine, the Institute of Medicine 
formally recognised the fundamental importance of “critically appraised and synthesized 
scientific evidence” resources.69 Furthermore, they acknowledged that as a medium for the 
promotion of “critically appraised and synthesized scientific evidence” rigorously developed 
clinical practice guidelines “have the power to translate the complexity of scientific research 
findings into recommendations for clinical practice and potentially enhance health care 
quality and outcomes. However, the current state of Clinical Practice Guideline (CPG) 
development has yet to meet this potential.”69 In order to capture defining characteristics that 
will allow clinical practice guidelines to achieve their full potential for practice change, the 
Institute of Medicine developed and promoted a new definition: “Clinical practice guidelines 
are statements that include recommendations intended to optimize patient care that are 
informed by a systematic review of evidence and an assessment of the benefits and harms of 
alternative care options.”69 
Rigorously developed clinical practice guidelines systematically review and grade the 
primary research evidence on a topic and then provide expert recommendations for 
implementation in clinical practice to aid clinicians in determining how and when to use the 
evidence.
69
 Clinical practice guidelines are advocated as a strategy to improve the quality and 
consistency of care provided by closing evidence-practice gaps.
70
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 Do guidelines guide practice? 
Dating back to 1977, multiple clinical practice guidelines have promoted treatment 
recommendations for the management of hypertension based on the results of numerous 
clinical trials.
71-73,74
 The Joint National Committee on Prevention, Detection, Evaluation, and 
Treatment of High Blood Pressure has published eight updates to their original guideline, with 
the most recent update published in 2014.
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The 2014 Joint National Committee guideline was developed by 48 panel members 
with expertise in hypertension, primary care, cardiology, clinical trials, research methodology 
and guideline development and implementation selected from over 400 volunteers who self-
nominated for participation. A literature search was conducted to identify RCTs focusing on 
adults aged 18 years or over with hypertension and included studies with the following pre-
specified subgroups: diabetes, coronary artery disease, peripheral artery disease, heart failure, 
previous stroke, chronic kidney disease (CKD), proteinuria, older adults, men and women, 
racial and ethnic groups, and smokers. Studies that included less than 100 persons or did not 
have a follow up period of at least one year were excluded from the review. The search was 
conducted in PubMed and CINAHL, with the full search strategy included in a supplementary 
document to the primary publication. An external methodology team reviewed the quality of 
included trials and summarised data into evidence tables. The panel was then responsible for 
developing clinical recommendations and grading the strength of each recommendation upon 
the quality of research evidence presented. 
A Strong - Grade A recommendation was made for the use of pharmacological 
treatment in adults aged 60 years who have a systolic blood pressure of 150 mmHg or higher, 
or diastolic blood pressure of 90 mmHg or higher to achieve a target goal of a systolic blood 
pressure lower than 150 mmHg or a goal of a diastolic blood pressure lower than 90 mmHg. 
A Strong – Grade A recommendation is the highest level of recommendation according to the 
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grading system used in the guideline, and indicates that there is high certainty based on 
research evidence that the net benefit is substantial.
75
 
Despite incorporation of similar recommendations for similar treatment thresholds and 
treatment targets in multiple major international guidelines, a recent report from the US 
highlights an evidence-practice gap resulting from underuse of these recommendations for the 
treatment of hypertension.
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 Utilising data from the most recent National Health and Nutrition 
Examination Survey, the American Heart Association estimated that 32.6% of adults in the 
US have hypertension. Of those patients with documented hypertension, 23.5% did not 
receive any treatment for their blood pressure, whilst 45.9% of treated patients did not achieve 
appropriate treatment targets for their systolic or diastolic blood pressures.  
In 1994 Grilli and colleagues published a review of 23 individual studies documenting 
evidence-practice gaps in 143 guideline-based clinical recommendations.
77
 They found a 
relationship between the complexity of a guideline and the adherence to recommendations 
within the guidelines, with evidence-practice gaps significantly higher with more complex 
guidelines.   
Grilli et al. conducted a literature search to identify papers published in the English 
language between 1980 and 1991. Studies that reported evidence-practice gaps in clinical 
practice guidelines developed by official medical professional organisations, task forces or 
government agencies were eligible for inclusion. The search was conducted in the MEDLINE 
database, with reference lists of relevant reviews and bibliographies also searched and 
personal contacts utilised. 
Evidence-practice gaps were measured by assessing adherence to guideline 
recommendations. Adherence was defined as either the proportion of physicians acting 
according to the recommendations in the guideline, or the proportion of patients treated 
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according to the recommendations in the guideline. Adherence to guideline recommendations 
from individual studies were extracted according to these definitions.  
The investigators assessed three pre-determined characteristics that they believed 
influenced the uptake of clinical recommendations made by clinical practice guidelines: 
complexity; trialability; and observability. Complexity referred to whether a practitioner with 
usual training and skills, working in an average setting: a) perceived it to be difficult to learn 
or understand the clinical intervention; or b) had no control over the resources required for 
implementation. Trialability referred to whether a practitioner with usual training and skills, 
working in an average setting, was able to experiment with the clinical intervention. 
Observability referred to whether a practitioner with usual training and skills, working in an 
average setting, was able to obtain timely feedback on any impact of the intervention on 
patients' outcomes. Recommendations within the guidelines in the included studies were 
classified independently by the investigators as high or low for each of these three pre-
determined categories.   
The literature search resulted in the identification of 47 potential studies that 
investigated adherence to guideline recommendations. Twenty-three guideline studies met the 
full inclusion criteria. These studies contained 143 individual recommendations for practice 
that addressed 70 different aspects of medical care. Adherence to recommendations within the 
guidelines in the included studies was assessed using chart audit data for 54% (77/143) of the 
recommendations, with a further 37% (53/143) assessed based on physician self-reporting, 
and 9% (13/143) assessed using administrative data. Adherence to guideline 
recommendations in the included studies was measured for a mean time interval of 2.9 years 
(range 1 to 9 years).  
Overall, major evidence-practice gaps existed for all the treatment recommendations, 
with 54.5% (95% CI, 50.2 to 58.9) of treatments delivered consistent with the guideline 
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recommendations. The magnitude of evidence-practice gaps differed by clinical area 
(P<0.001), with guideline compliant treatment highest in cardiac (63.6%) and cancer patients’ 
management (62.5%), and lowest in preventative care (46.2%), dental care (45.8%) and 
obstetrics and gynaecology (43.3%).  
An analysis of the classification of clinical recommendations according to the pre-
determined characteristics of complexity, trialability and observability demonstrated that there 
was significantly lower compliance (P=0.05) with recommendations that were highly complex 
(41.9%) compared to those that were judged to have low complexity (55.9%). There was also 
a significantly higher (P=0.03) compliance with recommendations that were judged to have 
high (easy) trialability (55.6%) compared to recommendations that had low trialability 
(36.8%). High versus low observability of the recommendation did not, however, demonstrate 
any significant difference in compliance rate (54.6% versus 52.4%). 
These findings of overall compliance rates reported by Grilli et al. are similar to the 
results obtained by Sur et al. in their 2006 survey of the American Urological Association 
members.
43
 Although 98.9% of the 710 members who responded to the survey reported they 
were aware of the American Urology Association Best Practice Guidelines, just 45% 
(320/710) reported they used the guidelines regularly in their decision making process.  
 Clinician confidence in clinical practice guidelines 
Despite clinical practice guidelines being tailored to meet clinicians’ needs for 
critically appraised and synthesized scientific evidence, some clinicians may not have 
confidence in clinical practice guidelines.
41, 43
  
In 2007 Kitto et al.
41
 asked Australian surgeons to rate their confidence in various 
sources of information using a five-point Likert scale, where one represented very confident 
and five represented not very confident. The most highly rated source was your own 
judgement with a mean score of 1.9 (SD 0.6), followed by information contained in 
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bibliographic databases with a mean score of 2.0 (SD 1.0) and textbooks with a mean score of 
2.1 (SD 0.5). In total, nine sources of evidence were rated. Of all nine sources, surgeons 
reported the least confidence in clinical practice guidelines, with a mean score of 3.2 (SD 
4.0).  
 Methods for improving clinical practice guidelines 
The ongoing existence of evidence-practice gaps has been identified as an issue in 
health care by organisations such as the National Institute of Clinical Studies in Australia.
11
 
Despite the promotion of clinical practice guidelines as a way to reduce evidence-practice 
gaps their success remains inconsistent. As such, there has been a notable increase over the 
last decade in the volume of research into methods to improve evidence uptake and close 
evidence-practice gaps.  
Simple reminders 
In 2003, Daucourt and colleagues published the results of a study investigating simple 
methods for supporting adherence to clinical practice guidelines for thyroid function testing.
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These methods included the use of an educational ordering form and the use of educational 
pocket reminder cards. 
The study was conducted in the region of Aquitaine in South-West France and 
included six hospitals who volunteered to participate. The hospitals included four general 
medical/surgical hospitals and two psychiatric hospitals, which ranged in size from 90 beds to 
904 beds.  
In preparation for the conduct of the study, the hospital’s quality committee, a regional 
working group and a national review group collaborated to develop National clinical practice 
guidelines for thyroid function tests in adults. The study design was a two-by-two factorial 
cluster RCT. Prior to randomisation, hospitals were matched according to size and activity 
with two small hospitals matched (171 beds and 90 beds), two medium sized hospitals 
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matched (535 beds and 494 beds) and two psychiatric hospitals matched (904 beds and 541 
beds). Within each pair, one hospital was then randomised using a random number table to 
receive an educational ordering form vs. control. Following this initial randomisation at the 
hospital level, wards within each hospital were then matched into pairs according to rates of 
thyroid function test ordering observed during a pilot study period. Within each pair, one 
ward was then randomly allocated using a random number table to receive educational pocket 
cards vs. control. 
At the end of the randomisation process, the authors reported the trial results in four 
distinct groups: 1) a dual intervention group who received the educational thyroid function 
test ordering form and the educational pocket card; 2) an ordering form intervention group; 3) 
a pocket card intervention group and; 4) a control group receiving neither intervention.  
The characteristics of the four groups differed significantly following randomisation. 
There was a higher proportion of women in the pocket card intervention group (73%) 
compared to the other groups (65% in dual intervention group; 63% in the ordering form 
intervention group; and 61% in the control group, P<0.01).  
Guideline conformity rate was calculated by evaluating the indication for ordering of 
each test against the recommendations in the guideline. An indication was not given for 3.7% 
(52/1,412) of tests in the study. Overall guideline conformity was 73.9% (1,005/1,360). When 
compared to the control group, the ordering form intervention group was the only group to 
demonstrate a significantly higher (P<0.0001) level of guideline conformity, with 82.6% 
(280/339) of tests ordered in accordance with recommendations compared to 62.0% (222/358) 
of tests ordered in accordance with recommendations from the guidelines in the control group. 
The results of this study demonstrate success with the use of an order form that acts as an 
educational reminder to improve adherence to recommendations within guidelines.   
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Printed guideline summary 
A 2014 Canadian publication outlines the development of a dissemination strategy to 
support national diabetes clinical practice guidelines and investigate whether their 
dissemination strategy led to improved patient outcomes.
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The study was conducted in Ontario Canada and involved a mailed dissemination to 
general practitioners of the 1998 update of the Canadian Diabetes Association national 
clinical practice guidelines for diabetes. A targeted cardiovascular disease educational toolkit 
was developed to support the guideline dissemination. The toolkit contained printed 
educational materials including a summary of sections of the guidelines relevant to general 
practitioners; a four page outline of the key elements in the guideline addressing 
cardiovascular risk; a small laminated cardiovascular disease risk assessment pocket card; and 
a patient information leaflet with a risk self-assessment tool and list of risk reduction 
strategies.  
The study was a pragmatic randomised controlled trial, with randomisation of the 
intervention at the level of the physician’s practice location. Using a computer generated 
randomisation sequence all general practitioners practicing in Ontario were randomised 
according to their practice location, therefore ensuring all physicians practicing at a single 
location would be allocated to the same group. The intervention group were mailed the 
updated guidelines and the cardiovascular disease educational toolkit in June 2009, while the 
control arm only received the guidelines at this time.  
The first part of the study involved the assessment of population based administrative 
data from the Ontario Ministry for Health recorded from July 2009 and April 2010 to measure 
rates of death and non-fatal myocardial infarction. All residents of Ontario aged 40 years and 
over who were diagnosed with diabetes as of July 1
st
 2009 were identified and grouped 
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according to which group their general practitioner had been randomised to. If they did not 
have a nominated general practitioner they were excluded.  
The final study population included 933,789 patients with diabetes living in Ontario. 
A total of 4,007 family practice locations were randomised into the study, however the total 
number of general practitioners involved is unclear. The baseline characteristics of both 
patients and practices were similar in both groups. According to data retrieved from the 
Ontario Diabetes Database, 2.5% (11,736/467,713) of patients cared for by physicians who 
received the intervention died or experienced a non-fatal myocardial infarction during the 
study period. The control group death and non-fatal myocardial infarction rate was also 2.5% 
(11,536/466,076) demonstrating that the intervention had no effect on these patient oriented 
outcomes.  
A second sub-study involved the collection of patient data from a group of randomly 
selected practices to assess the implementation of strategies aimed at cardiovascular risk 
reduction. Practices were selected from the primary intervention and control groups who 
received the initial guideline mail out, with 373 intervention practices approached and 395 
control practices approached. One physician per practice was randomly selected and 
contacted to request participation in the study. Participation was voluntary, with a total of 40 
physicians from each group included in the final sample. Records of a random selection of 20 
diabetic patients cared for by each physician during the study period were examined to collect 
data on treatments initiated by the physician targeted at cardiovascular risk reduction as per 
recommendations from the guidelines. There was no significant difference in the primary 
outcome of prescribing rates of statin medications in the intervention and control groups. 
Unexpectedly the patients in the intervention group were significantly less likely (P=0.04)  to 
achieve clinical practice guideline recommended blood pressure control targets, with 52.8% 
(420/795) of patients achieving a blood pressure less than the 130/80 mmHg compared to 
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63.5% (506/797) in the control group. There were no other significant differences in the rates 
of other clinical interventions initiated at the physician level.  
This large population based study failed to find any benefit from the use of printed 
educational summary materials to improve guideline adherence.  
Academic detailing 
An early study demonstrating the benefits of academic detailing was conducted by 
Avorn and colleagues in 1983.
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 The term academic detailing is used to describe an 
educational intervention provided by a peer, one-on-one and face-to-face. In this study, 
academic detailing was provided to the physician-participants in their practice office by a 
clinical pharmacist. The pharmacists reviewed the printed guideline materials with the 
physician, outlined the research evidence supporting the treatment recommendations and 
presented clinical cases to generate discussion surrounding the physician’s own clinical 
experiences. 
The study was a randomised controlled trial conducted over a three year period. The 
investigators selected three drugs that they targeted their intervention towards. Medicaid 
prescribing records from 1979 were used to identify the study sample. Reimbursed 
prescriptions for the three target drugs in the areas of Arkansas, New Hampshire, Vermont 
and the District of Columbia were identified. From 5,555 prescriptions written in 1979 in the 
four study states, physicians who had written 20 or more prescriptions per year from each of 
two drug groups, or 30 or more prescriptions per year from any one group, were included in 
the study sample. This resulted in a sample of 435 physicians.  
A randomised block method was used to allocate physicians to study groups. 
Physicians were initially divided into 12 blocks, balanced with equal numbers of physicians 
from each state in each block. Physicians in each block were then randomly allocated to one 
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of three groups; 1) a control no-intervention group; 2) a printed material intervention group 
and; 3) an academic detailing intervention group.  
The prescribing patterns of the control group were recorded; however they were not 
exposed to any form of intervention. This provided a baseline of usual prescribing patterns 
during the study period for comparison. The printed material intervention group were 
separated into two subgroups. The first subgroup received in the mail a series of plain 
educational materials modelled upon a US Federal Drug Administration (FDA) drug bulletin. 
Three separate drug bulletins were mailed twice over a period of four months. The second 
subgroup received the same information that was contained in the drug bulletin presented in a 
series of six colourful visually appealing documents. The third study group was provided with 
face-to-face academic detailing in addition to printed education materials.  
Medicaid data from January 1980 to December 1981 was used for the purpose of 
analysis in the study. There was a 4.6% loss to follow-up reported in the study, with 20 of the 
original 435 members of the study sample not included in the final analysis due to physician 
death, retirement and moving out of state.  
The academic detailing intervention resulted in a significantly greater reduction in 
overprescribing compared with the other groups. Physicians in the academic detailing group 
prescribed an average of 782 less prescriptions per physician than those in the control group 
(P=0.001).This represents an absolute reduction in overprescribing of 15.2% compared to the 
control group. 
Compared to the control group there was no significant difference in prescribing 
practices in the printed material group.  
Opinion Leaders 
In 2003, Berner et al. published the results of a study evaluating local opinion leaders 
in a standard quality improvement audit and feedback model. They found the formal 
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identification and inclusion of local opinion leaders improved adherence to treatment 
recommendations made in an unstable angina management clinical practice guideline.
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 An 
opinion leader is a local peer who is judged to be educationally influential.  
The study was an RCT with hospitals assigned to one of three groups: 1) no 
intervention; 2) standard quality improvement model utilising audit and feedback or; 3) a 
local opinion leader driven intervention in addition to the standard quality improvement 
model utilising audit and feedback. It is unclear what process or sequence was used for 
randomisation, or whether allocation concealment was maintained.  
A panel of experts selected five major quality indicators for measurement in the study 
from a national evidence based guideline for the care of unstable angina. The indicators 
included: the performance of an electrocardiogram within 20 minutes of arrival; receipt of 
aspirin or other antiplatelet therapy within 24 hours of admission; receipt of aspirin or other 
antiplatelet therapy at discharge; receipt of heparin during hospitalisation for patients at 
moderate to high risk for acute myocardial infarction or death and, receipt of beta-blockers 
during hospitalisation.  
Only hospitals in Alabama with at least 100 or more patients whose medical records 
were classified with discharge diagnostic codes for ‘unstable angina’, ‘angina pectoris’, 
‘coronary artery disease’ or ‘chest pain unspecified’ were eligible to participate in the study. 
From a total of 50 hospitals that met the eligibility criteria and were invited to participate, 22 
hospitals agreed to be involved in the study. Medicare records for 1,076 patients were 
reviewed to obtain compliance rates with the five quality indicators during a designated 
baseline period. Following implementation of the study interventions, medical records were 
again reviewed to obtain compliance rates with the five quality indicators during a designated 
follow-up period.   
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In the hospitals randomised to the opinion leader intervention group, opinion leaders 
were identified and chosen through a peer nomination and selection process. All family 
practitioners, general internists, cardiologists and emergency physicians were sent a letter 
explaining the study and a peer nomination form asking them to identify potential education 
leaders relative to unstable angina. The opinion leaders with the most votes were selected and 
sent a recruitment letter. From eight identified and nominated opinion leaders, one withdrew 
following orientation and the other seven agreed to participate.  
To support the quality improvement initiative, participating hospitals nominated an 
assigned quality improvement co-ordinator or project administrative contact to attend a half 
day orientation to the trial. This session provided a review of the unstable angina guidelines 
and presentation of blinded hospital-specific baseline compliance rates. Benchmarks of care 
were presented along with unblended feedback for their own hospital. In the opinion leader 
group hospitals, the opinion leader also attended these orientation sessions.  
Opinion leaders were provided with additional education on the role of the opinion 
leader and a presentation of strategies that may be used to improve quality improvement 
activities including academic detailing, audit and feedback, standing orders, chart reminders 
and education. Educational materials were also provided including powerpoint slides, 
guideline indicator definitions, baseline feedback data and copies of the unstable angina 
guidelines.  
Hospitals selected which of the five indicators they wished to target and then they 
were required to develop a quality improvement programme for their site which identified 
their targeted indicators.  
The delivery of antiplatelet medication within 24 hours of arrival was the only 
measure in which compliance rates were significantly changed post intervention (opinion 
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leader group 20.2% increase in compliance vs. standard quality improvement group 3.9% 
reduction in compliance; P=0.016).  
There were no significant differences in any of the other four quality of care indicators 
among the hospitals.  
In 1991 Lomas and colleagues published the findings from a study in which they 
sought to compare the effects of local opinion leaders vs. standard audit and feedback on 
compliance with a clinical practice guideline for the management of women who have had a 
previous caesarean section.
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 They also found an improvement in compliance attributable to 
the use of local opinion leaders.  
The study was conducted over a 24 month period from 1988 to 1989 in Ontario, 
Canada and followed up on the dissemination of a national clinical practice guideline. The 
clinical practice guideline was produced and disseminated in 1986 in collaboration with the 
Society of Obstetricians and Gynaecologists of Canada. The guideline contained clear 
statements addressing the high rates of repeat caesarean section for women who had a 
previous caesarean section. Recommendations for trial of labour with the intention of vaginal 
delivery for women with no absolute indication for repeat caesarean section (e.g. placenta 
previa) were made in the guideline.
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Hospitals recruited for potential participation in the study were community hospitals 
of at least 100 beds that did not have status as a teaching hospital, with a total of 51 hospitals 
in 24 counties being eligible. A random process was used to select 16 different counties and 
then one hospital was randomly selected from each of these 16 counties, all of whom agreed 
to participate. The 16 hospitals were randomly allocated to one of three study groups with; 1) 
eight hospitals in the guideline-only control group; 2) four hospitals in the guideline plus 
audit and feedback group and; 3) four hospitals in the guideline plus educationally influential 
opinion leader group.  
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All physicians practising in obstetrical care at the hospitals in the control group 
received only a mailed copy of the practice guideline in January 1988. Following the mail out, 
no further intervention was made.  
All physicians practising in obstetrical care at the hospitals in the audit and feedback 
group received a mailed copy of the practice guideline plus audit and feedback. This involved 
conducting medical audits of the charts of all women with a previous caesarean section to 
determine actual practice and holding quarterly departmental meetings to conduct feedback 
and discussion of the audit results.  
The opinion leader education group received a mailed copy of the practice guideline 
plus the opinion leader education intervention. A previously validated questionnaire
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 was 
utilised to identify one potential opinion leader in each participating hospital. Identified 
opinion leaders were provided with training in a one and a half day workshop on the evidence 
supporting the clinical practice guideline and principles of practice change. A package was 
then sent out to all physicians practising in obstetrical care at the hospitals in the opinion 
leader education group, mailed under the opinion leaders name, with a cover letter, 
information binder with a visually appealing shortened version of the guideline, a full copy of 
the guideline, bibliography of relevant studies and letters of support for the practice guideline 
and the study.  
The primary outcome studied was the physicians’ rates for trial of labour and vaginal 
birth over the 24 month study period. A total of 3,552 women were identified as having had a 
previous caesarean section in the study hospitals: 1,781 in control hospitals; 781 in audit and 
feedback hospitals and; 1,053 in opinion leader hospitals.  
There were significantly higher rates of all outcomes in the opinion leader education 
group when compared to the control and audit and feedback groups. The rate of trial of labour 
was significantly higher (P=0.002) in the opinion leader education group at 38.2% (282/739) 
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compared to 28.3% (349/1,233) in the audit and feedback group and 21.4% (112/524) in the 
control group. The rate of vaginal birth after caesarean section was also significantly higher 
(P=0.003) in the opinion leader education group at 25.3% (187/739) compared to 14.5% 
(179/1,233) in the audit and feedback group and 11.8% (62/524) in the control group. 
In 1998 Soumerai and colleagues reported the results of a study demonstrating that an 
opinion leader education and feedback intervention could significantly improve adherence to 
recommendations from the national American College of Cardiology/American Heart 
Association guidelines for the management of patients with acute myocardial infarction.
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The study was conducted in the state of Minnesota. From 45 eligible hospitals 
approached, 37 community hospitals agreed to participate. The study was a cluster RCT with 
randomisation occurring at the hospital level. There were 20 hospitals randomised to the 
intervention group and 17 hospitals randomised to the control group.  
Baseline data on the use of study drugs was collected in all 37 hospitals from October 
1
st
 1992 to July 31
st
 1993 with randomisation occurring on August 1
st
 1994. Potential study 
participants were identified from those patients with suspected acute myocardial infarction on 
hospital presentation. Patients were excluded if they died before admission, were transferred 
from a non-study hospital or had suffered an acute myocardial infarction in the two weeks 
prior to the study. Eligibility for study drugs was assessed in all included patients according to 
pre-specified criteria developed based upon the guidelines.  
Two years prior to the commencement of the study, the guidelines that were utilised in 
the study were disseminated through a mail out to hospital administration, medical directors, 
and directors of quality management and nursing at all Minnesota hospitals, as well as to 
cardiologists and general physicians’ offices.  
In the control hospitals, in addition to the previous mail out of the guideline, the 17 
hospitals were sent an audit report that summarised rates of study drug use in eligible patients 
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for each hospital involved in the study to allow them to compare their own rates of guideline 
adherence to other hospitals. No other intervention was provided.  
In the opinion leader experimental hospitals, the first phase of the intervention was the 
identification of opinion leaders. A previously validated opinion leader identification 
instrument was mailed out to 772 physicians identified as being responsible for prescribing 
cardiac medications in study patients at baseline, with a 35.8% (294/772) response rate. In 17 
out of the 20 hospitals, the first ranked opinion leaders received over 70% of votes at their 
hospital. The opinion leaders were invited to attend a one day meeting that promoted 
consensus and commitment to practice change according to the guideline recommendations. 
At these meetings, common barriers to change were identified and education on interventions 
to overcome these barriers was discussed. Feedback on current rates of adherence to the 
guidelines was provided in a report and opinion leaders also received educational tools for use 
in the participating hospitals.  
Within their participating hospital, opinion leaders implemented educational 
interventions, including formal lectures and informal educational sessions, with colleagues. 
Opinion leaders were also encouraged to revise protocols, clinical pathways and standing 
orders in their participating hospitals.  
There were no significant differences in the baseline characteristics of study groups, 
including no significant differences between the baseline rates of use of study drugs. The 
opinion leader intervention significantly increased the rate of aspirin use in elderly patients 
compared to the control intervention, where there was a reduction in the rate of aspirin use 
(17% vs. -4%, P=0.04).  The opinion leader experimental intervention also significantly 
increased the rate of beta-blocker use in all acute myocardial infarction patients compared to 
the control intervention (63% vs. 30%, P=0.02). There was no impact on the rates of use for 
thrombolytics or lignocaine. 
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Majumdar and colleagues reported a small 171 patient study where the use of local 
opinion leaders was not found to have a significant effect on the translation of evidence from 
a clinical practice guideline to outpatient patient care.
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The study was conducted in patients with known cardiovascular disease residing in 
Alberta and evaluated whether a local opinion leader endorsed one page evidence summary 
mailed to general physicians could improve prescribing practices of angiotensin-converting 
enzyme inhibitors and angiotensin receptor blockers for patients with heart failure, and 3-
hydorxy-3-methylglutaryl coenzyme-A-reductase inhibitors (statins) for patients with 
ischaemic heart disease.  
The study was a cluster RCT, with randomisation completed at the general physician 
(not individual patient) level using a computer generated randomisation sequence. All patients 
enrolled in the trial were then evaluated as intervention or control according to the group that 
their treating physician was randomised to. 
Opinion leaders were identified through the use of a previously validated instrument 
that was mailed to all 788 regional general physicians in the Alberta region.
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 There was a 
30% (236/788) response rate to this mail-out, with five physicians ‘consistently nominated’ as 
opinion leaders by the respondents. 
The intervention provided by the opinion leaders was a condition specific one page 
evidence summary generated in the form of a letter addressed to the general physician which 
identified the patient, their diagnosis (heart failure or ischaemic heart disease), briefly 
described the key evidence supporting the study medications and was signed by all five 
opinion leaders. This was faxed to the physician with the patients’ most recent medication 
profile. The control intervention group received a faxed copy only of the patients’ most recent 
medication profile.  
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Pharmacies in the Alberta region (n=244) were contacted and asked to participate in 
the study, with recruitment stopped once the sample size target of 40 pharmacies was reached. 
Patients were identified through the dispensing records of participating pharmacies, with 
patients with a prescription for specific medications used to treat cardiovascular disease (loop 
diuretics for heart disease and short acting nitrates for ischaemic heart disease) approached for 
consent to use their medical records.  
During the study period from January 2002 to June 2005, a total of 2,897 patients 
were screened for eligibility, with 171 patients identified with heart failure or ischaemic heart 
disease who were not currently receiving the study medications prior to study start selected 
for inclusion. There was no loss to follow-up and all analyses were conducted on an intention 
to treat basis. Despite small improvements in the rates of prescribing cardiovascular 
medications within six months of study period, the results were not statistically significant in 
this small sample of 171 patients. 
Targeted educational interventions 
The authors of a small 88 patient study published in 2002 demonstrated that a case 
based learning programme for general practitioners resulted in improved adherence to clinical 
practice guideline recommendations for treatment recommendations with lipid lowering 
therapy.
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The study was a cluster RCT involving 14 primary health care centres in Södertälje, 
Sweden. Each health care centre was matched with a second health care centre, taking into 
account patient and physician location, numbers, relationships, and the socioeconomic status 
of the patient populations. Within each matched pair, one centre was randomised to 
intervention or control groups. The resulting two groups contained 26 and 28 general 
practitioners, with an equal sex and age distribution. 
79 
Patients with a diagnosis of coronary artery disease who had visited the department of 
medicine at Södertälje Hospital in the year preceding the study were identified from the 
patient registry of Stockholm City Council and invited to participate. Patients were analysed 
in the control or intervention group according to which group their primary general 
practitioners health care centre was already randomised to.  
 The case based learning programme intervention involved the presentation of three to 
four seminars during the study year, conducted as an educational session with the presentation 
of a case scenario followed by an interactive discussion to problem solve. The session was 
only delivered to general practitioners in the intervention group and was facilitated by a local 
cardiologist.  
The control group received no further intervention other than the initial distribution 
and presentation of the practice guideline. 
A total of 88 patients were enrolled into the study, 43 in the control group and 45 in 
the study intervention group.  
The main study outcome was the measurement of low density lipoprotein cholesterol 
levels in study patients. In the intervention group, low density lipoprotein cholesterol levels 
were significantly lower (P<0.05) after two year follow up than in the control group (3.7 
mmol/L vs. 4.1 mmol/L).   
Succinct and concise evidence summary documents  
Clinicians consistently report underuse of detailed systematic reviews to support 
clinical practice decisions.
34-36, 44
 A succinct and concise evidence summary attempts to 
overcome time pressure related barriers to the use of systematic reviews by presenting key 
aspects of a systematic review in a much briefer format.
58, 87-89
  
In 2013 Perrier et al.
58
 published a paper outlining the structured process undertaken 
by their group to develop a shortened systematic review format that resulted in a succinct and 
80 
concise evidence summary tool. They describe a development process that included four 
phases: 1) selection of a systematic review and creation of initial prototypes; 2) a formal 
mapping exercise to identify barriers to practice change and formally link each barrier with a 
unique characteristic of the evidence summary tool; 3) an expert evaluation of usability of the 
tool and 4) a clinical content review.  
In the first phase of the development of their evidence summary tool, the investigators 
selected a published systematic review relevant to primary care that would serve as a useful 
template example to condense. The chosen publication was a systematic review of rosacea 
(adult acne) treatments published in 2007 by van Zuuen et al.
90
  The evidence summary tool 
was limited to a double-sided page in length with a focus on usability, usefulness and 
accessibility.  
During the mapping exercise conducted in phase two of the development process, 
barriers faced by clinicians when seeking research evidence to answer clinical questions were 
identified. Explicit design features were incorporated into the summary tool in an attempt to 
address each barrier. A total of 59 barriers were identified and grouped into five main 
domains; 1) obstacles related to recognising an information need; 2) obstacles related to 
formulating the question; 3) obstacles related to seeking information; 4) obstacles related to 
formulating the answer; and 5) obstacles related to using the answer to direct patient care.
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These 59 barriers were reviewed and reduced to 23 obstacles the researchers believed an 
evidence summary tool could overcome (See Table 3) 
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Table 3 Intrinsic obstacles to be overcome by an evidence summary tool. 
Obstacles reported by clinicians when using evidence summary resources 
Key aspect of topic not included in a resource that should logically include it  
      (Ex. Drug dosing not reported). 
Resource poorly organized. 
Resource not clinically oriented. 
Resource not authoritative or not trusted. 
Resource not current. 
Information incorrect. 
Information not current. 
Failure to define important terms. 
Vague or tangential information included. 
Unnecessarily cautious writing style. 
Tertiary care approach to primary care problem. 
Biased information due to conflicts of interest. 
Failure to address the actual clinical question. 
Failure to report the comparison of interest. 
Failure to report the outcome of interest. 
 Failure to report the population of interest. 
Evidence based on flawed methods. 
Failure to cite or include key relevant evidence. 
Failure to directly or completely answer the question. 
Answer directed at the wrong audience. 
Difficulty addressing unrecognised information needs apparent in the question. 
Answer not trusted. 
Answer inadequate. 
 
An inspection of the shortened systematic review format was conducted with mapping 
of specific strategies used in the tool to address each of the 23 intrinsic obstacles. For example 
the item resource poorly organised was addressed by using a table format to present 
information, with headings used within the table to organise and emphasise key information. 
The item resource not current was addressed through reporting of the date that the tool was 
created and the dates of any literature searches conducted. The item answer not trusted was 
addressed through the inclusion of the full citation of the original systematic review in the 
masthead of the document so that the user could make a judgement as to their belief in the 
trustworthiness of the source. The mapping exercise highlighted five items that were not 
addressed in the shortened review format which prompted the inclusion of additional 
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strategies to address each. For example the item failure to define important terms was not 
addressed, so the Authors included appropriate definitions of key terms (e.g. odds ratio etc).   
In stage three of the development process the authors engaged an external expert, with 
experience in research and human factors technology, to conduct a usability inspection of the 
tool. The evaluation identified no major usability issues, however moderate usability issues 
identified included wording that was potentially confusing to readers, placement of 
information that was inconsistent, or omissions that were potentially confusing. Minor issues 
including small font size and layout were also identified.  
The final stage of the development process was a clinical content review. The clinical 
content review was conducted by a family physician that identified small errors in the 
presentation of the case-based tool. Each phase of the development process stimulated 
alterations to the two evidence summary tool formats, with modifications made accordingly to 
result in the final prototypes.  
Following on from their publication in 2013 that outlined the development of their two 
evidence summary tool formats, in 2014 Perrier et al. conducted two rounds of focus groups 
with physicians to gain feedback on the presentation, layout, design and content of the two 
tools in order to determine the optimal format of the final design.
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The study involved family physicians recruited through attendance at formally 
planned educational events conducted by the Office of Continuing Education and Professional 
Development at the University of Toronto, or by referral from participants already enrolled. 
Participants were sent a recruitment e-mail prior to attendance at events, or recruited directly 
during attendance at events. Written informed consent was obtained from participants, and 
confidentiality was maintained during reporting of focus group feedback. Participants were 
incited to participate with the offer of lunch and an honorarium fee.  
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Three major themes were identified from the first round of focus groups; ease of use, 
clarity and implementation. Issues raised by participants that related to ease of use included: 
wanting to see information presented in a more intuitive manner, flagging important 
information for the reader through use of highlighting or bold text, and clearly identifying 
when no information was available. Participants identified that clarity could be improved by 
modifying the layout and content of the documents, for example by presenting information in 
tables. Despite not traditionally being available in a systematic review, participants identified 
wanting information included to direct them how to implement the summarised intervention 
in clinical practice.  
After modification in response to the first round, the second round of focus groups 
resulted in the emergence of four major themes: ease of use, clarity, brevity and 
implementation. The feedback and issues raised surrounding ease of use; clarity and 
implementation were similar to what was provided from participants in the first round of 
focus groups. However, in the second round, participants also highlighted that the prototypes 
included repetitive information and suggestions were made to shorten the document and focus 
on brevity to aid in understanding and rapid use.  
After refining their instrument in response to focus group feedback, Perrier et al. 
conducted a usability study.
88
 This study involved iterative cycles of testing with family 
physicians in order to identify any remaining areas requiring modification in the prototypes of 
their two evidence summary tools.  
Primary care physicians were recruited to participate in the usability study from the 
list of registered physicians with the College of Physicians and Surgeons of Ontario, Canada. 
From the 13,298 active family physicians and 3,520 general internists on the list, 152 were e-
mailed and informed about the study. It is unclear how the investigators selected which 
physicians were e-mailed. The physicians were asked to reply indicating a time and date that 
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they were available to participate. An honorarium fee was offered to encourage participation. 
Six physicians responded to the recruitment e-mail, with an additional four physicians 
recruited through referral by those six participants. The participants included five men and 
five women, with ages ranging from 30 to 65 years of age.  
The usability testing was conducted in three iterative cycles, with two participants 
involved in the first cycle, three participants involved in the second cycle and five participants 
involved in the third cycle. In each cycle participants were presented with the evidence 
summary tools in random order. They were given case scenarios and asked to complete a task 
relevant to the case scenario. Investigators observed and recorded participants as they 
interacted with the reviews and case scenarios, and conducted semi-structured interviews to 
learn about user satisfaction and to obtain feedback on improving the evidence summary tool.  
Between each cycle of testing, modifications were made to the evidence summary tool 
based on feedback from participants, with the next cycle using the updated documents. After 
the first cycle, the investigators made key information more prominent so that it could be 
found more readily. Following the feedback from the second cycle, the investigators made 
explanations more distinct. After feedback from the third cycle, no additional modifications 
were required and a decision was made to stop recruitment of participants and end the 
usability testing.  
In 2015 Perrier et al. reported the results of a pilot RCT evaluating the ability of their 
evidence summary tools to inform clinicians and to guide clinical decision making.
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A list of potentially eligible participants was obtained from Scott’s Canadian Medical 
Directory. An honorarium payment was offered as an incentive for participation. Physicians 
involved in any of the three previous studies
58, 87, 88
 during which the evidence summary tools 
were developed and tested were excluded from recruitment.  
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One thousand seven hundred and fifty recruitment e-mails were sent to potential 
participants, with 67 physicians responding and volunteering to participate. 
When participants visited the study website, they completed a screening questionnaire 
to determine eligibility. If eligible, they were directed to complete a consent form. Following 
consent they were randomly allocated to receive one of three different information sources: 1) 
a full length systematic review; 2) an evidence summary tool, and; 3) a case-based evidence 
summary tool. Both versions of the evidence summary tools focused on presenting the 
evidence reported in the systematic review provided to the first group.  
Eleven of the physicians who were consented and randomised failed to complete the 
pilot study, it is unclear which groups they were allocated to. From the 56 physicians who 
completed the pilot study, 22 were females and 34 were males. Eighty seven percent (49/56) 
had over 10 years experience practicing medicine. Half of the participants (28/56) indicated 
they had not participated in critical appraisal training and 96.43% (54/56) stated they had not 
conducted or published a systematic review.  
After reading their allocated information source (systematic review, evidence 
summary tool or case-based evidence summary tool), participants were presented with three 
questions: 1) Based on the information source you just read, please summarise the clinical 
bottom line; 2) After presentation of an appropriate clinical scenario, participants were asked 
would you apply the evidence you just read to this scenario and; 3) If they answered yes to 
question 2, the third question asked them to outline how they would apply the evidence to the 
case scenario. Agreement between groups was measured using a kappa statistic.  
For the first question, providing the clinical bottom line the kappa statistic was 1.00, 
indicating excellent agreement between groups. The kappa statistic of 1.00 for questions 
regarding applying the evidence from the systematic review or evidence summary to the case 
scenario provided also indicated excellent agreement. These high levels of agreement 
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demonstrate that clinicians from each of the groups took away the same clinical bottom line 
and applied the evidence to the clinical scenario in the same way. Because there was no 
information lost as a result of the summary process required to shorten the content of the 
systematic review to fit the design constraints of the summary tool, this pilot project provided 
important safety information to inform the conduct of a larger evaluation of the effectiveness 
of the evidence summary tools.  
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METHODS 
Purpose 
The purpose of this study was to explore attitudes towards the use of published 
research evidence in intensive care medicine and, based on an understanding of factors that 
inhibit and/or facilitate the appropriate use of published research evidence, to develop and 
evaluate an intervention to improve the use of research evidence by intensive care clinicians.  
To this end, we undertook a series of studies. We conducted a mail survey of intensive 
care specialists in Australia and New Zealand to understand attitudes, knowledge and current 
patterns of use of published research evidence in intensive care medicine. In response to 
insights gained from this initial survey, we developed two evidence summary tools to 
facilitate the appropriate use of published research evidence and, finally, we conducted an 
international on-line interventional study to evaluate the effectiveness of the summary tool. 
Study Aims  
Aim 1: To understand and describe attitudes towards and patterns of use of published 
research evidence in clinical decision making amongst intensive care specialists in Australia 
and New Zealand.  
Aim 2: To assess the level, patterns and characteristics of appropriate use of research 
evidence in intensive care medicine in Australia and New Zealand using a metric proposed 
and evaluated by De Vito et al.
45
  
Aim 3: To investigate whether identifiable clinician-level factors, characteristics of 
research studies, and factors that may inhibit research use are associated with the appropriate 
use of published research evidence in intensive care medicine. 
Aim 4: To design an intervention or tool to improve the use of published research 
evidence in clinical decision making.  
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Aim 5: To understand and describe attitudes towards and patterns of use of published 
research evidence in clinical decision making amongst a multinational mixed group of 
intensive care clinicians. 
Aim 6: To conduct an intervention to determine whether an evidence summary tool 
can improve the use of published research evidence to support clinical decision making. 
Aim 7: To evaluate competing versions of the evidence summary tool to determine 
whether specific elements of presentation of the tool can enhance the use of published 
research evidence to support clinical decision making.  
Aim 8: To investigate whether clinician-level factors, research experience, 
characteristics of research use and research attitudes predict the likelihood of practice change 
in response to using an evidence summary tool. 
Ethics and consent  
This study was designed in compliance with the National Statement on Ethical 
Conduct in Research Involving Humans.
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 Ethics approval was gained from the University of 
Sydney Human Research Ethics Committee (protocol number 13029; September 2010) 
(protocol number 2015/634; August 2015). Appendix A contains the letters of approval from 
the University of Sydney Human Research Ethics Committee for protocol 13029 and protocol 
2015/634. The study documents approved by the University of Sydney Human Research 
Ethics Committee for use in this project can be found in Appendix B, Appendix C, Appendix 
D and Appendix E. 
Data collection in this study involved the use of two separate self-administered 
questionnaire instruments, with submission of a completed questionnaire by a participant 
taken as an indication of voluntary consent to participate in the study. Recruitment 
correspondence with potential participants outlined that participation was voluntary, that there 
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would be no repercussion for non-participation, that they could withdraw from the study at 
any time, and that survey completion and submission was considered consent to participate.  
Summary of methods used to achieve each Aim 
Aim 1  
To understand and describe attitudes towards and patterns of use of published research 
evidence in clinical decision making amongst intensive care specialists in Australia and New 
Zealand, a methodologically rigorous mail survey of a representative random sample of 
intensive care specialists was conducted.  
A complete list of all practicing intensive care specialists in Australia and New 
Zealand was obtained from the College of Intensive Care Medicine. A random sample was 
identified by use of a random number list and blinded numbered postal surveys were sent by a 
nominated officer of the college. Responses were tracked by recording the identifying number 
of surveys as they were returned. Up to three repeat mail outs were completed according to 
the Dillman total design method in order to maximise response rates.
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Aim 2 
The metric proposed by De Vito et al. was utilised to calculate rates of appropriate 
use of research evidence.
45
 Appropriate use was defined as a participant who reported that 
they sometimes, often or always read RCT’s and meta-analyses and they sometimes, often or 
always used RCT’s and meta-analyses to support clinical decisions. Under this definition of 
appropriate use, when someone reported they rarely or never read RCT’s and meta-analyses 
and they rarely or never used RCT’s and meta-analyses to support clinical decisions they 
would not be classified as an appropriate user. 
Clinician-level characteristics, behaviours and beliefs were compared and contrasted 
between appropriate users and non-users. 
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Aim 3 
To identify clinician-level factors, characteristics of research studies, and factors that 
may inhibit research use that were associated with the appropriate use of published research 
evidence in intensive care medicine, multivariable logistic regression analysis was conducted.  
Factors under study were identified for evaluation in multivariable regression if the 
univariable P-value was less than 0.10. Backwards stepwise elimination was used to develop 
a final model to identify all statistically significant independent predictors of appropriate use. 
Aim 4 
To design an intervention or tool to improve the use of published research evidence in 
clinical decision making, an extensive review of published literature regarding interventions 
for addressing evidence-practice gaps was undertaken. Combined with an understanding of 
the factors that may inhibit appropriate evidence use by intensive care clinicians, an evidence 
summary tool was identified as the most appropriate tool.  
A mapping exercise was conducted to explicitly identify factors that inhibit the use of 
research evidence and guide the selection of design features for inclusion in the evidence 
summary tool. Two versions of the evidence summary tool were designed to overcome 
competing factors identified in Aim 3.  
Aim 5 
To understand and describe attitudes towards and patterns of use of published research 
evidence in clinical decision making amongst a multinational mixed group of intensive care 
clinicians, a methodologically rigorous online survey was conducted. The sampling frame 
included all subscribing members of the online critical care special interest discussion forum 
CCM-L, which is run out of the University of Pittsburgh. An e-mail invitation to participate 
was sent to all registered members of the list. Members who volunteered to participate in the 
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study were e-mailed the study questionnaire for completion and return via an anonymous and 
secure web-based drop box.  
Aim 6 
To determine whether an evidence summary tool can improve the use of published 
research evidence to support clinical decision making, a case-based scenario evaluation was 
designed. The international cohort of intensive care clinicians who volunteered to participate 
in the online questionnaire survey on attitudes towards research evidence were also presented 
with the case-based scenario evaluation of the evidence summary tool. Using a before-and-
after design, a change in belief in the benefit of the clinical intervention summarised in the 
evidence summary tool for the patient described in the case-based scenario was assessed. 
Aim 7 
To evaluate competing versions of the evidence summary tool, participants in the 
international online questionnaire survey on attitudes towards research evidence were 
randomly assigned to receive one of two alternate versions of the evidence summary tool. 
Participants were randomised on enrolment into one of two groups, with each group allocated 
a different version of the evidence summary tool.  
Using this randomised design, a difference between groups with regards to belief in 
the benefit of the clinical intervention summarised in the evidence summary tool for the 
patient described in the case-based scenario was assessed. 
Aim 8 
To investigate whether clinician-level factors, research experience, characteristics of 
research use and research attitudes predict the likelihood of practice change in response to 
using an evidence summary tool, multivariable least-squares regression analysis was 
conducted.    
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Factors under study were identified for evaluation in multivariable regression if the 
univariable P-value was less than 0.10. Backwards stepwise elimination was used to develop 
a final model to identify all statistically significant independent predictors of the likelihood of 
change. 
Detailed methods  
Aim 1: To understand and describe attitudes towards and patterns of use of published 
research evidence in clinical decision making amongst intensive care specialists in 
Australia and New Zealand.  
Survey instrument development and design  
The study involved a self-administered quantitative mail-out questionnaire survey of 
volunteer participants recruited from amongst all intensive care clinicians registered for 
practice in Australia and New Zealand.  
To inform the design of the survey instrument a literature search was conducted. 
Published studies evaluating physicians’ attitudes towards research evidence, the use of 
research evidence by physicians in clinical practice, or barriers towards the use of research 
evidence in clinical practice were obtained.
34-36, 39-45, 51, 68, 94
 In addition to the primary 
literature search, references from identified questionnaires were reviewed and obtained.  
A structured, self-administered mail out quantitative questionnaire was developed with 
a major focus on questions and elements taken from two key studies identified in the literature 
search.
34, 45
 The questionnaire was designed using Microsoft Office Word
a 
and then following 
completion, a PDF printable version of the questionnaire was created using Adobe Acrobat 
Pro 9
b
.  
                                                 
a
 Microsoft Corporation, Redmond, WA, USA. 
b
 Adobe Systems, San Jose, CA, USA. 
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Key elements of good survey design included the use of single-sided pages with a 
minimum font size of 12 points and limited use of bulk capital letters. Sections were separated 
with a single black line within the document and new questions were highlighted in bold. 
Careful consideration was given to limiting the amount of information collected in 
demographics in order to minimise reduced response rates from perceived threats to 
maintenance of anonymity.
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Although a formal cover page was not to be included, the first page of the 
questionnaire highlighted the short title, with the primary investigator’s name (PTH) and 
contact details, along with brief instructions on how to complete the survey question. As each 
question was presented, if the format of the question or the response options were changed 
from the previous question, clear instructions were provided to enable the respondent to 
complete the questionnaire without having to turn back pages and review prior instructions for 
clarification.
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 The final format of the questionnaire along with the complete wording of all 
questions in each section can be seen in Appendix C.   
Pilot Testing 
The questionnaire instrument was pilot tested for face validity and content validity by 
three intensive care clinicians. Pilot testers were selected by the primary investigator (PTH) 
based upon their similarity to the intended study population. The pilot testers were provided 
with specific instructions by the primary investigator (PTH) for completion of the pilot testing 
activity.  
Pilot testers were instructed to complete the questionnaire in full and take note of the 
time it took to complete the questionnaire. They were then asked to go back to consider and 
comment specifically on what they thought each question was asking, and provide feedback 
on clarity and overall readability, noting any difficulties in completing or understanding the 
questionnaire. Feedback was sought specifically on grammar, the flow and order of the 
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survey, any technical difficulties encountered during completion and general appearance of 
the survey. 
The responses and feedback from all three pilot testers were reviewed by the primary 
investigator, with questions and formatting modified according to the feedback received to 
improve clarity, readability and usability. One iteration of pilot testing was conducted.  
 Sampling frame and randomly selected survey population 
The intended target population for this study was intensive care specialists currently 
practicing in the field of intensive care medicine in Australia or New Zealand. The 
registration list of the College of Intensive Care Medicine (CICM), a medical specialty 
college statutorily responsible for specialist training and education in the specialised area of 
intensive care medicine in Australia and New Zealand was used as the sampling frame for 
obtaining the study population.  
At the time of submission of the ethics application for approval to conduct the study in 
May 2010, the CICM reported 685 registered members. Each of these registered members 
were assigned a membership number by the CICM at the time of their registration. These 
membership numbers ranged from number one (1) for the first member registered by the 
CICM to number 685, for the most recently registered member. To select a random subset of 
all members to be invited to participate in the study, SAS Version 6.2
c
 was used to generate a 
list of random numbers between 0 and 685.  
 Sample size 
Standard formulae for a simple random sample were used to calculate the sample size 
for this study:
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n = 4P(1-P)/L
2
 
1/n*= 1/n + 1/N : sampling fraction adjustment 
                                                 
c
 SAS Institute, Cary, NC, USA. 
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Given a 32.1% (P) rate of expected appropriate use of evidence as per the results of De 
Vito et al.,
45
 and a total population (N) of 685 physicians, a sample of 238 (n*) physicians 
would provide a precision (L) of five percent on the estimate of appropriate use, adjusted for 
the sampling fraction (n/N) being greater than ten percent of the total population. 
With this sample size, if a minimum 70% response rate was obtained, 6.3% precision 
would be achieved, which was deemed acceptable to allow the aims of the study to be 
attained. In the formula used, the term precision relates to the 95% confidence interval around 
the observed result. A range of plus or minus 6.3% in the 95% confidence interval represents 
very precise results.  Optimal survey methods were employed to maximise the chance of a 
70% response rate.
93, 98
 
 Survey packages 
Survey packages contained the survey instrument questionnaire, instructions for 
completing the questionnaire, a reply-paid stamped A4 response envelope, and a cover letter. 
Each survey package was marked with a survey identification number from 1 to 238. 
The cover letter outlined the purpose of the project and requested participation through 
completion and return of the questionnaire, along with assurances of the maintenance of 
confidentiality and anonymity.  
The reply-paid envelopes were addressed to the investigators and were also marked 
with the survey identification number enclosed in the package to enable tracking of responses. 
The cover letter and participant information statement were provided as approved by the 
University of Sydney Human Research Ethics Committee (see Appendix B).  
Survey packages were prepared by the study investigators (PTH and GSD) and 
delivered to the CICM for distribution to the randomly selected potential participants.  
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 Maintenance of anonymity and mail out procedure 
Along with the 238 survey packages, a master list linking the survey identification 
number on a specific package to the intended recipient was provided to the CICM. The 
intended recipient was identified on this master list using their assigned CICM membership 
number. The investigators did not have access to member’s names, only membership 
numbers. In order to ensure the confidentiality and anonymity of their members, the CICM 
designated one officer from the CICM to handle the generation of mailing address labels 
based on membership numbers supplied by the investigators. These mailing address labels 
were then applied to the survey package with the survey identification number assigned to 
that specific member, thus preventing the investigators from access to any identifying details 
of the CICM members.  
At no time prior to, during, or after the conduct of the study were the investigators 
given access to the identifying details of the CICM members.  
The first mail out of survey packages was conducted in January 2011, with two follow 
up mail outs conducted at four week intervals. 
 Follow up mail outs 
A copy of the master mail out list was kept by the primary investigator. When a 
numbered reply paid envelope containing a survey was returned to the investigators, the 
corresponding survey identification number was removed from the master mail out list, thus 
creating a list that contained only non-responders.  
Following an interval of four weeks, the list of non-responders was sent to the CICM 
officer, along with new complete survey packages that contained the survey instrument 
questionnaire, instructions for completing the questionnaire, a numbered reply-paid stamped 
A4 response envelope, and an updated cover letter highlighting that this was a follow up mail 
out.  
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As per the first mail out, responders to the second mail out were marked off the list as 
surveys were returned to the investigators.  
Following an interval of four weeks after this second mail out, the list of non-
responders was again sent to the CICM officer, along with new complete survey packages that 
contained the survey instrument questionnaire, instructions for completing the questionnaire, 
a numbered reply-paid stamped A4 response envelope, and an updated cover letter 
highlighting that this was a follow up mail out.  
Following the third mail out, the study was promoted at the annual CICM conference, 
by the CICM meeting convenor. The meeting convenor encouraged members who had 
received a survey to complete and return the survey to the study investigators. 
 Data Management 
All aspects of data management including data entry, data analysis, verification of data 
and storage of data, were conducted by the primary investigator at the Northern Clinical 
School Intensive Care Research Unit, located on campus at the Royal North Shore Hospital, 
Sydney. A custom Excel spreadsheet was developed using Microsoft Office
d
 for input of data.  
Following initial entry of the data, accuracy checks were conducted by the primary 
investigator on database entry, with clear errors and out of range mistakes corrected to the 
paper source record. On completion of database cleaning by the primary investigator, a 
colleague from the Northern Clinical School Intensive Care Research Unit who was not 
involved in the conduct of the project conducted an audit of the accuracy of data transcription 
by comparing fifty percent of all database entries directly to the paper source documents.  
 Statistical analysis 
Quantitative data was presented using descriptive statistics. Because most responses to 
balanced Likert scales demonstrate Normal distributions, results are reported as mean and 
                                                 
d
 Microsoft Corporation, Redmond, WA, USA. 
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standard deviation (SD),
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 or rates with numerator and denominator when appropriate. 
Ninety-five percent confidence intervals were reported where appropriate. All calculations 
were conducted using SAS Version 6.2
e
. 
Aim 2: To assess the level, patterns and characteristics of appropriate use of research 
evidence in intensive care medicine in Australia and New Zealand using a metric 
proposed and evaluated by De Vito et al.
45
  
Appropriate use was defined according to the metric established by De Vito et al.
45
 as 
to sometimes, often or very often read RCT’s and meta-analyses AND to sometimes, often or 
very often use RCT’s and meta-analyses.  
To identify appropriate use, the following key questions and response items from De 
Vito et al.’s study were included in the current questionnaire:  
Question 27) - How often do you read the following? 
 (a) published RCTs;  
 (e) published meta-analyses.  
Question 28) - How often do you use the following information sources to guide 
decisions in your clinical practice? 
(e) the results of an RCT; 
 (i) the results of a meta-analysis. 
Response options for these questions were presented on a balanced five-point Likert 
scale. Respondents were able to select from the options never, rarely (defined as once or 
twice a year), sometimes (defined as every month or so), often (defined as every week or so) 
or very often (defined as every day or so). The complete wording of the questions and all 
response items can be viewed in the questionnaire in Appendix C.  
                                                 
e
 SAS Institute, Cary, NC, USA. 
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A response of sometimes, often or very often for questions 27(a), 27(e); 28(e) and 28(i) 
was classified as a positive response in the appropriate use metric. A response of never or 
rarely for questions 27(a), 27(e); 28(e) and 28(i) was considered a negative response and was 
not scored in the appropriate use metric.  
 
To assess the level of appropriate use of research evidence amongst Australian and 
New Zealand intensive care specialists, a simple rate was calculated according to the 
following formulae:  
(n/N) x100 
where (n) is the number of appropriate users and (N) is the total number of 
respondents evaluated in the appropriate use metric. 
 Statistical analysis   
To assess the patterns and characteristics of appropriate use, characteristics, 
behaviours and beliefs were compared and contrasted between appropriate users and non-
users. Comparisons were conducted using t-tests or chi-square tests where appropriate. If 
group size for any cell for a chi-square test was less than five, Fisher’s Exact Test was 
calculated. 
A P-value less than 0.05 from an appropriate statistical test was accepted to identify 
statistical significance. A P-value less than 0.10, but greater than or equal to 0.05, from an 
appropriate statistical test was accepted to identify a trend towards statistical significance. All 
analysis was conducted using SAS Version 6.2
f
. 
                                                 
f
 SAS Institute, Cary, NC, USA. 
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Aim 3: To investigate whether identifiable clinician-level factors, characteristics of 
research studies, and factors that may inhibit research use are associated with the 
appropriate use of published research evidence in intensive care medicine. 
 Logistic regression model development 
The primary outcome for this analysis was the binary variable appropriate use yes/no. 
The purpose of this undertaking was to identify clinician-level factors and characteristics of 
research evidence that are independently associated with appropriate use. To this end, a 
multivariable logistic regression model was developed.   
Univariable logistic regression was undertaken to identify clinician-level factors and 
characteristics of research papers that would qualify for inclusion in the maximum model.  
Clinician-level factors or characteristics of research papers with a univariable P-value 
less than 0.10 were included in the maximum model.
100
 Backwards stepwise elimination was 
used to identify variables for removal from the maximum model. At each step, a P-value was 
calculated for each variable in the model, and the variable with the highest P-value was 
eliminated from the model.  All P-values were then re-calculated for all variables remaining in 
the model. This process was continued until all remaining P-values were less than 0.05.
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 A clinician-level factor or characteristic of a research paper was declared to be  
significantly and independently associated with appropriate use if it remained in the final 
multivariable model and had a P-value of <0.05.
102
 
Aim 4: To design an intervention or tool to improve the use of published research 
evidence in clinical decision making.  
An extensive review of published literature regarding interventions for addressing 
evidence-practice gaps was undertaken. This review identified a number of interventions or 
tools that qualified for consideration. These included: clinical practice guidelines;
69, 70
 simple 
101 
reminders;
78
 printed guideline summaries;
60
 academic detailing;
79
 opinion leaders;
80, 81, 84
 
targeted educational interventions;
86
 and evidence summary tools.
58
  
After careful consideration of the theoretical framework proposed by Haynes et al. 
that consistently placed evidence summary resources at the top of the hierarchy of research 
evidence,
54-57
 and the promising work by Perrier et al.
58, 87-89
 an evidence summary tool was 
identified as a viable approach in need of more extensive evaluation.  
 Evidence summary tool development and design  
A four-stage process was utilised to guide the development and design of the evidence 
summary tool:  
1. Updated focussed literature review on evidence summaries and barriers to evidence uptake. 
2. Recognised common barriers encountered by clinicians and ensured key design elements 
of the summary tool addressed each identified barrier.  
3. Selected a clinical intervention and identified all research evidence supporting that 
intervention for summarisation in the tool.  
4. Pilot tested for usability and clinical content.  
Stage one – Literature search 
To inform the design of the evidence summary tool a focussed literature search was 
conducted to identify published studies evaluating the development or design of any type of 
evidence summary resource or tool.
103
 A secondary focussed search identified publications 
that reported clinicians’ attitudes towards research evidence, factors that influence or inhibit 
the use of research evidence by physicians, preferences for research evidence, or barriers to 
the use of research evidence in clinical practice.  
Stage two - Mapping design elements to each barrier 
Identification of barriers commonly encountered when answering clinical questions 
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Based upon the publications identified in the secondary literature search, barriers 
commonly encountered by physicians when answering clinical questions were identified and 
explicitly listed. Two study investigators (PTH and GSD) independently reviewed the list and 
assessed each barrier for relevance and the ability to be addressed within the evidence 
summary tool design. Each barrier was categorised as able to be addressed or unable to be 
addressed. The two study investigators reviewed the individual ratings of relevance, resolving 
any differences of opinion by discussion until consensus was achieved.  
Identification of design elements to address identified barriers 
The mapping exercise identified explicit design elements of the summary tool that 
were appropriate for addressing each of the identified barriers. The two study investigators 
met to review proposed design elements, resolving any differences in opinion by discussion to 
create, by consensus, a final list of design elements to address each barrier within our 
evidence summary tool. 
Incorporation of design elements into template and first draft of evidence summary tool 
A structured single-sided one page evidence summary tool template was designed. 
The single page was split into specific sections, with each section clearly separated by a 
brightly coloured banner. Each section was given a short heading, used to convey the key 
message or content contained within the section, with bold font utilised to enhance the section 
headings. 
 There was minimal use of font less than 12 points and limited use of bulk capital 
letters. Colour was incorporated into the design of the evidence summary tool to enhance the 
visual appeal of the document. A coloured text box that was placed at the top of the document 
was used to highlight a clear title conveying the primary message of the evidence summary 
tool, the name and contact details of the primary investigator responsible for the development 
of the tool, and the credible body responsible for oversight of the tool. In this case, the 
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University of Sydney Northern Clinical School Intensive Care Research Unit served as the 
credible body. 
Stage three - Selection of a clinical intervention 
A clinical intervention was sought that was supported by evidence that contained as 
many of the characteristics of research evidence that were found to be statistically 
significantly associated with appropriate use (see Aim 3). In addition, it was required that 
there was a documented evidence-practice gap for the candidate intervention. Once the 
intervention was identified, a literature search was conducted to identify all RCTs and 
systematic reviews published with a focus on the intervention. 
After identification of the supporting evidence, the two study investigators 
independently abstracted key details from each study with regards to the target population and 
intervention. The methodological validity of the identified supporting evidence was also 
evaluated independently by the two investigators. Methodological validity focussed on the 
key criteria of allocation concealment, completeness of follow-up, blinding, intention to treat, 
post-hoc exclusions and early trial discontinuation.  
Stage four - Pilot testing 
Two practicing intensive care clinicians who were not involved in the development of 
the evidence summary tool were invited to undertake pilot testing. They were asked to act as 
expert reviewers to evaluate the usability and clinical content of the evidence summary tool.  
All original source evidence supporting the chosen clinical intervention was provided 
to the pilot testers. They were not required to evaluate the validity of the original evidence but 
they were required to evaluate the accuracy of the clinical content of the summary tool. 
Feedback was sought specifically on wording or grammatical suggestions, the flow and order 
of the evidence summary tool, the general appearance and visual appeal of the tool and any 
other issues they thought relevant.  
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The feedback from the pilot testers was reviewed by the primary investigator (PTH) 
and was used to guide modifications to the layout and content of the evidence summary tool 
to improve clarity, readability and usability. One round of pilot testing was conducted with 
each pilot tester and the tool was finalised.  
Aim 5: To understand and describe attitudes towards and patterns of use of published 
research evidence in clinical decision making amongst a multinational mixed group of 
intensive care clinicians. 
 Survey instrument development and design 
The study involved a self-administered quantitative online questionnaire survey of 
volunteer participants recruited from an international critical care special interest e-mail 
discussion group.  
To inform the design of the questionnaire instrument, a literature search was 
conducted.  Published studies evaluating intensive care clinicians’ attitudes towards research 
evidence, the use of research evidence by intensive care clinicians in clinical practice, or 
barriers towards the use of research evidence in intensive care medicine were obtained.
104
  
A structured self-administered questionnaire tool was prepared modelled largely on a 
published study investigating the use of research evidence amongst intensive care clinicians 
by Heighes and Doig.
104
 The questionnaire was designed using Microsoft Office Word
g
 and 
then following completion a live PDF form version of the questionnaire was created using 
Adobe Acrobat Pro 9
h
. All responses were captured electronically, directly in the PDF form.  
Key elements of good survey design included the use of single-sided pages with a 
minimum font size of 12 points and limited use of bulk capital letters. Sections were separated 
with a single black line within the document and new questions were highlighted in bold. 
                                                 
g
 Microsoft Corporation, Redmond, WA, USA. 
h
 Adobe Systems, San Jose, CA, USA. 
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Careful consideration was given to limiting the amount of information collected in 
demographics in order to minimise reduced response rates from perceived threats to 
maintenance of anonymity.
95
 
Although a formal cover page was not to be included, the first page of the 
questionnaire highlighted the short title, with the primary investigator and contact details, 
along with brief instructions on how to complete the survey question. As each question was 
presented, if the format of the question or the response options were changed from the 
previous question, clear instructions were provided to enable the respondent to complete the 
questionnaire without having to turn back pages and review prior instructions for 
clarification.
96
 The final format of the questionnaire along with the complete wording of all 
questions in each section can be seen in Appendix E.   
 Electronic data capture and on-line resources 
Following completion of the initial questionnaire design in Word, the document was 
converted into an active PDF form using Acrobat Pro 9
i
. Using the Adobe Form Wizard 
function, editable form fields were created with basic range checking to allow electronic data 
capture. Respondents were also able to print the form and fill in by hand, if desired (See 
Figure 5 next page).   
                                                 
i
 Adobe Systems, San Jose, CA, USA. 
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Figure 5. Adobe Form Wizard: Radio button and text field insertion. 
 
 
For response options that required respondents to only select one answer from any 
given options, the radio button feature was utilised. For example, question one asked 
respondents to indicate their gender from the allowable response options of male or female. 
Using the radio button feature, respondents could click on male or female but were unable to 
select both options. If they attempted to change their response, their initial selection would be 
removed automatically. This feature was utilised for all dichotomous questions or for 
questions with multiple response options that required only one answer to be selected.  
For questions that required numerical input, the text field feature was utilised to allow 
respondents to type in an answer in a number format. For example, where question two asked 
respondents’ current age, the text field feature was applied to an inserted text box, with a 
number format category selected and field value validation range restrictions applied to 
ensure a valid age in the range of 18 to 100 years was entered.  
If an invalid response was entered, a pop-up message was created that would be 
displayed informing the respondent as to why the response was invalid. When a valid 
response was entered, the respondent was automatically progressed to the next question.  
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Respondents could tab between questions or use the mouse to click on to the next 
question. A save button feature with an automatic action to execute a function (save, file as) 
was added to each page to enable respondents to save the document if they needed to stop 
during their completion of the questionnaire.  
 Pilot testing 
The questionnaire instrument was pilot tested by two intensive care clinicians who 
were selected by the primary investigator (PTH) due to their similarity to the intended study 
population. The pilot testers were provided with specific instructions by the primary 
investigator for the completion of the pilot testing activity. They were asked to complete the 
questionnaire in full, taking note of the time taken for completion. They were requested to 
provide comments on what they believed each question was asking and to provide feedback 
on the clarity and wording of individual questions, and overall readability.  
If any difficulties were encountered completing the questionnaire, including with the 
function of the editable form fields, they were asked to provide specific information on these 
difficulties. They were asked to go back and re-check response option buttons to ensure they 
were active and had recorded their responses correctly. They were asked to test the save 
function feature by saving and exiting their questionnaire and returning to ensure it had saved 
their input correctly.  
The responses and feedback from the pilot testers were reviewed by the primary 
investigator, with questions and formatting modified according to the feedback received to 
improve clarity, readability and usability. One iteration of pilot testing was completed.  
 Sampling frame and survey population 
The intended target population for this study was clinicians working in intensive care 
medicine in any country throughout the world. The sampling frame included all subscribing 
members of an international e-mail discussion group focussed on intensive care medicine run 
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by the University of Pittsburgh.
105
 The Critical Care Medicine e-mail list (CCM-L) is a free, 
multidisciplinary electronic-mail discussion group serving multinational subscribers, which 
has been actively running since 1994. Permission to utilise the e-mail subscribers list for the 
conduct of the study was obtained from Professor David Crippen, the CCM-L founder and 
moderator.  
 Sample size 
In 2002, a survey of CCM-L users was conducted with an overall response rate of 
72% (452/624 members).
105
 In May 2015, at the time of submission of ethics approval to 
conduct this study, CCM-L membership had increased to over 1,000 active participants. 
The standard formulae for a simple random sample was used to calculate the sample 
size for this study:
97 
n = 4P(1-P)/L
2
 
Estimating the appropriate use of research evidence is a key goal of this project, and 
can be used to drive sample size estimates. Given appropriate use by Australian and New 
Zealand intensive care specialists was estimated at 68.22% (P) in the survey by Heighes and 
Doig,
104
 it is reasonable to estimate similar rates amongst international clinicians. The above 
formula indicates that 88 respondents (n) would be required to obtain reasonable accuracy (L 
= 10%) in the estimate of appropriate use.  
 Electronic mail recruitment procedure 
Initial contact was made with all subscribing members of CCM-L in August 2015 
through the distribution of a generic recruitment e-mail which outlined the purpose of the 
study and requested volunteers to participate. Contact details (e-mail address) for the study 
investigators (PTH and GSD) were included at the end of the recruitment e-mail.  
A cover letter and participant information statement document that outlined the 
purpose of the project, along with assurances of confidentiality and anonymity was attached 
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as a PDF file to the recruitment e-mail to enable subscribing members of CCM-L to read in 
detail about the project and make an informed decision about participation. Appendix D 
contains the cover letter and participant information statement as approved by the University 
of Sydney Human Research Ethics Committee.  
Potential participants were requested to make contact with the study investigators via 
e-mail to indicate their interest in the study. 
On receipt of an expression of interest to participate, the participants were e-mailed a 
study questionnaire.  
 Follow up mail outs 
Following the initial recruitment e-mail to the CCM-L, follow-up reminder e-mails 
were sent out once a month for a period of one year until August 2016. E-mails were sent at 
irregular times (e.g. weekdays, weeknights and weekends) in order to capture a range of 
participants who may access the CCM-L e-mails at varied times around the world.  
 Maintenance of anonymity and return of questionnaire process 
In order to maintain the confidentiality and anonymity of the subscribing members of 
the CCM-L who volunteered to participate in this study, a web-based drop box was set up on 
a secure, encrypted University of Sydney research web site: 
https://research.evidencebased.net/dropbox. This server is physically located at the University 
of Sydney’s Northern Clinical School Intensive Care Research Unit, on campus at the Royal 
North Shore Hospital, Sydney.  
Respondents were provided with instructions regarding how to upload their completed 
questionnaire to the dropbox at their convenience. A direct link to the drop box was provided 
to potential participants in the e-mail when the survey package was sent, as well as within the 
editable questionnaire instrument document. The use of a dropbox enabled a respondent to 
anonymously upload their questionnaire without revealing any personal details to the 
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investigators. If the respondent encountered difficulties using the web-based dropbox, they 
were able to print the questionnaire instrument and complete it manually, then mail back to 
the investigators via regular postal services. There were no identifying marks on the survey, 
so use of the dropbox and postal returns were both anonymous. 
 Data Management 
All aspects of data management including data entry, data analysis, verification of data 
and storage of data, were conducted by the primary investigator (PTH) at the Northern 
Clinical School Intensive Care Research Unit, located on campus at the Royal North Shore 
Hospital, Sydney. Data was entered into a custom Excel spreadsheet created using Microsoft 
Office
j 
software.  
Following initial entry of the data, accuracy checks were conducted by the primary 
investigator on database entry, with clear errors and out of range mistakes corrected to the 
paper source record. On completion of database cleaning by the primary investigator a 
colleague from the Northern Clinical School Intensive Care Research Unit who was not 
involved in the conduct of the project conducted an audit of the accuracy of data transcription 
by comparing fifty percent of all database entries directly to the paper source documents.  
Statistical analysis 
Quantitative data was presented using descriptive statistics. Because most responses to 
balanced Likert scales demonstrate Normal distributions, results are reported as mean and 
standard deviation (SD),
99
 or rates with numerator and denominator when appropriate. 
Ninety-five percent confidence intervals were reported where appropriate. All calculations 
were conducted using SAS Version 6.2
k
. 
                                                 
j
 Microsoft Corporation, Redmond, WA, USA. 
k
 SAS Institute, Cary, NC, USA. 
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Aim 6: To conduct an intervention to determine whether an evidence summary tool can 
improve the use of published research evidence to support clinical decision making. 
Before-and-after evaluation of a case-based scenario  
To determine whether an evidence summary tool can improve the use of published 
research evidence to support clinical decision making, a case-based scenario evaluation was 
designed. The international cohort of intensive care clinicians who volunteered to participate 
in the online questionnaire survey on attitudes towards research evidence were also presented 
with the case-based scenario evaluation of the evidence summary tool. Using a before-and-
after design, a change in belief in the benefit of the clinical intervention summarised in the 
evidence summary tool for the patient described in the case-based scenario was assessed. 
Study items 
Study items created to address this specific Aim included the evidence summary tool 
and a case-based scenario relevant to the clinical intervention described in the evidence 
summary tool. The case-based scenario was developed to provide a realistic example of a 
patient typically cared for in an intensive care unit with the primary condition for which the 
intervention summarised in the evidence summary tool would be of benefit. 
Case-based scenario 
The case-based scenario was developed by the two study investigators (PTH and 
GSD) who designed the evidence summary tool. The case described in the scenario was 
chosen to reflect a patient who clearly met the eligibility criteria of the key RCT
5
 
demonstrating benefits from the clinical intervention described in the evidence summary tool. 
The clinical content of the case-based scenario was reviewed for accuracy by two intensive 
care clinicians not involved in the conduct of the study.    
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Evaluation 
Study participants were presented with the case-based scenario and then asked to 
indicate their strength in belief of benefit to this specific patient with regards to the clinical 
intervention described in the evidence summary tool. Participants were also asked to indicate 
their strength in belief of benefit attributable to five other clinical interventions that may or 
may not have been appropriate for the patient in the case-based scenario. Clinicians ranked 
their agreement with the statement ‘I believe this patient may benefit from [intervention 
name]’ with response options presented on a five point balanced Likert scale, ranging from 
strongly disagree to strongly agree.  
Immediately following this initial exposure to the case-based scenario, respondents 
were presented with the evidence summary tool and were instructed to carefully read the tool 
and consider the evidence presented.  
After reading the evidence summary tool, the participants were presented with the 
same case-based scenario, and again asked to rank the strength of their belief with a series of 
statements regarding the same clinical interventions evaluated in the before phase.  
Change in belief of benefits 
The primary outcome, change in belief of benefit, was assessed using change on 
response to the five point balanced Likert scale. The original response options ranged from 
strongly disagree, disagree, neutral, agree or strongly disagree.  
Statistical analysis 
Because most responses to balanced Likert scales demonstrate Normal distributions, 
results are reported as mean and standard deviation (SD).
99
 Ninety-five percent confidence 
intervals were reported where appropriate.  
The statistical significance of a change in beliefs was assessed using a paired t-test. A 
P-value less than 0.05 was accepted to identify statistical significance. A P-value less than 
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0.10, but greater than or equal to 0.05 was accepted to identify a trend towards statistical 
significance. All analysis was conducted using SAS Version 6.2
l
.   
Aim 7: To evaluate competing versions of the evidence summary tool to determine 
whether specific elements of presentation of the tool can enhance the use of published 
research evidence to support clinical decision making.  
Although expert methodologists consistently create evidence hierarchies that rank 
Systematic Reviews higher than RCTs as trustworthy sources of research evidence to guide 
clinical practice,
52-57
 clinicians report they read or use systematic reviews  
infrequently,
34-36, 39, 44, 51, 68
 or clinicians identified a preference for RCTs over systematic 
reviews and meta-analyses.
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 Because of this divergence, we hypothesised that an evidence 
summary tool that highlights the results from RCTs may perform differently to an evidence 
summary tool that highlights results from systematic reviews.  
Competing versions of evidence summary tools 
In order to evaluate this subtle difference, a clinical intervention was identified that 
was supported by significant benefit demonstrated in an RCT and significant benefit 
demonstrated in a systematic review. The comparison between these competing primary 
sources of evidence was undertaken by developing two alternate formats of presentation of 
the evidence summary tool. The two formats of the evidence summary tool were designed to 
be identical in all sections, except for the way in which the primary source of research 
evidence that supported the clinical intervention was cited and highlighted. 
Methods for evaluation 
The international cohort of intensive care clinicians who volunteered to participate in 
the online questionnaire survey on attitudes towards research evidence were also presented 
with the case-based scenario evaluation of the evidence summary tool. Upon providing 
                                                 
l
 SAS Institute, Cary, NC, USA. 
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consent, participants were randomly allocated to receive an evidence summary tool 
emphasising RCTs or an evidence summary tool emphasising systematic reviews as the 
source evidence. 
Study participants were presented with the case-based scenario and then asked to 
indicate their strength in belief of benefit to this specific patient with regards to the clinical 
intervention described in the evidence summary tool. Participants were also asked to indicate 
their strength in belief of benefit attributable to five other clinical interventions that may or 
may not have been appropriate for the patient in the scenario. Clinicians ranked their 
agreement with the statement ‘I believe this patient may benefit from [intervention name]’ 
with response options presented on a five point balanced Likert scale, ranging from strongly 
disagree to strongly agree.  
Immediately following this initial exposure to the case-based scenario, respondents 
were presented with the evidence summary tool and were instructed to carefully read the tool 
and consider the evidence presented.  
After reading the evidence summary tool, the participants were presented with the 
same case-based scenario and again asked to rank the strength in belief of benefit with a series 
of statements regarding the same clinical interventions evaluated in the before phase.  
Differences in belief of benefits 
The primary outcome, difference in belief of benefit between the two randomly 
allocated groups, was assessed using the differences in response to the five point balanced 
Likert scale. The response options ranged from strongly disagree, disagree, neutral, agree or 
strongly disagree.  
Sample Size 
The primary outcome was assessed using a five point balanced Likert scale, with 
response options ranging from strongly disagree, disagree, neutral, agree to strongly disagree  
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Data from previous surveys of intensive care clinicians’ attitudes towards using 
different types of evidence sources to support clinical decision making revealed common 
standard deviations (SD) of approximately 0.9 on this five point balanced Likert scale.
104
  
Using standard sample size formula, with an SD of 0.9, 70 respondents were required 
per evidence summary tool group in order to achieve 90% power to detect a 0.5 unit 
difference in our primary outcome: strength of belief in the reported benefits.  
Previous research has demonstrated that an effect equal to ½ the SD of the response 
scale is accepted by clinicians to represent a ‘meaningful difference’ in many qualitative 
aspects of health status.
106
  
Randomisation methods 
SAS Version 6.2
m
 was used to computer generate the simple randomisation sequence. 
Allocation concealment was maintained by not revealing the sequence before consent to 
participate was obtained. After consent was obtained, the participant was allocated to receive 
an evidence summary tool that emphasised RCTs or an evidence summary tool that 
emphasised systematic reviews as determined by the computer generated sequence. 
Statistical analysis  
The primary outcome, differences in belief of benefit between the two randomly 
allocated groups, was assessed using a standard t-test on univariable analysis. Multivariable 
analysis was also conducted to control for potential confounding due to baseline imbalance. 
Baseline imbalance was assessed using t-tests or chi-square tests, where appropriate. If 
group size for any cell for a chi-square test was less than five, Fisher’s Exact Test was 
calculated. A variable was considered to be a potential confounder due to baseline imbalance 
if the between group univariable P-value was less than 0.10. All potential confounders were 
included in a multivariable least-squares regression model, that was refined using backwards 
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 SAS Institute, Cary, NC, USA. 
116 
stepwise elimination. At each elimination step, a P-value was calculated for each variable in 
the model, and the variable with the highest P-value was eliminated from the model. All P-
values were re-calculated for all variables remaining in the model. This process was continued 
until all remaining P-values were less than 0.05. 
A P-value less than 0.05 from an appropriate statistical test was accepted to identify 
statistical significance. A P-value less than 0.10, but greater than or equal to 0.05, from an 
appropriate statistical test was accepted to identify a trend towards statistical significance. All 
analysis was conducted using SAS Version 6.2
m
. 
Aim 8: To investigate whether clinician-level factors, research experience, 
characteristics of research use and research attitudes predict the likelihood of practice 
change in response to using an evidence summary tool.  
Least-squares regression model development 
The primary outcome for this analysis was the variable change in belief of benefit,  
assessed using change on response to a five point balanced Likert scale. 
The purpose of this undertaking was to identify clinician-level factors and 
characteristics of research evidence that are independently associated with change in belief of 
benefit. To this end, a multivariable least-squares regression model was developed.   
Univariable least-squares regression was undertaken to identify clinician-level factors 
and characteristics of research papers that would qualify for inclusion in the maximum model.  
Clinician-level factors or characteristics of research papers with a univariable P-value 
less than 0.10 were included in the maximum model.
100
 Backwards stepwise elimination was 
used to identify variables for removal from the maximum model. At each step, a P-value was 
calculated for each variable in the model, and the variable with the highest P-value was 
eliminated from the model. All P-values were re-calculated for all variables remaining in the 
model. This process was continued until all remaining P-values were less than 0.05.
101
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 A clinician-level factor or characteristic of a research paper was declared to be  
significantly and independently associated with change in belief of benefits if it remained in 
the final multivariable model and had a P-value of <0.05.
102
 All analysis was conducted using 
SAS Version 6.2
n
. 
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RESULTS 
Aim 1 : To understand and describe attitudes towards and patterns of use of published 
research evidence in clinical decision making amongst intensive care specialists in 
Australia and New Zealand.  
 Quantitative mail-out questionnaire survey design   
The questionnaire included a total of 31 closed ended questions divided into five 
structured sections.  
The first section of the questionnaire was titled Demographics and addressed items 
related to year of registration as an intensive care specialist, gender and age. 
Section two addressed Research experience and included items related to experience 
and participation in research activities, continuing medical education time, computer usage, 
formal research qualifications and training in evidence-based medicine.  
In section three, Research knowledge, true or false technical statements were presented 
to test respondents’ knowledge of research terminology and methods. Respondents were 
required to select from three fixed responses (incorrect, not sure or correct) to indicate their 
understanding of each knowledge statement.  
The fourth section, Research attitudes, included six statements related to beliefs and 
attitudes regarding published research evidence, with respondents asked to select the most 
appropriate answer from a balanced five point Likert item response scale (strongly disagree, 
disagree, neutral, agree, strongly agree).  
The fifth section, Research use, contained questions that collected details of patterns 
of research use in clinical practice and other job related activities and characteristics of 
research evidence that may influence or inhibit use. 
The final format of the questionnaire along with the complete wording of all questions 
in each section can be seen in Appendix C.   
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 Pilot testing 
The two pilot testers identified that questions with multiple categories presented 
running cross the page were difficult to read. To improve readability, all questions with 
multiple categories were re-formatted so they sequenced down the page.  
The use of two different response scales within a questionnaire was identified as 
confusing by the pilot testers. Based upon this feedback, a five point Likert scale was chosen 
by the study investigators as the most appropriate scale, and questions with continuous rating 
response scales were re-formatted to be presented with five point Likert response scales.   
 Response rate 
A total of 238 potential respondents were mailed questionnaires. With 133 
questionnaires returned to the study investigators, an overall unit response rate of 55.9% 
(133/238) was achieved. This response rate was achieved through the conduct of three direct 
mail outs.  
Following the initial mail out on 17
th
 of January 2011, 30.3% (72/238) of 
questionnaires were returned to the investigators. On February 18
th
 2011, a second mail out 
was conducted with 165 follow up survey packages mailed to non-responders. Of these 165 
second mail out questionnaires 10.3% (17/165) were returned. On the 28
th
 of March 2011, 
148 follow up survey packages were mailed to non-responders in the third mail out, with 
28.4% (42/148) of these questionnaires returned.  
After verbal promotion of the study at the annual College of Intensive Care Medicine 
(CICM) conference (held on the 3
rd
 to 5
th
 June 2011) an additional two questionnaires were 
returned. The final response was received in June 2011, following which the survey was 
closed out.  
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 Missing items 
One questionnaire from the 133 questionnaires returned to the investigators was 
completely blank with an open text note appended stating “I’m retired, please don’t bother me 
again!” 
Overall incomplete data at the question item level was 2.8% (286 missing values from 
133 returned surveys with 77 question items on each survey). Missing values for individual 
question items ranged from 0.8% (1/133) missing to 13.5% (18/133) missing.  
Full details of item response rates for each individual question are reported in Table 4, 
Table 5, Table 6, Table 7, Table 8, Table 9, Table 10, Table 11 and Table 12.    
Responses 
Demographics 
The mean age of respondents was 51.20 (SD 8.57) years with males making up 81.5% 
(106/130) of the responding population. Respondents had practised as a registered Intensive 
Care Specialist for a mean of 12.60 (SD 7.00) years. See Table 4 for complete details. 
Research experience 
Fifty-five percent (72/129) of respondents reported holding an academic appointment 
at a university. The weekly mean time devoted to continuing medical education was 6.80 (SD 
4.39) hours per respondent, with daily internet use reported by 97.7% (128/131). Formal 
research training was reported by 31.3% (41/131) of respondents, whilst 40.8% (53/130) of 
respondents reported formal training in evidence-based medicine.    
Respondents reported participation in research activities in the clinical area, with 
87.8% (115/131) indicating they had consented a patient for enrolment in a clinical trial and 
47.3% (62/131) indicating involvement in the running of funded clinical trials. Additional 
details regarding Research experience can be found in Table 5. 
121 
Research knowledge 
The mean research knowledge score was 2.95 (SD 1.70) correct responses from six 
research knowledge questions. The question most commonly answered correctly was question 
number 17, with 96.2% (125/130) of respondents able to identify that the statement 
“Conventionally, results in a clinical trial are considered to be statistically significant (i.e. 
unlikely to have arisen by chance) if the P-value is less than 0.05 (p<0.05)” was true.  
The question most commonly answered incorrectly was question number 18, with 
only 14.7% (19/129) of respondents able to correctly identify that the statement “In a meta-
analysis, the I
2 
metric is a measure of heterogeneity that is dependent on the number of 
patients included in a trial” was true. 
Table 6 lists complete details of all six knowledge statements, item response rates and 
the number of respondents identifying the correct response for each question.  
Research attitudes 
Positive feelings (agree or strongly agree) towards using published research evidence 
in clinical practice were reported by 65.4% (85/130) of respondents, and 75.4% (98/130) of 
respondents also reported that their colleagues had positive feelings (agree or strongly agree) 
towards using published research evidence in clinical practice.  
Eighty-six percent (112/130) of respondents reported positive feelings (agreed or 
strongly agreed) towards using the results of an RCT to guide their clinical practice, whereas 
59.2% (77/130) of respondents reported positive feelings towards using the results of a 
systematic review to guide their clinical practice (agreed or strongly agreed).  
Table 7 lists complete details of all Research attitude statements. 
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Research use 
Ninety-six percent (126/130) of respondents reported they used the concepts of 
evidence-based medicine in their own clinical practice at least sometimes, which was defined 
as 'every month or so'.  
With regards to the frequency of reading different types of research evidence, 97.7% 
(127/130) of respondents reported they read RCTs at least sometimes, whereas 65.1% 
(84/129) of respondents reported they read information in the Cochrane library at least 
sometimes. Complete details regarding frequency of reading specific types of research 
evidence are reported in Table 8. 
In a question regarding frequency of using different types of research evidence to 
guide clinical practice, Published Evidence Based Guidelines were used by 96.9% (126/130) 
of respondents at least sometimes whereas 67.7% (88/130) of respondents reported using 
information in the Cochrane Library to guide clinical decisions at least sometimes. Complete 
details regarding patterns of use of research evidence are reported in Table 9 and Table 10. 
Respondents were given a list of statements describing factors that may help their 
decision to use the results of published research evidence to change clinical practice and 
asked to rank how often they found these factors helpful. One hundred percent (129/129) of 
respondents rated 'the results have clear benefit to my patients' as helpful at least sometimes 
whereas 'the paper presents a full economic analysis' was rated as helpful at least sometimes 
by 62.0% (80/129) of respondents. Complete details reported in Table 11 
When presented with a list of statements describing factors that may inhibit their use 
of research evidence, 56.9% (74/130) of respondents agreed or strongly agreed with the 
statement ‘I have difficulty finding the time to read’. Ten percent (13/129) of respondents 
agreed or strongly agreed with the statement 'appraising published research papers is not 
part of my role'. Table 12 provides complete responses to this item.  
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Table 4. Demographics  
Variable  Response Rate  
(n/N)
&
 
Result 
 
Q1. Years practising as a Registered 
Intensive Care Specialist, mean (SD) 
 127/133 12.60 (7.00) 
Q2. Gender - male, percent (n/N)   130/133 81.5% (106/130) 
Q3. Age in years, mean (SD)  129/133 51.20 (8.57) 
SD – standard deviation; n/N – number of reported events/Number of responses; n/N& item 
response rate/unit response rate  
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Table 5. Research experience 
Variable 
Responses 
(n/N)
&
 
Percent 
Q4. Level of training or qualification in research
*
 131/133  
Research Fellowship
*
 12/131 9.1% 
Formal Research Methodology Course
*
 11/131 8.4% 
Graduate Level Research Methodology Course
*
   
Graduate Certificate  0 
Graduate Diploma 6/131 4.6% 
Masters 8/131 6.1% 
PhD 15/131 11.5% 
            No formal research qualification 90/131 68.7% 
Q5. Level of training or qualification in EBM
#
 130/133  
Have attended a non-university based EBM course or 
workshop
#
 
47/130 36.2% 
Have attended a University based EBM course or workshop
#
 14/130 10.8% 
Have attended a McMaster University EBM course or 
workshop
#
 
 0 
No formal EBM training  77/130 59.2% 
Q6. Academic appointment held at a university, percent (n/N) 72/129 55.8%  
Q7. Have you ever published any research papers as a named 
contributing or primary author? 
101/131 77.1% 
Q8. Are you involved in the running of any funded clinical 
trials? 
62/131 47.3% 
Q9. Have you ever consented a patient for a clinical trial? 115/131 87.8% 
Q10. Are you or have you been named as an investigator on 
an ethics submission for a funded clinical trial? 
88/131 67.2% 
Q11. Weekly CME hours, mean (SD)  132/133 6.80 (4.39) 
Q12. Frequency of internet use: percent (n/N) 131/133  
      Daily  128/131 97.7%  
     At least weekly  3/131 2.3%  
     Less than weekly   0% 
     Never   0% 
Q13. Use a computer for the purposes of: percent (n/N)  131/133  
     Word processing  125/131 95.4% 
     Data analysis  69/131 52.7% 
     Search databases for published papers  122/131 93.1% 
     Other   108/131 82.4% 
PhD – Doctor of Philosophy; EBM – Evidence Based Medicine; CME – continuing medical 
education; n/N
&
 item response rate/unit response rate; n/N – number of reported 
events/Number of responses  
*respondents able to select more than one level of training or qualification in research 
#respondents able to select more than one level of training or qualification in EBM 
&respondents able to select more than one purpose for using a computer 
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Table 6. Research Knowledge  
Variable  
(Question number, knowledge statement and 
correct answer) 
Correct 
Response  
(n/N)
&
 
Percent 
Q14. The CONSORT Statement is an 
international guidance document intended to 
improve the reporting of RCT's.  
(True) 
79/130 60.8% 
Q15. Allocation concealment refers to the act 
of masking which treatment a patient enrolled 
in a clinical trial is currently receiving from the 
treating clinician.  
(False) 
39/129 30.2% 
Q16. The PRISMA Statement is an 
international guidance document intended to 
address the suboptimal reporting of systematic 
reviews and meta-analyses of RCTs.  
(True) 
58/129 45.0% 
Q17. Conventionally, results in a clinical trial 
are considered to be statistically significant (i.e. 
unlikely to have arisen by chance) if the P-
value is less than 0.05 (p<0.05).  
(True) 
125/130 96.2% 
Q18. In a meta-analysis, the I
2 
metric is a 
measure of heterogeneity that is dependent on 
the number of patients included in a trial. 
(True) 
19/129 14.7% 
Q19. The forest plot is a graph used in a meta-
analysis to detect publication bias in which the 
estimate of risk is plotted against sample size.  
(False) 
60/129 46.5% 
   
 
Average score out of 6 (SD) 
 
 2.95 (1.70) 
CONSORT - Consolidated Standards of Reporting Trials; RCTs – randomised controlled 
trials; PRISMA - Preferred Reporting Items for Systematic Reviews and Meta-Analyses; n/N
&
 
item response rate/unit response rate; n/N – number of reported events/Number of responses 
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Table 7. Research attitudes 
Allowable responses:  Strongly disagree (Score 1); Disagree (Score 2); Neutral (Score 3); Agree (Score 4); Strongly agree (Score 5). 
Variable  
(Question number) 
Response 
Rate  
(n/N)
&
 
Respondents selecting each response category  
Percent (n/N) 
Mean score 
(SD) 
1 2 3 4 5 
Q20. Positive feelings towards EBM*  130/133 
2.3 
(3/130) 
16.9 
(22/130) 
15.4 
(20/130) 
55.4 
(72/130) 
10.0 
(13/130) 
3.53 (0.97) 
Q21. Colleagues positive feelings towards EBM* 130/133 
1.5 
(2/130) 
3.9 
(5/130) 
18.5 
(24/130) 
66.9 
(87/130) 
8.5 
(11/130) 
3.78 (0.72) 
Q22. Positive feelings towards using RCTs to guide 
clinical practice*  
130/133 
0 
(0/130) 
2.3 
(3/130) 
11.5 
(15/130) 
76.2 
(99/130) 
10.0 
(13/130) 
3.94 (0.55) 
Q23. Positive feelings towards using systematic review/ 
meta-analysis to guide clinical practice* 
130/133 
1.5 
(2/130) 
11.5 
(15/130) 
27.7 
(36/130) 
54.6 
(71/130) 
4.6 
(6/130) 
3.49 (0.82) 
Q24. Time limitations restrict the incorporation of EBM 
into my clinical practice* 
130/133 
9.2 
(12/130) 
43.1 
(56/130) 
20.8 
(27/130) 
24.6 
(32/130) 
2.3 
(3/130) 
2.68 (1.02) 
Q25. Research evidence has not made a difference to 
my clinical practice* 
130/133 
36.9 
(48/130) 
54.6 
(71/130) 
6.2 
(8/130) 
1.5 
(2/130) 
0.8 
(1/130) 
1.75 (0.71) 
 
EBM – Evidence Based Medicine; RCT's – Randomised Controlled Trials; n/N& item response rate/unit response rate; n/N – number of reported 
events/Number of responses; SD – standard deviation 
*Summary of question only, for complete wording of questions see Appendix C. 
  
1
2
7 
Table 8. Frequency of research use 
Allowable responses:  Never (Score 1); Rarely = once or twice a year (Score 2); Sometimes = every month or so (Score 3);  
Often = every week or so (Score 4); Very often = every day or so (Score 5). 
Variable  
(Question and response item) 
Response 
Rate  
(n/N)
&
 
Respondents selecting each response category 
Percent (n/N) 
Mean score 
(SD) 
1 2 3 4 5 
Q26. How often do you use the concepts of EBM in 
your clinical practice? 
130/133 
0 
(0/130) 
3.1 
(4/130) 
23.9 
(31/130) 
51.5 
(67/130) 
21.5 
(28/130) 
3.92 (0.76) 
Q27: How often do you read the following:         
     Published RCTs 130/133 
0 
(0/130) 
2.3 
(3/130) 
32.3 
(42/130) 
55.4 
(72/130) 
10.0 
(13/130) 
3.73 (0.67) 
     Published EBGs 130/133 
0 
(0/130) 
10.8 
(14/130) 
45.4 
(59/130) 
40.8 
(53/130) 
3.1 
(4/130) 
3.36 (0.72) 
     Textbooks 130/133 
3.1 
(4/130) 
13.1 
(17/130) 
42.3 
(55/130) 
33.9 
(44/130) 
7.7 
(10/130) 
3.30 (0.90) 
     Published Meta-analyses 130/133 
1.5 
(2/130) 
14.6 
(19/130) 
51.5 
(67/130) 
30.8 
(40/130) 
1.5 
(2/130) 
3.16 (0.75) 
     Information in Cochrane Library 129/133 
4.6 
(6/130) 
30.0 
(39/130) 
48.5 
(63/130 
12.3 
(16/130) 
3.9 
(5/130) 
2.81 (0.86) 
EBM – Evidence Based Medicine; RCTs – Randomised Controlled Trials; EBGs – Evidence Based Guidelines; n/N& item response rate/unit 
response rate; n/N – number of reported events/Number of responses; SD – standard deviation 
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Table 9. Types of research used 
Allowable responses:  Never (Score 1); Rarely = once or twice a year (Score 2); Sometimes = every month or so (Score 3); 
Often = every week or so (Score 4); Very often = every day or so (Score 5). 
Variable  
(Question and response item) 
Listed in order from most highly ranked  
Response 
Rate  
(n/N)
&
 
Respondents selecting each response category  
Percent (n/N) 
Mean score 
(SD) 
1 2 3 4 5 
Q28. How often do you use the following information sources to guide decisions in your clinical practice? 
    Published EBGs 130/133 
0 
(0/130) 
3.1 
(4/130) 
43.1 
(56/130) 
46.1 
(60/130 
7.7 
(10/130 
3.58 (0.68) 
    Results of an RCT 129/133 
0 
(0/129) 
5.4 
(7/129) 
41.1 
(53/129 
47.3 
(61/129) 
6.2 
(8/129) 
3.54 (0.70) 
    Advice given by colleague 130/133 
0 
(0/130) 
6.9 
(9/130) 
50.8 
(66/130) 
34.6 
(45/130) 
7.7 
(10/130) 
3.43 (0.74) 
    Textbook information 129/133 
0 
(0/130) 
14.0 
(18/129) 
51.9 
(67/129) 
30.2 
(39/129) 
3.9 
(5/129) 
3.24 (0.77) 
    Conference presentations 130/133 
0 
(0/130) 
20.0 
(26/130) 
47.7 
(62/130) 
28.5 
(37/130) 
3.9 
(5/130) 
3.16 (0.79) 
    Results of a Meta-analysis 130/133 
2.3 
(3/130) 
23.9 
(31/130) 
47.7 
(62/130) 
23.1 
(30/130) 
3.1 
(4/130) 
3.01 (0.83) 
    Information from Google search 130/133 
3.9 
(5/130) 
26.2 
(34/130) 
41.5 
(54/130) 
23.1 
(30/130) 
5.4 
(7/130) 
3.00 (0.93) 
    Evidence summary journals 129/133 
8.5 
(11/129) 
28.7 
(37/129) 
39.5 
(51/129) 
17.8 
(23/129) 
5.4 
(7/129) 
2.83 (1.00) 
    Results of Cochrane review 130/133 
3.1 
(4/130) 
29.2 
(38/130) 
53.1 
(69/130) 
13.9 
(18/130) 
0.8 
(1/130) 
2.80 (0.74) 
EBGs – Evidence Based Guidelines; RCTs – Randomised Controlled Trials; n/N& item response rate/unit response rate; n/N – number of 
reported events/Number of responses; SD – standard deviation 
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Table 10. Situations where research is used 
Allowable responses:  Never (Score 1); Rarely = once or twice a year (Score 2); Sometimes = every month or so (Score 3);  
Often = every week or so (Score 4); Very often = every day or so (Score 5). 
Variable  
(Question and response item) 
Listed in order from most highly ranked  
Response 
Rate  
(n/N)
&
 
Respondents selecting each response category  
Percent (n/N) 
Mean score 
(SD) 
1 2 3 4 5 
Q29: How often do you use published research evidence in the following situations? 
    Preparing a presentation for colleagues 129/133 
0 
(0/129) 
4.7 
(6/129) 
30.2 
(39/129) 
48.8 
(63/129) 
16.3 
(21/129) 3.77 (0.76) 
    Preparing a teaching session for trainees 129/133 
0 
(0/129) 
3.9 
(5/129) 
32.6 
(42/129) 
48.1 
(62/129) 
15.5 
(20/129) 
3.75 (0.76) 
    Improving my knowledge 130/133 
0 
(0/130) 
3.1 
(4/130) 
29.2 
(38/130) 
58.5 
(76/130) 
9.2 
(12/130) 
3.74 (0.67) 
    Developing guidelines or protocols 129/133 
0.8 
(1/129) 
11.6 
(15/129) 
30.2 
(39/129) 
43.4 
(56/129) 
14.0 
(18/129) 
3.58 (0.90) 
    Making individual patient care decisions 128/133 
0 
(0/128) 
7.8 
(10/128) 
39.1 
(50/128) 
43.0 
(55/128) 
10.2 
(13/128) 
3.55 (0.78) 
    Settling clinical dispute re patient management 128/133 
1.6 
(2/128) 
15.6 
(20/128) 
45.3 
(58/128) 
32.0 
(41/128) 
5.5 
(7/128) 
3.24 (0.84) 
    Reviewing management of a past patient (eg M&Ms) 129/133 
0.8 
(1/129) 
10.9 
(14/129) 
58.9 
(76/129) 
25.6 
(33/129) 
3.9 
(5/129) 
3.21 (0.71) 
    Preparing to provide information to patient / NOK 129/133 
3.9 
(5/129) 
36.4 
(47/129) 
39.5 
(51/129) 
20.2 
(26/129) 
0 
(0/129) 
2.76 (0.82) 
M&M – morbidity and mortality meetings; NOK – next of kin; n/N& item response rate/unit response rate; n/N – number of reported 
events/Number of responses; SD – standard deviation 
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Table 11. Factors that help the use of research to change practice 
Variable  
(Question and response item) 
Listed in order from most highly ranked 
Response 
Rate  
(n/N)
&
 
Respondents selecting each response category * 
Percent (n/N)  
Mean score 
(SD) 
1 2 3 4 5 
Q30: How often are the following factors likely to help your decision to use the results of published research evidence to change practice? 
The results have clear benefit to my patients 129/133 
0 
(0/129) 
0 
(0/129) 
2.3 
(3/129) 
58.9 
(76/129) 
38.8 
(50/129) 
4.36 (0.53) 
The project was methodologically sound, with no major 
flaws 
129/133 
0 
(0/129) 
0 
(0/129) 
8.5 
(11/129) 
62.8 
(81/129) 
28.7 
(37/129) 
4.20 (0.58) 
The intervention is described in enough detail so that I could 
implement it in my clinical practice 
128/133 
0 
(0/128) 
15.6 
(2/128) 
11.7 
(15/128) 
58.6 
(75/128) 
28.1 
(36/128) 
4.13 (0.67) 
The paper fully explored all the possible benefits and harms 129/133 
0 
(0/129) 
0.8 
(1/129) 
12.4 
(16/129) 
65.9 
(85/129) 
20.9 
(27/129) 
4.07 (0.60) 
The project included a lot of patients 128/133 
0 
(0/128) 
0.8 
(1/128) 
17.2 
(22/128) 
62.5 
(80/128) 
19.5 
(25/128) 
4.01 (0.63) 
I understand the pathophysiological rationale of the 
intervention 
129/133 
0 
(0/129) 
2.3 
(3/129) 
18.6 
(24/129) 
55.0 
(71/129) 
24.0 
(31/129) 
4.01 (0.72) 
The paper was clearly written (i.e. concise, coherent, to the 
point, logical) 
128/133 
0 
(0/128) 
0 
(0/128) 
14.8 
(19/128) 
71.1 
(91/128) 
14.1 
(18/128) 
3.99 (0.54) 
The paper is the second publication on this topic to 
demonstrate a significant benefit to patients 
129/133 
0.8 
(1/129) 
2.3 
(3/129) 
23.3 
(30/129) 
55.0 
(71/129) 
18.6 
(24/129) 
3.88 (0.76) 
The project involved multiple study centres 129/133 
0 
(0/129) 
3.9 
(5/129) 
27.1 
(35/129) 
50.4 
(65/129) 
18.6 
(24/129) 
3.84 (0.77) 
Other Intensivists have changed practice based on this paper 129/133 
0 
(0/129) 
9.3 
(12/129) 
34.1 
(44/129) 
41.1 
(53/129) 
15.5 
(20/129) 
3.63 (0.86) 
The project was conducted in my own health care system 129/133 
4.7 
(6/129) 
11.6 
(15/129) 
29.5 
(38/129) 
42.6 
(55/129) 
11.6 
(15/129) 
3.45 (1.00) 
The results will reduce costs but patient outcomes will not be 
compromised 
129/133 
1.6 
(2/129) 
15.5 
(20/129) 
39.5 
(51/129) 
38.8 
(50/129) 
4.7 
(6/129) 
3.29 (0.84) 
# 
table continued over page 
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#
 table continued from previous page 
The paper was written by a recognised expert in the field 129/133 
1.6 
(2/129) 
20.2 
(26/129) 
34.9 
(45/129) 
39.5 
(51/129) 
3.9 
(5/129) 
3.24 (0.87) 
The CONSORT or QUOROM statements were followed 115/133 
9.6 
(11/115) 
9.6 
(11/115) 
42.6 
(49/115) 
28.7 
(33/115) 
7.8 
(9/115) 
3.10 (1.04) 
I have seen the author present the findings of the project at a 
conference 
128/133 
2.3 
(3/128) 
27.3 
(35/128) 
39.1 
(50/128) 
25.0 
(32/128) 
5.5 
(7/128) 
3.02 (0.92) 
The paper presents a full economic analysis 129/133 
7.0 
(9/129) 
31.0 
(40/129) 
37.2 
(48/129) 
22.5 
(29/129) 
2.3 
(3/129) 
2.82 (0.94) 
CONSORT - Consolidated Standards of Reporting Trials; QUOROM - Quality of Reporting of Meta-analyses; n/N
&
 item response rate/unit 
response rate; n/N – number of reported events/Number of responses; SD – standard deviation 
* Response options:  Never helps (Score 1); Rarely helps (Score 2); Sometimes helps (Score 3); Often helps (Score 4); Very often helps (Score 5). 
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Table 12. Factors that inhibit the use of research in clinical practice 
Variable  
 
Response 
Rate (n/N)
&
 
Responses to each category * Percent (n/N)  Mean score 
(SD) 1 2 3 4 5 
Q31: The following factors inhibit my use of published research evidence in clinical practice 
I believe there is a lack of good evidence providing 
meaningful answers to my clinical problems. 
129/133 
1.6 
(2/129) 
10.9 
(14/129) 
31.0 
(40/129) 
45.0 
(58/129) 
11.6 
(15/129) 
3.54 (0.89) 
Individual patient variation is not accounted for in the results 
of published research. 
128/133 
1.6 
(2/128) 
20.3 
(26/128) 
25.8 
(33/128) 
42.2 
(54/128) 
10.2 
(13/128) 
3.39 (0.97) 
I have difficulty finding the time to read. 130/133 
3.1 
(4/130) 
19.2 
(25/130) 
20.8 
(27/130) 
50.0 
(65/130) 
6.9 
(9/130) 
3.38 (0.98) 
I can find papers using MEDLINE, but it is difficult to find 
key papers good enough to guide my practice. 
130/133 
5.4 
(7/130) 
29.2 
(38/130) 
20.8 
(27/130) 
37.7 
(49/130) 
6.9 
(9/130) 
3.12 (1.08) 
I do not trust observational studies enough to use them to 
guide my practice. 
129/133 
6.2 
(8/129) 
27.1 
(35/129) 
35.7 
(46/129) 
26.4 
(34/129) 
4.7 
(6/129) 
2.96 (0.99) 
I do not have enough training in EBM. 130/133 
8.5 
(11/130) 
30.8 
(40/130) 
30.8 
(40/130) 
25.4 
(33/130) 
4.6 
(6/130) 
2.87 (1.04) 
I have difficulties convincing my hospital to stock new drugs. 129/133 
7.0 
(9/129) 
37.2 
(48/129) 
29.5 
(38/129) 
23.3 
(30/129) 
3.1 
(4/129) 
2.78 (0.98) 
I have difficulties critically appraising papers. 130/133 
11.5 
(15/130) 
35.4 
(46/130) 
26.9 
(35/130) 
24.6 
(32/130) 
1.5 
(2/130) 
2.69 (1.02) 
I have insufficient authority to introduce some new practices 
into my hospital. 
129/133 
10.1 
(13/129) 
41.9 
(54/129) 
20.2 
(26/129) 
25.6 
(33/129) 
2.3 
(3/129) 
2.68 (1.04) 
My colleagues do not support me when I am the first to 
change my own practice using new research evidence. 
129/133 
7.8 
(10/129) 
44.2 
(57/129) 
34.9 
(45/129) 
11.6 
(15/129) 
1.6 
(2/129) 
2.55 (0.86) 
I have difficulties using MEDLINE. 130/133 
19.2 
(25/130) 
46.2 
(60/130) 
14.6 
(19/130) 
16.2 
(21/130) 
3.9 
(5/130) 
2.39 (1.09) 
Studies conducted in Europe and the USA do not apply to my 
patients. 
130/133 
12.3 
(16/130) 
53.9 
(70/130) 
24.6 
(32/130) 
7.7 
(10/130) 
1.5 
(2/130) 
2.32 (0.85) 
Appraising published research papers is not part of my role. 129/133 
22.5 
(29/129) 
53.5 
(69/129) 
14.0 
(18/129) 
9.3 
(12/129) 
0.8 
(1/129) 
2.12 (0.89) 
MEDLINE - U.S. National Library of Medicine® premier bibliographic database; EBM – Evidence Based Medicine; USA – United States of 
America;  n/N
&
 item response rate/unit response rate; n/N – number of reported events/Number of responses; SD – standard deviation 
* Response options:  Strongly disagree (Score 1); Disagree (Score 2); Neutral (Score 3); Agree (Score 4); Strongly agree (Score 5)
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 Aim 2: To assess the level, patterns and characteristics of appropriate use of research 
evidence in intensive care medicine in Australia and New Zealand using a metric 
proposed and evaluated by De Vito et al.
45
  
 Appropriate use rates 
Items contributing to the calculation of the appropriate use metric 
According to the metric proposed by De Vito et al., appropriate use of research 
evidence is defined as reading RCTs and systematic reviews at least sometimes and using 
RCTs and systematic reviews in clinical practice at least sometimes.
45
  
Whilst 97.7 % (127/130) of respondents reported reading RCTs at least sometimes, 
93.8% (122/129) of respondents reported using RCTs to guide clinical practice at least 
sometimes. Furthermore, 83.8% (109/130) of respondents reported reading systematic reviews 
at least sometimes, whilst 73.8% (96/130) reported using systematic reviews to guide clinical 
practice at least sometimes. Table 13 shows complete responses for each category to the four 
key questions used to score appropriate use.  
Calculation of appropriate use rate  
A total of 129 respondents (N=129) provided complete responses to all four key 
questions and were eligible for calculation of the appropriate use metric. From these 129 
respondents, 88 (n) reported they read RCTs at least sometimes and read systematic reviews at 
least sometimes and used RCTs at least sometimes and used systematic reviews at least 
sometimes. Thus, the overall appropriate use rate was 88/129 (68.2%, 95% CI 59.4 to 76.1).  
Characteristics of appropriate users vs. non-users 
Demographics 
There was no significant difference in the age (50.48 vs. 52.12 years, P=0.32), gender 
(males 82.6% vs. 82.9%, P=0.96) or years practicing intensive care (12.55 vs. 12.74, P=0.89) 
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of appropriate users compared to non-users. Complete details of demographic characteristics 
can be seen in Table 14. 
Research experience 
Significantly more appropriate users reported they had published a paper as a named 
contributing or primary author (72/87 vs. 27/41, P=0.034), consented a patient for enrolment 
in a clinical trial (81/87 vs. 33/41, P=0.034) and had been involved in the running of funded 
clinical trials (51/87 vs. 11/41, P=0.00080). Furthermore, there was a trend towards more 
appropriate users reporting they had formal training in evidence-based medicine (41/87 vs. 
12/41, P=0.057). There were no differences in any other aspects of research experience (Table 
15). 
Research Knowledge 
Appropriate users scored significantly higher on the six knowledge questions than non-
users (mean score 3.26/6 vs. 2.24/6, P=0.0014). Table 16 lists complete details of all six 
knowledge statements, item response rates and the number of correct responses by group for 
each question.  
Research attitudes 
Appropriate users had significantly stronger positive feelings towards evidence-based 
medicine (mean score 3.76 vs. 3.05, P<0.0001), significantly stronger positive feelings towards 
using RCTs to guide clinical practice (mean score 4.01 vs. 3.78, P=0.048) and significantly 
stronger positive feelings towards using systematic reviews to guide clinical practice (3.80 vs. 
2.8, P<0.0001). Appropriate users demonstrated a trend towards stronger disagreement with the 
statement research evidence has not made a difference to my clinical practice (mean score 1.65 
vs. 1.93, P=0.055). No other aspects of research attitudes differed between groups (see Table 
17 for complete details).  
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Research use 
The responses to the five point balanced Likert scale rating frequency were graded such 
that a score of three equated to the statement at least sometimes. The scale ranged from a score 
of one (never) to a score of five (very often). Table 18, Table 19 and Table 20 report questions 
related to frequency of research use. Complete details of the scale can be found in these tables. 
Appropriate users reported using the concepts of EBM in clinical practice significantly 
more frequently than non-users (mean score 4.09 vs. 3.54, P<0.0001).  
Appropriate users reported reading all types of information resources significantly 
more frequently than non-users: (RCT mean frequency score 3.86 vs. 3.44, P=0.00070; clinical 
practice guideline frequency score 3.56 vs. 2.95, P<0.0001; textbook frequency score 3.43 vs. 
3.00, P=0.029; systematic review frequency score 3.43 vs. 2.56, P<0.0001; Cochrane Library 
frequency score 3.02 vs. 2.34, P<0.0001). Table 18 reports complete results. 
Appropriate users also reported using most types of information resources to guide 
clinical practice significantly more frequently than non-users: (RCT mean frequency score 3.75 
vs. 3.24, P<0.0001; clinical practice guideline frequency score 3.75 vs. 3.24, P<0.0001; 
systematic review frequency score 3.42 vs. 2.10, P<0.0001; Cochrane Library frequency score 
3.03 vs. 2.29, P<0.0001). There was a trend towards more frequent use of textbooks to guide 
clinical practice by appropriate users (frequency score 3.18 vs. 3.06, P=0.099). There was no 
difference between groups with regards to the frequency of using advice given by colleagues, 
conference presentations, information from a Google search or evidence summary journals. 
Table 19 lists complete details for this item.  
Besides using research evidence to guide clinical practice, appropriate users reported 
using published research evidence significantly more frequently in teaching sessions for 
trainees (mean frequency score 3.85 vs. 3.53, P=0.024), to improve my knowledge (mean 
frequency score 3.92 vs. 3.37, P<0.0001), to settle a clinical dispute regarding patient 
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management (mean frequency score 3.43 vs. 2.86, P=0.0004), for conducting Mortality and 
Morbidity rounds (mean frequency score 3.32 vs. 2.96, P=0.012), and to prepare to provide 
information to a patient or patient’s family (mean frequency score 2.89vs. 2.50, P=0.013). 
There was a trend towards more frequent use of research evidence by appropriate users to 
develop guidelines or protocols (mean frequency score 3.67 vs. 3.38, P=0.086). Complete 
details for all items related to situations where research evidence is used can be seen in Table 
20. 
The responses to the five point balanced Likert scale rating factors that might help 
research evidence to change practice were graded such that a score of three equated to the 
statement sometimes helps. The scale ranged from a score of one (never helps) to a score of 
five (very often helps). Table 21 reports complete responses to this question and presents 
complete details of the response scale. 
Appropriate users reported that if a project was methodologically sound, with no major 
flaws it was significantly more likely to help change practice compared to non-users (mean 
score 4.32 vs. 3.93, P=0.0003). Furthermore, compared to non-users, appropriate users judged 
research evidence as significantly more likely to help change practice if the paper fully 
explored all possible benefits and harms (mean score 4.16 vs. 3.88, P=0.013), included a lot of 
patients (mean score 4.08 vs. 3.82, P=0.032), was clearly written (mean score 4.10 vs. 3.83, 
P=0.018), involved multiple study centres (mean score 4.02 vs. 3.43, P<0.0001), was consistent 
with the CONSORT or QUORUM statements (mean score 3.10 vs. 2.87, P=0.015), and 
presented a full economic analysis (mean score 3.01 vs. 2.43, P=0.00090). 
The responses to the five point balanced Likert scale rating agreement with statements 
regarding factors that may inhibit the use of research evidence were graded such that a score of 
three equated to neutral. The scale ranged from a score of one (strongly disagree) to a score of 
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five (strongly agree). Table 22 reports complete responses to this question and presents 
complete details of the response scale. 
Overall, appropriate users demonstrated less agreement with statements regarding 
potential factors that may inhibit the use of research evidence. Compared to non-users, 
appropriate users reported significantly weaker agreement with the statements individual 
patient variation is not accounted for in the results of published research (mean score 3.25 vs. 
3.69, P=0.018) and appraising published research papers is not part of my role (mean score 
1.94 vs. 2.55, P=0.00030). Appropriate users reported a trend towards weaker agreement with 
the statements I can find papers using MEDLINE, but it is difficult to find key papers good 
enough to guide my practice (mean score 2.99 vs. 3.37, P=0.064), I have difficulties using 
MEDLINE (2.25 vs. 2.63, P=0.057) and I do not have enough training in EBM (mean score 
2.75 vs. 3.10, P=0.076). 
Table 22 provides details of all responses related to this question. 
  
1
3
8
 
Table 13 Individual responses to key questions used to score appropriate use 
Allowable responses:  Never (1); Rarely = once or twice a year (2); Sometimes = every month or so (3);  
Often = every week or so (4); Very often = every day or so (5). 
Variable  
(Question and response item) 
Listed in order from most highly ranked  
Response 
Rate  
(n/N)
& 
Respondents selecting each response category  
Percent (n/N) 
Mean score 
(SD) 
1 2 3* 4* 5* 
Q27: How often do you read the following:  
 
 
     
 
a: Published RCTs 130/133 
0 
(0/130) 
2.3 
(3/130) 
32.3 
(42/130) 
55.4 
(72/130) 
10.0 
(13/130) 
3.73 (0.67) 
e: Published Meta-analyses 130/133 
1.5 
(2/130) 
14.6 
(19/130) 
51.5 
(67/130) 
30.8 
(40/130) 
1.5 
(2/130) 
3.16 (0.75) 
Q28. How often do you use the following information 
sources to guide decisions in your clinical practice? 
 
     
 
e: Results of an RCT 129/133 
0 
(0/130) 
5.4 
(7/130) 
41.1 
(53/129) 
47.3 
(61/129) 
6.2 
(8/129) 
3.54 (0.70) 
i: Results of a Meta-analysis 130/133 
2.3 
(3/130) 
23.9 
(31/130) 
47.7 
(62/130) 
23.1 
(30/130) 
3.1 
(4/130) 
3.01 (0.83) 
RCTs – randomised controlled trials; n/N& item response rate/unit response rate; n/N – number of reported events/Number of responses; SD – 
standard deviation 
*A response of sometimes (3), often (4) or very often (5) contributed to the appropriate use metric 
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Table 14. Appropriate users vs. non-users: Demographics 
Variable Appropriate 
Users (N= 88) 
Non-Users  
(N=41) 
P-value 
Q1. Years practising as a Registered 
Intensive Care Specialist, mean (SD) 
12.55 (7.42) 
n=86 
12.74 (6.24) 
n=39 
0.89 
Q2. Gender - male, percent (n/N)  82.6% (71/86) 82.9% (34/41) 0.96 
Q3. Age in years, mean (SD) 50.48 (8.25) 52.19 (9.12) 0.32 
n/N – number of reported events/Number of responses; SD – standard deviation 
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Table 15. Appropriate users vs. non-users: Research experience 
Variable 
Appropriate Users 
percent (n/N) 
Non-Users 
percent (n/N) 
P-value  
Q4. Level of training or qualification in research
*
   
Research Fellowship
*
 8.1% (7/87) 12.2% (5/41) 0.45 
Formal Research Course
*
 10.3% (9/87) 4.9% (2/41) 0.31 
Graduate Level Research Course
*
 26.4% (23/87) 14.6% (6/41) 
0.22 
Graduate Certificate 0% (0/23) 0% (0/6) 
Graduate Diploma 26.1% (6/23) 0% (0/6) 
Masters 26.1% (6/23) 33.3% (2/6) 
PhD 47.8% (11/23) 66.7% (4/6) 
No formal research qualification 66.7% (58/87) 70.7% (29/41) 0.65 
Q5. Level of training or qualification in EBM
#
   
Non-university course or workshop
#
 39.1% (34/87) 29.3% (12/41) 0.28 
University course or workshop
#
 11.5% (10/87) 9.8% (4/41) 0.77 
McMaster University course or 
workshop
#
 
0 0  
No formal EBM training  52.9% (46/87) 70.7% (29/41) 0.057 
Q6. Academic appointment held at a 
university, percent (n/N) 
57.0% (49/86) 57.5% (23/40) 0.96 
Q7. Have you ever published any 
research papers as a named 
contributing or primary author? 
82.8% (72/87) 65.9% (27/41) 0.034 
Q8. Are you involved in the running 
of any funded clinical trials? 
58.6% (51/87) 26.8% (11/41) 0.00080 
Q9. Have you ever consented a patient 
for a clinical trial? 
93.1% (81/87) 80.5% (33/41) 0.034 
Q10. Are you or have you been named 
as an investigator on an ethics 
submission for a funded clinical trial? 
69.0% (60/87) 65.9% (27/41) 0.73 
Q11. Weekly CME hours, mean(SD) 
7.27 (3.74) 
n=88 
5.83 (5.37) 
n=41 
0.13 
Q12. Frequency of internet use: percent (n/N)   
Daily 98.9% (86/87) 95.1% (39/41) 
0.20 
At least weekly 1.2% (1/87) 4.9% (2/41) 
Less than weekly 0 0  
Never 0 0  
Q13. Use a computer for the purposes of:  percent (n/N)
&
   
Word processing 94.3% (83/88) 95.1% (39/41) 0.94 
Data analysis 55.7% (49/88) 43.9% (18/41) 0.19 
Search databases for published 
papers 
95.5% (84/88) 87.8% (36/41) 0.057 
Other  79.3% (68/87) 88.1% (36/42) 0.44 
PhD – Doctor of Philosophy; EBM – Evidence Based Medicine; CME – continuing medical 
education; n/N – number of reported events/Number of responses 
*respondents able to select more than one level of training or qualification in research 
#
respondents able to select more than one level of training or qualification in EBM 
&
respondents able to select more than one purpose for using a computer 
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Table 16. Appropriate users vs. non-users: Research knowledge 
Variable  
(Question number and correct answer) 
Appropriate 
Users 
percent (n/N) 
Non-Users 
percent 
(n/N) 
P-value 
Q14. The CONSORT Statement is an international 
guidance document intended to improve the 
reporting of RCT's.  
(True) 
69.3%  
(61/88) 
41.5%  
(17/41) 
0.0027 
 
Q15. Allocation concealment refers to the act of 
masking which treatment a patient enrolled in a 
clinical trial is currently receiving from the treating 
clinician.  
(False) 
33.0%  
(29/88) 
25.0%  
(10/40) 
0.37 
Q16. The PRISMA Statement is an international 
guidance document intended to address the 
suboptimal reporting of systematic reviews and 
meta-analyses of RCTs.  
(True) 
51.7%  
(45/87) 
29.3%  
(12/41) 
0.018 
 
Q17. Conventionally, results in a clinical trial are 
considered to be statistically significant (ie unlikely 
to have arisen by chance) if the p value is less than 
0.05 (p<0.05).  
(True) 
98.9%  
(87/88) 
90.2%  
(37/41) 
0.019 
Q18. In a meta-analysis, the I
2 
metric is a measure 
of heterogeneity that is dependent on the number of 
patients included in a trial. (True) 
19.3%  
(17/88) 
12.5%  
(5/40) 
0.35 
Q19. The forest plot is a graph used in a meta-
analysis to detect publication bias in which the 
estimate of risk is plotted against sample size.  
(False) 
54.6%  
(48/88) 
27.5%  
(11/40) 
0.0046 
 
    
 Average score out of 6 (SD) 3.26 (1.66) 2.24 (1.61) 0.0014 
CONSORT - Consolidated Standards of Reporting Trials; RCTs – randomised controlled trials; 
PRISMA - Preferred Reporting Items for Systematic Reviews and Meta-Analyses; n/N – 
number of reported events/Number of responses 
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Table 17. Appropriate users vs. non-users: Research attitudes 
Allowable responses:  Strongly disagree (Score 1); Disagree (Score 2); Neutral (Score 3); 
Agree (Score 4); Strongly agree (Score 5) 
 
Appropriate 
Users (N=88) 
Non-Users 
(N=41) 
 
Variable  (Question number) Mean Score (SD) P-value 
 
Q20. Positive feelings towards EBM*  
 
3.76 (0.86) 3.05 (1.02) 0.00010 
Q21. Colleagues positive feelings towards EBM* 
3.83 (0.73) 
n=87 
3.68 (0.69) 
n=41 
0.29 
Q22. Positive feelings towards using RCTs to 
guide clinical practice*  
4.01 (0.49) 3.78 (0.65) 0.048 
Q23. Positive feelings towards using systematic 
review/meta-analysis to guide clinical practice* 
3.80 (0.61) 2.83 (0.83) <0.0001 
Q24. Time limitations restrict the incorporation of 
EBM into my clinical practice* 
2.66 (1.04) 2.68 (0.99) 0.90 
Q25. Research evidence has not made a difference 
to my clinical practice* 
1.67 (0.72) 1.93 (0.65) 0.055 
EBM – Evidence Based Medicine; RCT's – Randomised Controlled Trials; SD – standard 
deviation 
*Summary of question only, for complete wording of questions, see Appendix C. 
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Table 18. Appropriate users vs. non-users: Frequency of research use 
Allowable responses:  Never (Score 1); Rarely = once or twice a year (Score 2); 
Sometimes = every month or so (Score 3); Often = every week or so (Score 4); 
Very often = every day or so (Score 5). 
Variable  
Appropriate 
Users (N=88) 
Non-Users 
(N=41) 
 
(Question number and response item) Mean Score (SD) P-value 
Q26. How often do you use the concepts of 
EBM in your clinical practice? 
4.09 (0.67) 3.54 (0.81) <0.0001 
Q27: How often do you read the following:     
Published RCTs 3.86 (0.63) 3.44 (0.67) 0.00070 
Published EBGs 3.56 (0.62) 2.95 (0.74) <0.0001 
Textbooks 3.43 (0.76) 3.00 (1.12) 0.029 
Published Meta-analyses 3.43 (0.54) 2.56 (0.78) <0.0001 
Information in Cochrane Library 
3.02 (0.76) 
n=87 
2.34 (0.88) 
n=41 
<0.0001 
EBM – Evidence Based Medicine; RCTs – Randomised Controlled Trials; EBGs – Evidence 
Based Guidelines; SD – standard deviation 
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Table 19. Appropriate users vs. non-users: Types of research used  
Allowable responses:  Never (Score 1); Rarely = once or twice a year (Score 2); 
Sometimes = every month or so (Score 3); Often = every week or so (Score 4); 
Very often = every day or so (Score 5). 
Variable  
Appropriate 
Users (N=88) 
Non-Users 
(N=41) 
 
(Question number and response item) Mean Score (SD) P-value 
Q28.  How often do you use the following information sources to guide decisions in your 
clinical practice? 
Published EBGs 3.75 (0.63)  3.24 (0.66) 
 
<0.0001 
Results of an RCT 3.73 (0.62)  3.15 (0.69) 
 
<0.0001 
Advice given by colleague 3.40 (0.67)  3.54 (0.84) 
 
0.32 
Textbook information 
3.31 (0.73) 
 
n=88 
3.06 (0.73) 
n=40
 0.099 
Conference presentations 3.18 (0.81)
 
 3.10 (0.74)
 
0.57 
Results of a Meta-analysis 3.42 (0.58)  2.10 (0.49) 
 
<0.0001 
Information from Google search 3.09 (0.92)  2.83 (0.95) 
 
0.14 
Evidence summary journals 
2.92 (1.04)  
n=87 
2.66 (0.91) 
 
n=41
 0.17 
Results of Cochrane review 3.03 (0.63)  2.29 (0.72) 
 
<0.0001 
EBGs – Evidence Based Guidelines; RCTs – Randomised Controlled Trials; SD – standard 
deviation 
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Table 20. Appropriate users vs. non-users: Situations where research is used 
Allowable responses:  Never (Score 1); Rarely = once or twice a year (Score 2); 
Sometimes = every month or so (Score 3); Often = every week or so (Score 4); 
Very often = every day or so (Score 5). 
Variable  
Appropriate 
Users (N=88) 
Non-Users 
(N=41) 
 
(Question and response item) Mean Score (SD) P-value 
Q29: How often do you use published research evidence in the following situations 
Preparing a presentation for colleagues 
3.84 (0.76) 
 
n=88 
3.63 (0.81) 
n=40
 0.15 
Preparing a teaching session for trainees 3.85 (0.74) 3.53 (0.78) 
 
0.024 
Improving my knowledge 3.92 (0.59)  3.37 (0.66) 
 
<0.0001 
Developing guidelines or protocols 
3.67 (0.85) 
 
n=88 
3.38 (0.98) 
 
n=40
 0.086 
Making individual patient care decisions 
3.73 (0.71)
  
n=88 
3.15 (0.81)
 
n=39 
<0.0001 
Settling clinical dispute re patient management 
3.43 (0.83) 
 
n=87 
2.86 (0.72) 
 
n=40 
0.00040 
Reviewing management of a past patient (e.g. 
M&Ms) 
3.32 (0.75)  
n=88 
2.96 (0.58) 
 
n=40
 0.012 
Preparing to provide information to patient/ NOK 
2.89 (0.78) 
 
n=88 
2.50 (0.85) 
 
n=40
 0.013 
M&M – morbidity and mortality meetings; NOK – next of kin; SD – standard deviation 
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Table 21. Appropriate users vs. non-users: Factors that help the use of research to change 
practice 
Allowable responses:  Never helps (Score 1); Rarely helps (Score 2); 
Sometimes helps (Score 3); Often helps (Score 4); Very often helps (Score 5). 
Variable  
Appropriate 
Users (N=88) 
Non-Users 
(N=41) 
 
(Question and response item) Mean Score (SD) P-value 
Q30: How often are the following factors likely to help your decision to use results of 
published research evidence to change practice? 
The results have clear benefit to my patients 
4.41 (0.54)  
n=88 
4.28 (0.51) 
 
n=40
 0.19 
The project was methodologically sound, with no 
major flaws 
4.32 (0.58)  
n=88 
3.93 (0.47) 
 
n=40
 0.00030 
The intervention is described in enough detail so 
that I could implement it in my clinical practice 
4.21 (0.70) 
 
n=87 
4.00 (0.55) 
n=41 
 0.10 
The paper fully explored all the possible benefits 
and harms 
4.16 (0.59)  
n=88 
3.88 (0.61)
 
n=40
 0.013 
The project included a lot of patients 
4.08 (0.63)
  
n=88 
3.82 (0.60) 
 
n=39
 0.032 
I understand the pathophysiological rationale of 
the intervention 
4.00 (0.71) 
n=88 
4.03 (0.77) 
n=40
 0.86 
The paper was clearly written (i.e. concise, 
coherent, to the point, logical) 
4.10 (0.57) 
 
n=87 
3.83 (0.45) 
 
n=40
 0.018 
The paper is the second publication on this topic 
to demonstrate a significant benefit to patients  
3.97 (0.76)  
n=88 
3.70 (0.72) 
 
n=40
 0.066 
The project involved multiple study centres 
4.02 (0.71)
  
n=88 
3.43 (0.75)
 
n=40
 <0.0001 
Other Intensivists have changed practice based on 
this paper 
3.68 (0.84)  
n=88 
3.55 (0.88) 
 
n=40
 0.42 
The project was conducted in my own health care 
system 
3.55 (0.98)  
n=88 
3.23 (1.03) 
 
n=40 
0.094 
The results will reduce costs but patient outcomes 
will not be compromised 
3.36 (0.80) 
n=88 
3.15 (0.92) 
 
n=40
 0.19 
The paper was written by a recognised expert in 
the field 
3.30 (0.85) 
n=88 
3.13 (0.94) 
 
n=40
 0.31 
The CONSORT or QUOROM statements were 
followed 
3.31 (0.97)
 
n=81 
2.77 (1.15) 
 
n=31
 0.015 
I have seen the author present the findings of the 
project at a conference 
3.10 (0.90)
 
n=87 
2.87 (0.95) 
 
n=39
 0.19 
The paper presents a full economic analysis 
3.01 (0.94)
 
n=88 
2.43 (0.84)
 
n=40
 0.00090 
CONSORT - Consolidated Standards of Reporting Trials; QUOROM - Quality of Reporting of 
Meta-analyses; SD – standard deviation 
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Table 22. Appropriate users vs. non-users: Factors that inhibit the use of research in 
clinical practice 
Allowable responses:  Strongly disagree (Score 1); Disagree (Score 2);  
Neutral (Score 3); Agree (Score 4); Strongly agree (Score 5). 
Variable  
Appropriate 
Users (N=88) 
Non-Users 
(N=41) 
 
(Question and response item) Mean Score (SD) P-value 
Q31: The following factors inhibit my use of published research evidence in clinical 
practice: 
I believe there is a lack of good evidence 
providing meaningful answers to my clinical 
problems. 
3.49 (0.87)  
n=88 
3.63 (0.93) 
 
n=40
 0.42 
Individual patient variation is not accounted for in 
the results of published research. 
3.25 (0.97)  
n=88 
3.69 (0.92) 
 
n=39
 0.018 
I have difficulty finding the time to read. 3.33 (0.97)  3.46 (0.98) 
 
0.47 
I can find papers using MEDLINE, but it is 
difficult to find key papers good enough to guide 
my practice. 
2.99 (1.03) 3.37 (1.13) 
 
0.064 
I do not trust observational studies enough to use 
them to guide my practice. 
2.92 (1.00) 
n=88 
3.03 (0.97)
 
n=40
 0.58 
I do not have enough training in EBM. 2.75 (1.02) 3.10 (1.04)
 
0.076 
I have difficulties convincing my hospital to stock 
new drugs. 
2.80 (1.03) 
n=88 
2.73 (0.88)
 
n=40
 0.71 
I have difficulties critically appraising papers. 2.60 (1.01) 2.88 (1.03) 
 
0.15 
I have insufficient authority to introduce some 
new practices into my hospital. 
2.58 (0.99) 
n=88 
2.88 (1.11) 
n=40
 0.14 
My colleagues do not support me when I am the 
first to change my own practice using new 
research evidence. 
2.52 (0.84)  
n=88 
2.60 (0.90) 
 
n=40
 0.64 
I have difficulties using MEDLINE. 2.25 (1.00) 2.63 (1.18) 
 
0.057 
Studies conducted in Europe and the USA do not 
apply to my patients. 
2.24 (0.86) 2.49 (0.81) 
 
0.12 
Appraising published research papers is not part of 
my role. 
1.94 (0.79)
 
 2.55 (0.96)
 
0.00030 
MEDLINE - U.S. National Library of Medicine® premier bibliographic database; EBM – 
Evidence Based Medicine; USA – United States of America; SD – standard deviation 
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Aim 3: To investigate whether identifiable clinician-level factors, characteristics of 
research studies, and factors that may inhibit research use are associated with the 
appropriate use of published research evidence in intensive care medicine.  
To identify clinician-level factors and characteristics of research studies that were 
associated with the appropriate use of research evidence, multivariable logistic regression 
analysis was conducted. The primary outcome for this analysis was the binary variable 
appropriate use (yes/no). 
Factors under study were identified for evaluation in multivariable regression if the 
univariable P-value was less than 0.10. Backwards stepwise elimination was used to develop a 
final model to identify all statistically significant independent predictors of appropriate use. 
 Univariable analysis 
Clinician-level factors assessed for inclusion in the multivariable model included 
demographics (Table 23), research experience (Table 24) and research knowledge (Table 25). 
Characteristics of research evidence considered for inclusion in the final model are reported in 
Table 26.  Factors that may inhibit the use of research evidence are reported in Table 27. 
The following clinician-level factors were identified as candidates for evaluation in 
multivariable regression based on a univariable regression P-value less than 0.10: No formal 
training in EBM (OR 0.46, P=0.058), published as a named primary author (OR 2.49, 
P=0.036), experience running funded clinical trials (OR 3.86, P=0.00010), have consented a 
patient for a clinical trial (OR 3.27, P=0.040), CME hours per week (OR 1.10, P=0.086), mean 
knowledge score (OR 1.47, P=0.0022) and have used a computer for the purpose of a database 
search (OR 3.89, P=0.073). 
The following characteristics of research studies were identified as candidates for 
evaluation in multivariable regression based on a univariable regression P-value less than 0.10: 
project conducted in own health care system (OR 1.38, P=0.096), project included a lot of 
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patients (OR 1.96, P=0.036), paper was clearly written (OR 2.41, P=0.021), paper fully 
explored all possible benefits and harms (OR 2.26, P=0.017), paper was methodologically 
sound, with no major flaws (OR 3.84, P=0.00080), study consistent with CONSORT or 
QUOROM statements (OR 1.64, P=0.018), project involved multiple study centres (OR 3.07, 
P<0.0001), paper is the second publication on this topic to demonstrate a significant benefit to 
patients (OR 1.59, P=0.071), paper presents a full economic analysis (OR 2.06, P=0.0016).  
Factors that may inhibit research use that were identified as candidates for evaluation in 
multivariable regression based on a univariable regression P-value less than 0.10 included: 
difficulties using MEDLINE (OR 0.72, P=0.060), can find papers using MEDLINE, but 
difficulties finding key papers good enough to guide practice (OR 0.71; 0.066), belief that 
appraising published research papers is not part of job role (OR 0.46, P=0.00070), belief that 
they do not have enough training in EBM (OR 0.72, P=0.078), belief that individual patient 
variation is not accounted for in the results of published research (OR 0.61, P=0.021). 
 Multivariable analysis 
All variables with a P-value less than 0.10 from the univariable analysis were included 
in a comprehensive multivariable model. After backwards stepwise elimination of non-
significant variables, the following variables remained statistically significantly independently 
associated with appropriate use: 
Mean knowledge score from six knowledge questions (OR 1.28, P=0.030),  
Q8: Experience running funded clinical trials (OR 3.35, P=0.0081) and, 
Q30(m): Project involved multiple study centres (OR 2.10, P=0.0017).  
Complete details of the final model are reported in Table 28. 
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Table 23. Demographics: Univariable analysis of relationship with appropriate use 
Variable* Parameter 
Estimate 
SE  
parameter 
estimate 
Odds Ratio 
(95% CI) 
P-value 
Q1. Years practising -0.0040 0.027 
1.00 
(0.94 to 1.05) 
0.88 
Q2. Gender (male referent)  0.013 0.25 
1.03 
(0.383 to 2.750) 
0.96 
Q3. Age in years -0.022 0.022 
0.98 
(0.94 to 1.02) 
0.31 
SE – standard error; CI – confidence interval 
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Table 24.  Research experience: Univariable analysis of relationship with appropriate use 
Variable* Parameter 
Estimate 
Standard 
Error  
Odds Ratio 
(95% CI) 
P-value 
Q4. Research training
*      
   Research Fellowship
*
 0.23 0.31 
1.59 
(0.47 to 5.34) 
0.46 
   Research Course
*
 -0.41 0.40 
0.44        
(0.09 to 2.16) 
0.31 
   Graduate Level Course
* 
0.72 0.50 
2.06 
(0.77 to 5.54) 
0.15 
   None 0.095 0.21 
1.21        
(0.54 to 2.71) 
0.65 
Q5. EBM training
#     
   Non-university course
#
 0.22 0.20 
0.65        
(0.290 to 1.434) 
0.28 
   University course
#
 -0.092 0.31 
0.83        
(0.25 to 2.83) 
0.77 
   McMaster University
#
 0    
   None  0.38 0.20 
0.46 
(0.21 to 1.02) 
0.059 
Q6. Academic appointment  0.011 0.19 
1.02        
(0.48 to 2.18) 
0.96 
Q7. Published author -0.46   0.22 
2.49 
(1.06 to 5.85) 
0.036 
Q8. Run clinical trials -0.67 0.21 
3.86 
(1.72 to 8.70) 
<0.0001 
Q9. Consented a patient -0.59 0.29 
3.27 
(1.05 to 10.20) 
0.040 
Q10. Named on ethics 
submission  
-0.071 0.20 
0.87 
(0.39 to 1.91) 
0.73 
Q11. Weekly CME hours 0.091 0.053 
1.10  
(0.99 to 1.21) 
0.086 
Q12. Internet use:  0.74 0.62 
4.41        
(0.39 to 0.10) 
0.23 
Q13. Computer use:
&
     
    Word processing -0.031 0.44 
0.94  
(0.17 to 5.35) 
0.94 
    Data analysis -0.25 0.19 
0.61 
(0.29 to 1.28) 
0.19 
    Database search -0.68 0.38 
3.89 
(0.88 to 17.20) 
0.073 
    Other  0.35 0.27 
2.01        
(0.69 to 5.83) 
0.20 
CME- continuing medical education; CI – confidence interval 
*respondents able to select more than one level of training or qualification in research 
#respondents able to select more than one level of training or qualification in EBM 
&respondents able to select more than one purpose for using a computer 
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Table 25. Research knowledge: Univariable analysis of relationship with appropriate use 
Variable* 
 
Parameter 
Estimate 
SE 
parameter 
estimate 
Odds Ratio 
95% CI 
P-value 
Q14. CONSORT Statement  1.16 0.39 
3.19 
(1.48 to 6.88) 
0.0031 
Q15. Allocation concealment 0.39 0.43 
1.47        
(0.64 to 3.42) 
0.37 
Q16. PRISMA Statement  0.95 0.41  
2.59        
(1.17 to 5.72) 
0.019 
Q17. Statistical significance  2.24 1.14 
9.41        
(1.02 to 87.02) 
0.048 
Q18. I
2 
metric  0.52 0.55   
1.68        
(0.57 to 4.91) 
0.35 
Q19. Forest plot  1.15 0.41  
3.16        
(1.41 to 7.12) 
0.0054 
Mean knowledge score 0.39 0.13 
1.47 
(1.15 to 1.89) 
0.0022 
CONSORT - Consolidated Standards of Reporting Trials; PRISMA - Preferred Reporting 
Items for Systematic Reviews and Meta-Analyses; SE – standard error; CI – confidence 
interval 
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Table 26. Factors that help research change practice: Univariable analysis of relationship 
with appropriate use 
Variable * 
 
Parameter 
Estimate 
SE 
parameter 
estimate 
Odds Ratio 
95% CI 
P-value 
Q30: Influential factors*     
Results have clear benefit 0.49 0.37 
1.63        
(0.79 to 3.35) 
0.19 
Methodologically sound, no 
major flaws 
1.35 0.40 
3.84        
(1.75 to 8.44) 
0.00080 
Intervention described in 
detail for implementation 
0.47 0.29  
1.61        
(0.90 to 2.85) 
0.11 
Explores benefits and harms 0.82 0.34 
2.26        
(1.16 to 4.41) 
0.017 
Includes a lot of patients 0.68 0.32 
1.96        
(1.05 to 3.68) 
0.036 
Pathophysiological rationale 
is understood 
-0.048 0.26 
0.95        
(0.57 to 1.60) 
0.86 
Clearly written 0.88 0.38 
2.41        
(1.14 to 5.10) 
0.021 
Second publication to show 
benefit  
0.46 0.267 
1.59        
(0.96 to 2.63) 
0.071 
Project involved multiple 
study centres 
1.12 0.29 
3.07        
(1.73 to 5.47) 
<0.0001 
Other Intensivists have 
changed practice from results 
0.19 0.23 
1.20        
(0.77 to 1.88) 
0.42 
Project was conducted own 
health care system 
0.32 0.19 
1.38        
(0.95 to 2.00) 
0.096 
Results will reduce costs but 
not compromise patients   
0.30 0.23 
1.35        
(0.87 to 2.11) 
0.19 
Paper written by expert  0.22 0.22 
1.25        
(0.81 to 1.92) 
0.31 
CONSORT or QUOROM 
followed 
0.50 0.21 
1.64        
(1.09 to 2.48) 
0.018 
Seen author present results at 
a conference 
0.28 0.22    
1.33        
(0.87 to 2.02) 
0.19 
Paper presents economic 
analysis 
0.72 0.23 
2.06        
(1.32 to 3.23) 
0.0016 
CONSORT - Consolidated Standards of Reporting Trials; QUOROM - Quality of Reporting of 
Meta-analyses; SE – standard error; CI – confidence interval 
*Summary of question and identifiers only, for complete wording of questions and influential 
factors, see Appendix C. 
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Table 27. Factors that inhibit research use: Univariable analysis of relationship with 
appropriate use 
Variable* 
 
Parameter 
Estimate 
SE 
parameter 
estimate 
Odds Ratio 
95% CI 
P-value 
Q31: Inhibiting factors*     
Lack of good evidence -0.18 0.22 
0.84        
(0.54 to 1.29) 
0.42 
Individual patient variation is 
not accounted for in results 
-0.50   0.22 
0.61        
(0.40 to 0.93) 
0.021 
Difficulty finding the time to 
read 
-0.15 0.20 
0.86        
(0.58 to 1.28) 
0.46 
Difficult to find key papers 
that are good enough 
-0.34 0.18 
0.71        
(0.50 to 1.02) 
0.066 
Do not trust observational 
studies to guide practice 
-0.11 0.20    
0.90        
(0.61 to 1.31) 
0.58 
Do not have enough training 
in EBM 
-0.33   0.19 
0.72        
(0.50 to 1.04) 
0.078 
Difficulties convincing my 
hospital to stock new drugs 
0.074 0.20 
1.08        
(0.73 to 1.58) 
0.71 
Difficulties critically 
appraising papers 
-0.27 0.19    
0.76        
(0.53 to 1.11) 
0.15 
Insufficient authority to 
introduce new practices 
-0.28 0.19 
0.76        
(0.53 to 1.09) 
0.14 
Colleagues do not support me 
if the first to change practice  
-0.11 0.22 
0.90        
(0.58 to 1.39) 
0.64 
Difficulties using MEDLINE. -0.33 0.18 
0.72        
(0.51 to 1.01) 
0.060 
Studies conducted in Europe 
and USA do not apply  
-0.34 0.22 
0.71        
(0.46 to 1.10) 
0.12 
Appraising published 
research not part of my role 
-0.79 0.23   
0.46        
(0.29 to 0.72) 
0.0007
0 
MEDLINE - U.S. National Library of Medicine
®
 premier bibliographic database; EBM – 
Evidence Based Medicine; SE – standard error; CI – confidence interval 
*Summary of question and identifiers only, for complete wording of questions and inhibiting 
factors, see Appendix C. 
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Table 28. Final multivariable model: Factors independtly associated with appropriate 
use. 
Variable  
 
 
Parameter 
Estimate 
SE 
parameter 
estimate 
Odds Ratio 
95% CI 
P-value 
Mean knowledge score  0.310 0.14 
1.28 
(0.963 to 1.701) 
0.030 
Q8. Involved in running 
funded clinical trials. 
1.21 0.46 
3.35 
(1.369 to 8.214 
0.0081 
Q30m. Multicentred clinical 
trial  
0.74 0.33 
2.10  
(1.101 to 3.994) 
0.024 
SE – standard error; CI – confidence interval; Knowledge score: Total score correct out of six; 
Q8: Is involved in the running of any funded clinical trials; Q30(m): The project involved 
multiple study centres 
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Aim 4: To design an intervention or tool to improve the use of published research 
evidence in clinical decision making.  
 Evidence summary tool development and design  
Literature search 
Key publications that reported clinicians’ attitudes towards research evidence, 
characteristics of published research evidence that help change practice, preferences for types 
of research evidence, or factors inhibit the use of research evidence.
34-36, 39-45, 51, 68, 94, 104
  
Additional key published studies were identified that summarised the literature related 
to barriers encountered by clinicians when using evidence summary resources.
58, 91
  
Mapping exercise 
Ely et al. identified 59 factors commonly encountered by clinicians that inhibit the use 
of research evidence when attempting to answer clinical questions. 
91
 Perrier et al. identified 25 
barriers to research transfer in their review of the field.
58
 Additionally, Heighes and Doig 
investigated the importance of 11 factors that inhibit the use of research evidence amongst 
intensive care clinicians.
104
 The complete list of barriers and inhibitory factors was reviewed by 
two investigators (PTH and GSD) and 27 barriers were deemed relevant and addressable in the 
design of the evidence summary tool. The complete list of barriers is reported in Table 29.  
During the mapping exercise, a specific design element was proposed to ensure each 
barrier was addressed within the evidence summary tool design. For example, for the barrier 
resource poorly organised the design element to address this barrier was tool structured and 
designed with clear sections to organise content. For the barrier resource not current the 
design element to address this barrier was date of production of evidence summary tool 
included in footer on document.  Table 29 reports the complete results of the mapping exercise. 
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Table 29. Barriers encountered by clinicians when using research evidence and design 
elements included in the evidence summary tool to address each barrier 
1. Topic or relevant aspect of topic not included in a resource that should include it 
Based on the title of the article or book, coverage of the topic would have been expected. Design element:  
Patient group, intervention and outcome all included in title to ensure the topic of tool is clearly identifiable. 
2. Resource poorly organised 
Resources may be poorly organised within a personal library or reprint file. Information within a resource may 
be poorly organised or have inadequate titles or subtitles. Design element:  Tool structured and designed with 
clearly separated sections to organise content. 
3. Resource not clinically oriented 
For example, textbooks may be organised by organ system rather than by disease, which forces the doctor to 
“work backwards.” Design element:  Title of evidence summary tool clearly identified clinical topic and use of 
a clinical intervention. 
4. Resource not authoritative or not trusted 
The resource may not be authoritative or it may not be trusted by the searcher.  Design element:  Research 
unit name, contact details and professional logo included in document to demonstrate legitimacy of authors.  
Full references of publications summarised in tool included in document. 
5. Resource not current 
The resource may not be current or it may be difficult to know if it is current (for example, undated internet 
sites and printed material). Design element:  Date of production of evidence summary tool included in footer 
on document.  
6. Incorrect information 
The information simply may be wrong.   Design element:  Clinical content review conducted to ensure transfer 
of information from primary sources was correct. Primary sources of evidence published in high quality peer-
reviewed journals.   
7. Information not current 
The resource containing the information may be current, but the information itself is not current. Design 
element:  Primary evidence sources published within last 3 years. Dates of publication included in the full 
citation listed on tool.  
8. Failure to anticipate ancillary information needs 
There is inadequate anticipation of likely ancillary or follow up questions (for example, the name of a 
recommended drug is provided but not the dose, forcing the searcher to consult another resource). Design 
element:  Links to educational resources to enable successful implementation of intervention provided. 
9. Failure to define important terms 
The information includes terms that are not defined. For example, treatment may vary depending on whether 
the disease is mild, moderate, or severe, but these terms are not defined.  Design element:  All important 
clinical terms defined within document. 
10. Inadequate description of clinical procedures  
A clinical procedure (for example, thoracentesis) is described but there is insufficient detail to allow the doctor 
to do it.  Design element:  Guide for implementation of intervention in clinical practice included. 
11. Vague or tangential information 
The information does not allow the question to be answered directly because of a vague, tangential, or overly 
general format.  Design element:  Clear, succinct and firm summary of important information. 
12. Unnecessarily cautious writing style 
The information is overly cautious and may contain unnecessary hedge words (“can,” “may,” etc). The caution 
may be legitimate (inadequate evidence to support a definitive statement), but it may be unnecessary 
Design element:  Writing style is direct and logical with an active voice used to convey benefit to patients. 
13. Tertiary care approach to primary care problem 
Available information may take an urban interventionist tertiary care approach, which may not be useful to a 
rural primary care doctor with a non-interventionist philosophy.  Design element:  The intervention examined 
specifically relates to the treatment of the medical problem.  
14. Biased information due to conflicts of interest 
The author or editor may have conflicts of interest.  Design element:  No affiliations with industry that would 
influence findings or presentation of tool. 
15. Failure to address the clinical question 
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Available studies have not adequately addressed the question (for example, “Is smoking a risk factor for 
sinusitis?”).  Design element:  A specific and focused clinical question is addressed. 
16. Failure to study the comparison of interest 
Drug companies often sponsor clinical trials comparing drug A with placebo, but the question is whether drug 
A is better than drug B.  Design element:  A comparison of interest is addressed. 
17. Failure to study the outcome of interest 
An intermediate outcome, such as serum cholesterol level, may be studied rather than more clinically Yes 
outcomes, such as myocardial infarction or death.  Design element:  A clear primary outcome is addressed.   
18. Failure to study the population of interest 
It may not be appropriate to apply results from a referral population to the primary care setting.  Design 
element: A patient population of interest is clearly identified. 
19. Evidence based on flawed methods 
Multiple flaws (for example, selection bias, misclassification bias, confounding, etc) may invalidate the results.  
Design element:  Primary evidence sources obtained from high quality peer-reviewed journals. Quality 
assessment of primary evidence sources conducted and reported within tool. 
20. Failure to cite or include relevant evidence 
Evidence exists but is not cited. It may be difficult to know if evidence exists and, if it exists, to what extent it 
has been used to write a chapter or review.  Design element:  Full reference citations of primary evidence 
sources provided with links in electronic version that take reader directly to abstract in PubMed.  
21. Inadequate synthesis of multiple bits of information 
Relevant evidence is available but consists of numerous bits of information that have not been randomized or 
interpreted. Evidence may be randomized but not systematically or rigorously. Conflicting evidence is 
presented without providing a definitive recommendation for the clinician who must make a decision. Design 
element:  Information synthesised to provide clinical bottom line and numbers of patients saved with 
intervention. 
22. Difficulty applying results of randomised clinical trials to individual patients 
Clinical trials are often narrow in scope and may not apply to patients with comorbid conditions. Design 
element:  Clear identification of patient population that can benefit from intervention with one tool based 
primarily on RCT results. 
23. Failure to directly or completely answer the question 
Once the relevant information has been gathered, the searcher fails to directly or completely answer the 
doctor’s question (for example, owing to the inadequacy of available information or an inadequate synthesis 
of adequate information).  Design element:  Primary outcome addressed along with clinically important 
benefits and harms thus providing a comprehensive answer to the clinical usefulness of the intervention.  
24. Answer directed at the wrong audience 
Answers for patients may not be helpful to doctors. Design element:  The target audience is established with 
writing of the document directed towards this group. 
25. Difficulty addressing unrecognised information needs apparent in the question 
It may not be clear how to address unrecognised information needs that are evident in the question. For 
example, the question might ask about the dose of a drug that is contraindicated (“What is the dose of 
tetracycline for acne in a pregnant woman?”).  Design element:  Potential harms arising from the intervention 
and rates of occurrence are outlined in the tool. 
26. Answer not trusted 
A seemingly adequate answer may not be used if the doctor does not trust the source.  Design element:  
Primary evidence sources obtained from high quality peer-reviewed journals. Full reference citations of primary 
evidence sources provided with links in electronic version that take reader directly to abstract in PubMed. 
27. Answer inadequate 
If the answer is thought to be inadequate by the doctor, it may not be used to direct patient care. Design 
element: The physiological rationale for HOW the intervention works and steps for implementing the 
intervention in clinical practice are provided along with references to additional educational resources.   
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 Selection of a clinical intervention to be presented in the evidence summary tool 
Univariable analysis conducted to identify characteristics of research evidence that 
were associated with appropriate use (Aim 3) indicated the following characteristics of 
published research papers were significantly associated with increased appropriate use: sound 
methods with no major flaws (OR 3.84, P=0.00080), multicentred study (OR 3.07, P=0.00010), 
clear concise writing style (OR 2.41, P=0.021), fully explored all possible benefits and harms 
(OR 2.26, P=0.017), reported an economic analysis (OR 2.06, P=0.0016), larger study size (OR 
1.96, P=0.036),with reporting and conduct consistent with the CONSORT statement (OR 1.64, 
P=0.018).  
Results of the multivariable analysis conducted to identify characteristics of research 
evidence that were independently associated with appropriate use (Aim 3) indicated clinicians 
may be more likely to use evidence from multicentre studies (OR 2.10, P=0.024). No other 
characteristics of research evidence remained statistically significant in the final multivariable 
model.  
The use of prone positioning in patients with severe acute respiratory distress was 
identified as an area of practice in intensive care medicine for which the supporting evidence 
fulfils the criteria described above and for which a proven evidence-practice gaps exist.
5, 6, 32, 33
 
Pilot testing 
The feedback from pilot testing and clinical content review of the evidence summary 
tool highlighted that the section titled ‘implementing prone positioning in suitable patients’ 
was unclear, and that it was difficult to differentiate the beginning of each step in the 
implementation process. Identification numbers were added to each step in the implementation 
process to improve clarity. Suggestions for minor changes to wording and grammar were also 
made by pilot testers to improve readability. The final evidence summary tool is shown in 
Figure 6 (over page).  
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Figure 6. Evidence summary tool 
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Aim 5: To understand and describe attitudes towards and patterns of use of published 
research evidence in clinical decision making amongst a multinational mixed group of 
intensive care clinicians. 
 Quantitative e-mail questionnaire survey design 
The questionnaire included a total of 26 closed ended questions divided into three main 
sections. 
The first section titled Demographics and Research Experience addressed items related 
to year of registration as an intensive care specialist, gender, age, experience and participation 
in research activities, continuing medical education time, formal research qualifications and 
training in evidence-based medicine.  
The second section titled Research attitudes included statements related to beliefs and 
attitudes regarding published research evidence, with respondents asked to select the most 
appropriate answer from a balanced five point Likert item response scale (strongly disagree, 
disagree, neutral, agree, strongly agree).  
The third section titled Research use collected details of patterns of research use in 
clinical practice. 
Based on the items collected above, the metric appropriate use was calculated as per 
the methods of De Vito et al.
45
 
The complete questionnaire can be viewed in Appendix E.  
 Pilot testing 
The two pilot testers identified that large response boxes for some questions made it 
difficult to determine which question they applied to. To improve readability, the size of 
response boxes was adjusted and spacing between questions was increased.  
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The use of small font in the footer of the questionnaire document was identified by the 
pilot testers as difficult to read, to improve readability all font size was set to a minimum of 12 
points.  
 Response rate 
The sample for this study included 1,000 members of the Critical Care Medicine e-mail 
List (CCM-L), an e-mail discussion forum run out of the University of Pittsburgh. The first 
recruitment e-mail was sent to all members on the 25
th
 August 2015, with monthly recruitment 
e-mails sent out for a period of one year until August 2016. In response to these recruitment e-
mails, 122 members agreed to participate in the survey.  
All 122 volunteer participants were sent questionnaires by e-mail. In order to maximise 
response rates, follow up e-mails were sent to all participants who received questionnaires at 
least twice (January 2016 and August 2016). The final questionnaire was received in August 
2016 following which the survey was closed out. 
Ninety-three participants returned questionnaires, resulting in an overall response rate 
of 9.3% (93/1,000). 
 Missing items 
Six of the 93 questionnaires were returned completely blank. Overall incomplete data at 
the question item level was 9.7% (341 missing values from 93 returned surveys with 38 
question items on each survey). Missing values for individual questions ranged from 6.5% 
(87/93) missing to 25.8% (69/93) missing.  
Full details of item response rates by individual question are reported in Table 30,Table 
31,Table 32,Table 33,Table 34 and Table 35. 
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Responses   
Demographics 
The mean age of respondents was 49.59 (9.33) years with males making up 87.3% 
(62/71) of the responding population. Respondents reported a mean of 20.03 (9.87) years of 
clinical experience working in the field of intensive care medicine. Fifty percent (43/86) of 
respondents worked as a full time intensive care specialist and 25.6% (22/86) worked as a part 
time intensive care specialist. Nurses (6/86), pharmacists (2/86) and respiratory therapists 
(2/86) also participated in this study.  
The largest number of respondents reported their primary country of residence as the 
United States (15/70), followed by Australia (11/70). Primary country of residence of 
respondents is shown by country in Figure 7 (next page).  
Complete details of demographics of all respondents can be seen in Table 30. 
Research experience 
Forty percent (30/71) of respondents reported that they held an academic appointment 
at a university. The weekly mean time devoted to continuing medical education was 6.19 (SD 
3.99) hours per week. Formal research training was reported by 44.8% (39/87) of respondents, 
whilst 47.1% (41/87) reported they had completed formal training in evidence-based medicine.  
Full details regarding research experience can be found in Table 31. 
Research attitudes 
Ninety-three percent (82/87) of respondents reported positive feelings (agreed or 
strongly agreed) towards using the results of an RCT to guide their clinical practice, whereas 
83.7% (72/86) of respondents reported positive feelings towards using the results of a 
systematic review to guide their clinical practice (agreed or strongly agreed). 
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Research use 
Ninety-nine percent (84/85) of respondents reported they used the concepts of 
evidence-based medicine in their own clinical practice at least sometimes, which was defined 
as 'every month or so'.  
With regards to the frequency of reading different types of research evidence, 95.4% 
(83/87) of respondents reporting they read RCTs at least sometimes whereas 72.4% (63/87) of 
Figure 7 Primary country of residence 
15.71%
1.43%
7.14%
5.71%
2.86%
5.71%
4.29%
1.43%
2.86%
2.86%
4.29%
5.71%
1.43% 4.29%
2.86%
1.43%
2.86%
5.71%
21.43%
Australia (n=11) Brazil (n=1) Canada (n=5) Germany (n=4)
Greece (n=2) India (n=4) Italy (n=3) Japan (n=1)
Netherlands (n=2) New Zealand (n=3) Pakistan (n=1) Portugal (n=4)
Saudi Arabia (n=2) Slovakia (n=3) South Africa (n=1) Spain (n=2)
Sweden (n=2) United Kingdom (n=4) United States (n=15)
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respondents reported they read information in the Cochrane library at least sometimes. 
Complete details regarding frequency of reading specific types of research evidence are 
reported in Table 33. 
In a question regarding frequency of using different types of research evidence to guide 
clinical practice, Published Evidence Based Guidelines were used by 96.65% (84/87) of 
respondents at least sometimes whereas 78.2% (68/87) of respondents reported using 
information in the Cochrane Library to guide clinical decisions at least sometimes. Complete 
details regarding patterns of use of research evidence are reported in Table 34. 
Appropriate use 
Responses were reviewed for each respondent to the four key questions within the 
questionnaire designed to measure appropriate use according to the metric of De Vito et al.
45
 
A total of 87 respondents (N=87) provided complete responses to all four key questions 
and were eligible for calculation of the appropriate use metric. From these 87 respondents, 73 
reported they read RCTs at least sometimes and read systematic reviews at least sometimes 
and used RCTs at least sometimes and used systematic reviews at least sometimes.  
Thus, the overall appropriate use rate was 73/87 (83.9%, 95% CI 76.2 to 90.9). Table 
35 shows complete responses for each of the four key questions used to score appropriate use.   
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Table 30. Demographics 
Variable  Response 
Rate (n/N)
&
   
Result 
 
Q1. Gender - male, percent (n/N)   71/93 87.3% (62/71) 
Q2. Age in years, mean (SD)  69/93 49.59 (9.33) 
Q4. Years working in ICU, mean (SD)  70/93 20.03 (9.87) 
Q5. Academic appointment (university), percent (n/N) 70/93 40.3% (30/71) 
Q6. Weekly CME hours, mean (SD)  70/93 6.19 (3.99) 
Q7. Current primary work role:  86/93  
   Part time ICU, primary specialty other field   25.6% (22/86) 
   Full time ICU specialist   50.0% (43/86) 
   ICU trainee   2.3% (2/86) 
   Nurse   7.00% (6/86) 
   Dietitian   0 
   Physiotherapist   0 
   Occupational therapist   0 
   Respiratory therapist   2.3% (2/86) 
   Pharmacist   2.3% (2/86) 
   Other   10.5% (9/86) 
n/N - number of reported events/Number of responses; SD - standard deviation; ICU - 
Intensive Care Unit; CME - Continuing Medical Education; n/N
&
 item response rate/unit 
response rate 
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Table 31. Research experience 
Variable 
Response rate 
(n/N)
&
 
Result 
percent (n/N) 
Q8. Level of training or qualification in research
*
 87/93  
Research Fellowship
*
  13.8% (12/87) 
Formal Research Methodology Course
*
  18.4% (19/87) 
Graduate Level Research Methodology Course
*
   
Graduate Certificate  3.5% (3/87) 
Graduate Diploma  3.5% (3/87) 
Masters  9.2% (8/87) 
PhD  5.8% (5/87) 
No formal research qualification  55.2% (48/87) 
Q9. Level of training or qualification in EBM
#
 87/93  
Have attended a non-university based EBM course 
or workshop
#
 
 35.6% (31/87) 
Have attended a McMaster University course or 
workshop
#
 
 
0 
Have attended a University based EBM course or 
workshop
#
 
 
12.6% (11/87) 
No formal EBM training   52.9% (46/87) 
PhD – Doctor of Philosophy; EBM – Evidence Based Medicine; n/N& item response rate/unit 
response rate; n/N – number of reported events/Number of responses  
*respondents able to select more than one level of training or qualification in research 
#
respondents able to select more than one level of training or qualification in EBM 
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Table 32. Research attitudes 
Allowable responses:  Strongly disagree (Score 1); Disagree (Score 2); Neutral (Score 3); Agree (Score 4); Strongly agree (Score 5). 
Variable  
(Question number) 
Response  
Rate  
(n/N)
&
 
Respondents selecting each category  
Percent (n/N) 
Mean score 
(SD) 
1 2 3 4 5 
Q25. My feeling towards using the results of an 
RCT to guide my clinical practice are positive  
87/93 
0    
(0/87) 
1.2    
(1/87) 
5.8 
(5/87) 
54.0 
(47/87) 
39.1 
(34/87) 
4.31 (0.63) 
Q26. My feelings towards using the results of a 
systematic review/meta-analysis to guide my 
clinical practice are positive 
86/93 
0   
(0/86) 
2.3 
(2/86) 
14.0 
(12/86) 
50.0 
(43/86) 
33.7 
(29/86) 
4.15 (0.74) 
RCT – randomised controlled trial; n/N& item response rate/unit response rate; n/N – number of reported events/Number of responses; SD – 
standard deviation 
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Table 33. Frequency of research use 
Allowable responses:  Never (Score 1); Rarely = once or twice a year (Score 2); Sometimes = every month or so (Score 3); 
Often = every week or so (Score 4); Very often = every day or so (Score 5). 
Variable  
(Question and response item) 
 
Response 
Rate  
(n/N)
&
 
Respondents selecting each category 
Percent (n/N) 
Mean score 
(SD) 
1 2 3 4 5 
Q10. How often do you use the concepts of EBM in 
your clinical practice? 
85/93 
1.2 
(1/85) 
0   
(0/85) 
16.5 
(14/85) 
42.4 
(36/85) 
40.0 
(34/85) 
4.20 (0.80) 
Q11: How often do you read the following:  
(Listed in order from most highly ranked) 
 
     
 
Published RCTs 87/93 
0   
(0/87) 
4.6 
(4/87) 
12.6 
(11/87) 
57.5 
(50/87) 
25.3 
(22/87) 
4.03 (0.75) 
Published EBGs  87/93 
0   
(0/87) 
5.8 
(5/87) 
33.3 
(29/87) 
36.8 
(32/87) 
24.1 
(21/87) 
3.79 (0.88) 
Published systematic reviews/meta-analyses 87/93 
0   
(0/87) 
5.8 
(3/87) 
36.8 
(32/87) 
43.7 
(38/87) 
16.1 
(14/87) 
3.72 (0.77) 
Evidence summaries 87/93 
2.3 
(2/87) 
6.9 
(6/87) 
40.2 
(35/87) 
33.3 
(29/87) 
17.2 
(15/87) 
3.56 (0.94) 
Information in Cochrane Library 87/93 
1.2 
(1/87) 
26.4 
(23/87) 
42.5 
(37/87) 
25.3 
(22/87) 
4.6 
(4/87) 
3.06 (0.87) 
Textbooks 83/93 
6.0 
(5/83) 
39.8 
(33/83) 
24.1 
(20/83) 
21.7 
(18/83) 
8.4 
(7/83) 
2.87 (1.09) 
EBM – Evidence Based Medicine; RCTs – Randomised Controlled Trials; EBGs – Evidence Based Guidelines; n/N& item response rate/unit 
response rate; n/N – number of reported events/Number of responses; SD – standard deviation 
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Table 34. Types of research used 
Allowable responses:  Never (Score 1); Rarely = once or twice a year (Score 2); Sometimes = every month or so (Score 3);  
Often = every week or so (Score 4); Very often = every day or so (Score 5). 
Variable  
(Question and response item) 
Listed in order from most highly ranked  
Response 
Rate  
(n/N)
&
 
Respondents selecting each category  
Percent (n/N) 
Mean score 
(SD) 
1 2 3 4 5 
Q12: How often do you use the following information 
sources to guide decisions in your clinical practice? 
       
Published EBGs  87/93 
0   
(0/87) 
5.8 
(3/87) 
20.7 
(18/87) 
44.8 
(39/87) 
31.0 
(27/87) 
4.03 (0.81) 
Results of an RCT 87/93 
0   
(0/87) 
4.6 
(4/87) 
18.4 
(16/87) 
50.6 
(44/87) 
26.4 
(23/87) 
3.99 (0.80) 
Results of a systematic review/meta-analysis 87/93 
1.2 
(1/87) 
12.6 
(11/87) 
25.3 
(22/87) 
39.1 
(34/87) 
21.8 
(19/87) 
3.68 (0.99) 
Results of Cochrane review 87/93 
2.3 
(2/87) 
19.5 
(17/87) 
37.9 
(33/87) 
33.3 
(29/87) 
6.9 
(6/87) 
3.23 (0.92) 
Advice given by colleague  87/93 
4.6 
(4/87) 
10.3 
(9/87) 
51.7 
(45/87) 
27.6 
(24/87) 
5.8 
(5/87) 
3.20 (0.87) 
Textbook information 87/93 
2.3 
(2/87) 
26.4 
(23/87) 
32.2 
(28/87) 
29.9 
(26/87) 
9.2 
(8/87) 
3.17 (1.00) 
Evidence summary journals  87/93 
4.6 
(4/87) 
25.3 
(22/87) 
31.0 
(27/87) 
28.7 
(25/87) 
10.3 
(9/87) 
3.15 (1.06) 
Information from Google search 87/93 
4.6 
(4/87) 
23.0 
(20/87) 
40.2 
(35/87) 
20.7 
(18/87) 
11.5 
(10/87) 
3.12 (1.04) 
EBGs – Evidence Based Guidelines; RCTs – Randomised Controlled Trials; n/N& item response rate/unit response rate; n/N – number of 
reported events/Number of responses; SD – standard deviation 
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 Table 35. Individual responses to key questions used to score appropriate use 
Allowable responses:  Never (1); Rarely = once or twice a year (2); Sometimes = every month or so (3);  
Often = every week or so (4); Very often = every day or so (5). 
Variable  
(Question and response item) 
Listed in order from most highly ranked  
Response 
Rate  
(n/N)
& 
Respondents selecting each category  
Percent (n/N) 
Mean score 
(SD) 
1 2 3* 4* 5* 
Q11: How often do you read the following:         
a: Published RCTs 87/93 
0   
(0/87) 
4.6 
(4/87) 
12.6 
(11/87) 
57.5 
(50/87) 
25.3 
(22/87) 
4.03 (0.75) 
e: Published Meta-analyses 87/93 
0   
(0/87) 
5.8 
(3/87) 
36.8 
(32/87) 
43.7 
(38/87) 
16.1 
(14/87) 
3.72 (0.77) 
Q12. How often do you use the following information 
sources to guide decisions in your clinical practice? 
 
     
 
e: Results of an RCT 87/93 
0   
(0/87) 
4.6 
(4/87) 
18.4 
(16/87) 
50.6 
(44/87) 
26.4 
(23/87) 
3.99 (0.80) 
h: Results of a Meta-analysis 87/93 
1.15 
(1/87) 
12.6 
(11/87) 
25.3 
(22/87) 
39.1 
(34/87) 
21.8 
(19/87) 
3.68 (0.99) 
RCTs – randomised controlled trials; n/N& item response rate/unit response rate; n/N – number of reported events/Number of responses; SD – 
standard deviation 
*A response of sometimes (3), often (4) or very often (5) was allocated a score of 1 on the appropriate use metric 
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Aim 6: To conduct an intervention to determine whether an evidence summary tool can 
improve the use of published research evidence to support clinical decision making. 
 Online interventional study  
Case-based scenario  
A clinical case-based scenario was developed that outlined a typical ICU patient 
presenting with a clinical condition that would benefit from treatment with the intervention 
‘prone positioning’ as summarised in the evidence summary tool. 
“Mr Mathews, a 68 year old male who weighs 89kg (196lb) and is 178cm (5'10") 
in height was admitted to your ICU 30 hours ago with community acquired 
pneumonia and sepsis. Chest x-ray showed diffuse bilateral opacities and a BiPAP 
trial for worsening respiratory function failed. He was intubated 26 hours ago and 
commenced on mechanical ventilation for the management of severe ARDS. 
This morning, Tidal Volume is 450mls, PEEP is set at 14cmH2O with an FiO2 of 
0.8 and a PaO2:FiO2 ratio of 73. You have attempted multiple lung recruitment 
manoeuvres with no visible improvement and remain concerned with his 
respiratory status.” 
 Belief in the benefit of specific clinical interventions 
Before reading the evidence summary tool 
Before reading the evidence summary tool, 88.5% (77/87) of respondents reported they 
agreed with the statement that the patient in the clinical scenario would benefit from prone 
positioning (agree or strongly agree). 
With regards to the five other listed clinical interventions, agreement (agree or strongly 
agree) that the patient in the clinical scenario would benefit from High Frequency Oscillatory 
Ventilation was 16.1% (14/87), for Non-Invasive BiPAP agreement was 2.3% (2/86), for 
Corticosteroids agreement was 20.7% (18/87), for increased levels of PEEP agreement was 
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56.3% (49/87), and for ECMO agreement was 52.9% (46/87). Table 36 provides complete 
responses to these question items. 
After reading the evidence summary tool 
After reading the evidence summary tool, 93.1% (81/87) of respondents reported they 
agreed the patient in the clinical scenario would benefit from prone positioning (agree or 
strongly agree).  
With regards to the five other listed clinical interventions, agreement (agree or strongly 
agree) that the patient in the clinical scenario would benefit from High Frequency Oscillatory 
Ventilation was 17.2% (15/87), for Non-Invasive BiPAP agreement was 2.3% (2/86), for 
Corticosteroids agreement was 18.6% (16/86), for increased levels of PEEP agreement was 
51.7% (45/87), and for ECMO agreement was 49.4% (43/87). Table 37 provides complete 
responses to these question items. 
Change in strength of belief of benefit from before to after 
Comparing strength of agreement before reading the evidence summary tool to strength 
of agreement after reading the evidence summary tool, there was a significant increase in the 
strength of agreement with the statement that the patient in the clinical scenario would benefit 
from prone positioning (mean score change 0.32, 95% CI 0.19 to 0.46, P<0.001).   
There was also a significant reduction in strength of agreement with the statement that 
the patient in the clinical scenario would benefit from increased levels of PEEP (mean score 
change -0.15, 95% CI -0.24 to -0.06, P=0.0020) and a trend towards a reduction in the strength 
of agreement the statement the patient in the clinical scenario would benefit from ECMO 
(mean score change -0.13, 95% CI -0.26 to 0.01, P=0.070). Table 38 provides complete 
responses to these question items. 
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Table 36. Belief in the benefit of specific clinical interventions, before reading evidence summary tool 
Allowable responses:  Strongly disagree (Score 1); Disagree (Score 2); Neutral (Score 3); Agree (Score 4); Strongly agree (Score 5).  
Variable  
(Intervention) 
 
Response  
Rate  
(n/N)
&
 
Respondents selecting each category  
Percent (n/N) 
Mean score 
(SD) 
1 2 3 4 5 
Q13. I believe that this patient may benefit from 
High Frequency Oscillatory Ventilation. 87/93 
16.1 
(14/87) 
36.8 
(32/87) 
31.0 
(27/87) 
14.9 
(13/87) 
1.2 
(1/87) 
2.48 (0.97) 
Q14. I believe that this patient may benefit from 
Prone Positioning. 87/93 
1.2 
(1/87) 
4.6 
(4/87) 
5.8 
(5/87) 
48.3 
(42/87) 
40.2 
(35/87) 
4.22 (0.84) 
Q15. I believe that this patient may benefit from 
Non-Invasive BiPAP ventilation  86/93 
64.0 
(55/86) 
25.6 
(22/86) 
8.1 
(7/86) 
2.3 
(2/86) 
0  
(0/86) 
1.49 (0.75) 
Q16. I believe that this patient may benefit from the 
use of Corticosteroids 87/93 
17.2 
(15/87) 
32.2 
(28/87) 
29.9 
(26/87) 
17.2 
(15/87) 
5.8 
(3/87) 
2.58 (1.07) 
Q17. I believe that this patient may benefit from the 
use of increased levels of PEEP 87/93 
1.2 
(1/87) 
16.1 
(14/87) 
26.4 
(23/87) 
41.4 
(36/87) 
14.9 
(13/87) 
3.53 (0.98) 
Q18. I believe that this patient may benefit from 
ECMO  87/93 
1.2 
(1/87) 
11.5 
(10/87) 
34.5 
(30/87) 
44.8 
(39/87) 
8.1 
(7/87) 
3.47 (0.85) 
BiPAP - Bi-Level Positive Airway Pressure; PEEP - Positive End Expiratory Pressure; ECMO – Extra-Corporeal Membrane Oxygenation; n/N& 
item response rate/unit response rate; n/N – number of reported events/Number of responses; SD – standard deviation 
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Table 37. Belief in the benefit of specific clinical interventions, after reading evidence summary tool 
Allowable responses:  Strongly disagree (Score 1); Disagree (Score 2); Neutral (Score 3); Agree (Score 4); Strongly agree (Score 5).  
Variable  
(Intervention) 
 
Response  
Rate  
(n/N)
&
 
Respondents selecting each category  
Percent (n/N) 
Mean score 
(SD) 
1 2 3 4 5 
Q19. I believe that this patient may benefit from 
High Frequency Oscillatory Ventilation. 87/93 
20.7 
(18/87) 
37.9 
(33/87) 
24.1 
(21/87) 
12.6 
(11/87) 
4.6 
(4/87) 
2.43 (1.10) 
Q20. I believe that this patient may benefit from 
Prone Positioning. 87/93 
0    
(0/87) 
0    
(0/87) 
6.9 
(6/87) 
32.2 
(28/87) 
60.9 
(53/87) 
4.54 (0.63) 
Q21. I believe that this patient may benefit from 
Non-Invasive BiPAP ventilation  86/93 
61.6 
(53/86) 
24.4 
(21/86) 
8.2 
(7/86) 
2.3 
(2/86) 
0  
(0/86) 
1.48 (0.75) 
Q22. I believe that this patient may benefit from the 
use of Corticosteroids 86/93 
19.8 
(17/86) 
29.1 
(25/86) 
32.6 
(28/86) 
16.3 
(14/86) 
2.3 
(2/86) 
2.52 (1.06) 
Q23. I believe that this patient may benefit from the 
use of increased levels of PEEP 87/93 
5.8 
(3/87) 
21.8 
(19/87) 
23.0 
(20/87) 
36.8 
(32/87) 
14.9 
(13/87) 
3.38 (1.09) 
Q24. I believe that this patient may benefit from 
ECMO  87/93 
5.8 
(3/87) 
13.8 
(12/87) 
33.3 
(29/87) 
43.7 
(38/87) 
5.8 
(5/87) 
3.35 (0.91) 
BiPAP - Bi-Level Positive Airway Pressure; PEEP - Positive End Expiratory Pressure; ECMO – Extra-Corporeal Membrane Oxygenation; n/N& 
item response rate/unit response rate; n/N – number of reported events/Number of responses; SD – standard deviation 
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Table 38. Change in belief in the benefit of specific clinical interventions from before to after reading evidence summary tool 
Allowable responses:  Strongly disagree (Score 1); Disagree (Score 2); Neutral (Score 3); Agree (Score 4); Strongly agree (Score 5). 
 Mean Score (SD)  
Mean change in 
score (SD)  
95% CI 
Paired t-test 
P-value  
Before EST 
(n=87) 
After EST 
(n=87) 
Q19-Q13. I believe that this patient may benefit 
from High Frequency Oscillatory Ventilation. 
2.48 (0.97) 2.43 (1.10) -0.06 (0.47) -0.16 to 0.04 0.25 
Q20-Q14. I believe that this patient may benefit 
from Prone Positioning. 
4.22 (0.84) 4.54 (0.63) +0.32 (0.64) 0.19 to 0.46 <0.0010 
Q21-Q15. I believe that this patient may benefit 
from Non-Invasive BiPAP ventilation  
1.49 (0.75) 1.48 (0.75) -0.01 (0.36) -0.09 to 0.06 0.77 
Q22-Q16. I believe that this patient may benefit 
from the use of Corticosteroids 
2.58 (1.07) 2.52 (1.06) -0.08 (0.56) -0.20 to 0.04 0.32 
Q23-Q17. I believe that this patient may benefit 
from the use of increased levels of PEEP 
3.53 (0.98) 3.38 (1.09) -0.15 (0.45) -0.24 to -0.06 0.0020 
Q24-Q18. I believe that this patient may benefit 
from ECMO  
3.47 (0.85) 3.35 (0.91) -0.13 (0.64) -0.26 to 0.01 0.070 
BiPAP - Bi-Level Positive Airway Pressure; PEEP - Positive End Expiratory Pressure; ECMO – Extra-Corporeal Membrane Oxygenation;  
EST – evidence summary tool; SD – standard deviation; CI – confidence interval  
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Aim 7: To evaluate competing versions of the evidence summary tool to determine 
whether specific elements of presentation of the tool can enhance the use of published 
research evidence to support clinical decision making.  
 Competing versions of evidence summary tools 
 The differences between the competing versions of the evidence summary tools were 
minimal, and restricted to two sections.  
In the first section titled Prone Positioning in ARDS saves lives, the evidence-summary 
tool emphasising evidence from meta-analyses contained the statement “This is supported by a 
significant mortality reduction in two well conducted meta-analyses including 6 RCTs 
enrolling a total of 1,016 patients” whereas the evidence summary tool emphasising evidence 
from RCTs contained the statement “This is supported by a significant mortality reduction in a 
well conducted RCT analysing 466 patients from 27-hospitals and 5 smaller RCTs enrolling an 
additional 542 patients.” 
 In the final section of the evidence summary tool titled Brief summary of Evidence 
Reviewed, the version with an emphasis on meta-analyses contained the statement “Meta-
analyses published in CMAJ and ICM in 2014. The six included RCTs enrolled 22 - 474 
patients each. Five RCTs were free from major flaws, whilst 1 RCT had a high risk of bias due 
to failure to conceal allocation. One meta-analysis included all six trials whilst the second 
focused on adult patients, and included the four trials that were free from major flaws,” 
whereas the final version emphasising RCTs contained the statement “466 patient RCT 
published in NEJM in 2013. There were no major flaws in this paper. Five additional RCTs 
enrolled 22 – 344 patients each. Four of these additional RCTs were free from major flaws, 
whilst 1 RCT had a high risk of bias due to failure to conceal allocation.” 
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All other sections of the competing evidence summary tools were identical. Figure 8 
demonstrates the formatting of the two contrasting sections of the competing evidence 
summary tools. 
 
 Results of randomised evaluation 
A total of 62 participants were randomised to receive the RCT-based evidence 
summary tool (RCT group), and 60 participants were randomised to receive the systematic 
review / meta-analysis based evidence summary tool (MA group).  
Seventy-one percent (44/62) of the RCT group returned their questionnaires and 81.7% 
(49/60) were returned by the MA group (p=0.24). 
Figure 8. Contrasting sections of the different versions of the competing evidence 
summary tools. 
 
Evidence Summary tool emphasising meta-analyses: 
 
 
Evidence summary tool emphasising RCTs: 
 
 
 
 
 
 
 
 
 179 
Baseline balance 
Demographics 
The mean age of respondents was not significantly different between the RCT group 
and the MA group (49.2 vs. 49.9, P=0.75). There was no significant difference in the balance 
of gender (29/33 vs. 33/38 males, P=0.90) or primary country of residence (P=0.41, (see Figure 
9 and Figure 10). Table 39 reports complete details. 
Research experience  
The groups did not differ significantly with respect to any aspect of research 
experience. Complete details by group for formal research training or qualification, along with 
EBM training or qualification can be found in Table 40. 
Research use 
There was a significant difference in the reported frequency of reading published 
systematic reviews/meta-analyses between groups, with responses indicating the RCT group 
read systematic reviews more often than those randomised to the MA group (mean frequency 
score 3.93 vs. 3.53, P=0.016). There were no other significant differences in any aspect of the 
frequency of research read between the two randomised groups. There were also no significant 
differences between groups with regards to the frequency of using a variety of research 
resources to guide clinical practice decisions. See Table 41 and Table 42 for complete details.  
Research attitudes 
There were no significant differences between groups with regards to their attitudes 
towards using research to guide practice decisions, as shown in Table 43. 
Appropriate use 
The appropriate use metric could be calculated for 42 /42 participants allocated to the 
RCT group and 45/45 participants allocated to the MA group. No significant difference was 
found between groups with regards to appropriate use (35/42 vs. 38/45, P=0.89). 
 180 
Baseline belief in the benefit of specific clinical interventions  
A clinical case-based scenario was developed that outlined a typical ICU patient 
presenting with a clinical condition that would benefit from treatment with the intervention 
‘prone positioning’ as summarised in the evidence summary tool. 
“Mr Mathews, a 68 year old male who weighs 89kg (196lb) and is 178cm 
(5'10") in height was admitted to your ICU 30 hours ago with community 
acquired pneumonia and sepsis. Chest x-ray showed diffuse bilateral opacities 
and a BiPAP trial for worsening respiratory function failed. He was intubated 26 
hours ago and commenced on mechanical ventilation for the management of 
severe ARDS. 
This morning, Tidal Volume is 450mls, PEEP is set at 14cmH2O with an FiO2 of 
0.8 and a PaO2:FiO2 ratio of 73. You have attempted multiple lung recruitment 
manoeuvres with no visible improvement and remain concerned with his 
respiratory status.” 
Prior to reading the assigned evidence summary tool there was no significant difference 
between groups (mean score 4.31 vs. 4.13, P=0.33) with regards to the strength of agreement 
with the statement that the patient in the clinical scenario would benefit from prone 
positioning. 
 Prior to reading the assigned evidence summary tool, there was a significant difference 
between groups with regards to their strength of agreement with statements regarding benefits 
from Corticosteroids (mean score 2.33 vs. 2.80, P=0.042) and an increased level of PEEP 
(mean score 3.86 vs. 3.22, P=0.0020).  
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Primary outcome: Differences between groups  
Univariable analysis 
After reading the assigned evidence summary tool there was no significant difference 
between groups on univariable analysis (mean score 4.57 vs. 4.51, P=0.66) with regards to the 
strength of agreement with the statement that the patient in the clinical scenario would benefit 
from prone positioning. 
Multivariable analysis controlling for baseline imbalance  
After controlling for potential confounders identified as being in imbalance at baseline, 
backwards elimination stepwise regression revealed there was no significant difference 
between groups with regards to strength of agreement with the statement that the patient in the 
clinical scenario would benefit from prone positioning, (difference between groups 0.016, 
P=0.91). 
Potential confounders offered to the multivariable model based on univariable analysis 
of imbalance included: 
Q9(a): Attendance at a short EBM course of workshop (P=0.077) 
Q11(e): Frequency of reading systematic review/meta-analysis (P=0.016) 
Q16: Baseline belief in the benefits of corticosteroids (P=0.042) 
Q17: Baseline belief in the benefits of increased levels of PEEP (P=0.0020) 
Only variables with a multivariable P-value less than 0.05 were retained by the 
stepwise elimination procedure. Study group was forced to remain in the model at all steps. 
The final multivariable model included the following statistically significant variables: 
Q16: Pre-existing belief in the benefits of corticosteroids (P=0.014)  
Q17: Pre-existing belief in the benefits of increased levels of PEEP (P=0.010)  
Complete details of the final model are reported in Table 45. 
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Figure 9 RCT group primary country of residence  
0.00%
6.06%
6.06%
6.06%
6.06%
6.06%
9.09%
0.00%
12.12%
3.03%
0.00% 6.06%
6.06%
0.00%
0.00%
9.09%
21.21%
0.00%
3.03%
Australia (n=4) Brazil (n=0) Canada (n=3) Germany (n=2)
Greece (n=0) India (n=2) Italy (n=1) Japan (n=0)
Netherlands (n=2) New Zealand (n=2) Pakistan (n=0) Portugal (n=1)
Saudi Arabia (n=2) Slovakia (n=2) South Africa (n=0) Spain (n=2)
Sweden (n=0) United Kingdom (n=3) United States (n=7)
Figure 10 MA Group primary country of residence 
5.41%
5.41%
0.00%
0.00%
2.70%
5.41%
5.41%
2.70%
18.92%
8.11%
2.70%2.70%
0.00%
2.70%
5.41%
2.70%
21.62%
2.70%
5.41%
Australia (n=7) Brazil (n=1) Canada (n=2) Germany (n=2)
Greece (n=2) India (n=2) Italy (n=2) Japan (n=1)
Netherlands (n=0) New Zealand (n=1) Pakistan (n=1) Portugal (n=3)
Saudi Arabia (n=0) Slovakia (n=1) South Africa (n=1) Spain (n=0)
Sweden (n=2) United Kingdom (n=1) United States (n=8)
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Table 39 Baseline balance: Demographics  
Variable RCT Group 
(N=44) 
MA Group 
(N=49) 
P-value 
 
Q1. Gender - male, percent (n/N)  87.9% (29/33) 86.8% (33/38) 0.90 
Q2. Age in years, mean (SD) 49.21 (10.53) 
n= 33 
49.94 (8.20) 
n=36 
0.75 
Q4. Years working in ICU,  
mean (SD) 
20.61 (10.22) 
n= 33 
19.51 (9.66) 
n=37 
0.65 
ICU - intensive care unit; RCT group – randomised controlled trial summary tool intervention 
group; MA group – meta-analysis summary tool intervention group; SD - standard deviation; 
n/N - number of reported events/Number of total responses 
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Table 40  Baseline balance: Research experience 
 RCT Group MA Group P-value 
Q5. Academic appointment held at a 
university, percent (n/N) 42.4% (14/33) 42.1% (16/38) 0.83 
Q6. Weekly CME hours, mean (SD) 
6.48 (4.22) 
n=33 
5.92 (3.80) 
n=37 
0.59 
Q7. Current primary work role: percent (n/N)   
Part time ICU, primary specialty other field 24.4% (10/41) 26.7% (12/45) 
0.23 
Full time ICU specialist 61.0% (25/41) 40.0% (18/45) 
ICU trainee 0% (0/41) 4.4% (2/45) 
Nurse 4.9% (2/41) 8.9% (4/45) 
Dietitian 0% (0/41) 0% (0/45) 
Physiotherapist 0% (0/41) 0% (0/45) 
Occupational therapist 0% (0/41) 0% (0/45) 
Respiratory therapist 0% (0/41) 4.4% (2/45) 
Pharmacist 0% (0/41) 4.4% (2/45) 
Other 9.8% (4/41) 11.1% (9/45) 
Q8. Level of training or qualification 
in research
*
 
RCT Group 
percent (n/N) 
MA Group 
percent (n/N) 
P-value 
Research Fellowship
*
 16.7% (7/42) 11.1% (5/45) 0.46 
Formal Research Methodology Course
*
 16.7% (7/42) 26.7% (12/45) 0.26 
Graduate Level Research Methodology 
Course
*
    
Graduate Certificate 2.4% (1/42) 4.4% (2/45) 0.60 
Graduate Diploma 2.4% (1/42) 4.4% (2/45) 0.60 
Masters 4.8% (2/42) 13.3% (6/45) 0.17 
PhD 7.1% (3/42) 4.4% (2/45) 0.59 
No formal research qualification 61.9% (26/42) 48.9% (22/45) 0.23 
Q9. Level of training or qualification 
in EBM
#
 
RCT Group 
percent (n/N) 
MA Group 
percent (n/N) 
P-value 
Non-university course
#
 26.2% (11/42) 44.4% (20/45) 0.077 
McMaster University EBM course
#
 0 0  
University course
#
 16.7% (7/42) 8.9% (4/45) 0.28 
No formal EBM training  57.1% (24/42) 51.1% (23/45) 0.58 
CME - continuing medical education; EBM – Evidence Based Medicine; PhD – Doctor of 
Philosophy; RCT group – randomised controlled trial summary tool intervention group; MA 
group – meta-analysis summary tool intervention group; n/N - number of reported 
events/Number of total responses 
*respondents able to select more than one level of training or qualification in research 
#
respondents able to select more than one level of training or qualification in EBM 
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Table 41. Baseline balance: Frequency of research read 
Allowable responses:  Never (Score 1); Rarely = once or twice a year (Score 2);  
Sometimes = every month or so (Score 3); Often = every week or so (Score 4);  
Very often = every day or so (Score 5). 
 Mean Score (SD) 
P-value 
 
RCT Group  
(N=42) 
MA Group  
(N=45) 
Q10. How often do you use the concepts of 
EBM in your clinical practice? 
4.33 (0.82) 
(n=42) 
4.07 (0.77) 
(n=43) 
0.13 
Q11: How often do you read the following:     
Published RCTs 4.05 (0.80) 4.02 (0.72) 0.88 
Published EBGs  3.79 (0.92) 3.80 (0.84) 0.94 
Published systematic reviews/meta-analyses 3.93 (0.71) 3.53 (0.79) 0.016 
Evidence summaries 3.60 (0.96) 3.53 (0.92) 0.76 
Information in Cochrane Library 3.05 (0.94) 3.07 (0.81) 0.92 
Textbooks 2.71 (1.02) 
(n=42) 
3.02 (1.15) 
(n=41) 
0.20 
EBM – evidence based medicine; RCTs – randomised controlled trials; EBGs – evidence based 
guidelines; SD – standard deviation; RCT group – randomised controlled trial summary tool 
intervention group; MA group – meta-analysis summary tool intervention group 
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Table 42. Baseline balance: Frequency of research used to guide decisions 
Allowable responses:  Never (Score 1); Rarely = once or twice a year (Score 2); 
Sometimes = every month or so (Score 3); Often = every week or so (Score 4); 
Very often = every day or so (Score 5). 
 Mean Score (SD)  
P-value Q12: How often do you use the following 
information sources to guide decisions in your 
clinical practice? 
RCT Group 
(N=42) 
MA Group 
(N=45) 
Published EBGs  4.10 (0.79) 3.98 (0.84)
 
0.50 
Results of an RCT 4.05 (0.80) 3.93 (0.81) 0.51 
Results of a systematic review/meta-analysis 3.76 (0.98) 3.60 (1.01) 0.45 
Results of Cochrane review 3.38 (0.83) 3.09 (1.00) 0.14 
Advice given by colleague  3.33 (0.75) 3.07 (0.96) 0.16 
Textbook information 3.05 (0.99) 3.29 (1.01) 0.26 
Evidence summary journals  3.14 (1.12) 3.16 (1.02) 0.96 
Information from Google search 3.26 (0.96) 2.98 (1.10) 0.20 
EBGs – Evidence Based Guidelines; RCTs – Randomised Controlled Trials; SD – standard 
deviation; RCT group – randomised controlled trial summary tool intervention group; MA 
group – meta-analysis summary tool intervention group 
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Table 43. Baseline balance: Research attitudes 
Allowable responses:  Strongly disagree (Score 1); Disagree (Score 2);  
Neutral (Score 3); Agree (Score 4); Strongly agree (Score 5) 
 Mean Score (SD) 
P-value 
 
RCT Group 
(N=42) 
MA Group 
(N=45) 
Q25. My feeling towards using the results of an 
RCT to guide my clinical practice are positive  4.38 (0.54) 4.24 (0.71) 0.31 
Q26. My feelings towards using the results of a 
systematic review/meta-analysis to guide my 
clinical practice are positive 
4.15 (0.69) 
(n=41) 
4.16 (0.80) 
(n=45) 
0.96 
RCT – randomised controlled trial; SD – standard deviation; RCT group – randomised 
controlled trial summary tool intervention group; MA group – meta-analysis summary tool 
intervention group 
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Table 44. Baseline balance: Belief in the benefit of specific clinical interventions 
Allowable responses:  Strongly disagree (Score 1); Disagree (Score 2); Neutral (Score 3); 
Agree (Score 4); Strongly agree (Score 5). 
 Mean Score (SD)  
P-value 
 
RCT Group 
(n=42) 
MA Group 
(n=45) 
Q13. I believe that this patient may benefit 
from High Frequency Oscillatory Ventilation. 
2.36 (0.96) 2.60 (0.99) 0.25 
Q14. I believe that this patient may benefit 
from Prone Positioning. 
4.31 (0.72) 4.13 (0.94) 0.33 
Q15. I believe that this patient may benefit 
from Non-Invasive BiPAP ventilation  
1.45 (0.74) 
(n=42) 
1.52 (0.76) 
(n=44) 
0.67 
Q16. I believe that this patient may benefit 
from the use of Corticosteroids 
2.33 (1.07) 2.80 (1.04) 0.042 
Q17. I believe that this patient may benefit 
from the use of increased levels of PEEP 
3.86 (0.93) 3.22 (0.93) 0.0020 
Q18. I believe that this patient may benefit 
from ECMO  
3.57 (0.89) 3.38 (0.81) 0.29 
BiPAP - Bi-Level Positive Airway Pressure; PEEP - Positive End Expiratory Pressure; ECMO 
– Extra-Corporeal Membrane Oxygenation; SD – standard deviation; RCT group – randomised 
controlled trial summary tool intervention group; MA group – meta-analysis summary tool 
intervention group 
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Table 45. Final Multivariable Model – Outcome is belief in the benefit of prone 
positioning (Q20) 
Variable  
 
 
Parameter 
Estimate 
SE parameter 
estimate 
P-value 
RCT vs. MA group 0.016 0.14 0.91 
Q16 corticosteroids 0.15 0.061 0.014 
Q17 increased PEEP 0.18 0.069 0.010 
Q16 - I believe that this patient may benefit from the use of Corticosteroids, before reading the 
evidence summary tool; Q17- I believe that this patient may benefit from the use of increased 
levels of PEEP, before reading the evidence summary tool; SE – standard error 
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 Aim 8: To investigate whether clinician-level factors, research experience, characteristics 
of research use and research attitudes predict the likelihood of practice change in 
response to using an evidence summary tool. 
To identify clinician-level factors that were associated with a change in the strength of 
belief in the benefits of prone positioning in response to viewing an evidence summary tool, 
multivariable least squares regression analysis was conducted. The primary outcome for this 
analysis was the continuous variable change in the strength of belief. 
Factors under study were identified for evaluation in multivariable regression if the 
univariable P-value was less than 0.10. Backwards stepwise elimination was used to develop a 
final model to identify all statistically significant independent predictors of change in the 
strength of belief. 
 Univariable analysis 
The following factors were identified as candidates for evaluation in multivariable 
regression based on a univariable regression P-value less than 0.10. These factors were related 
to an  increase in the strength of belief in the benefits of prone positioning: lower frequency of 
reading information in Cochrane Library (P=0.094),  lower frequency of reading published 
meta-analyses (P=0.070), lower frequency of reading evidence summary journals (P=0.078), 
lower frequency of using evidence summary journals (P=0.015), weaker pre-existing belief in 
the benefits of prone positioning (P<0.0001), stronger pre-existing belief in the benefits of 
corticosteroids (P=0.061), less positive feelings towards using RCTs to guide practice 
(P=0.0015), less positive feelings towards using systematic review/ meta-analyses to guide 
practice (P=0.11).  
For complete details of the univariable relationships between all clinician-level factors, 
measures of research experience, characteristics of research use and research attitudes with 
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change in strength of belief in the benefits of prone positioning, see Table 46, Table 47 and 
Table 48. 
 Multivariable analysis 
All variables with a P-value less than 0.10 from the univariable analysis were included 
in a comprehensive multivariable model. After backwards stepwise elimination of non-
significant variables, the following variables remained statistically significantly independently 
associated with a change in the belief in the benefits of prone positioning. These factors were 
associated with an increase in the strength of belief the benefits of prone positioning:  
Lower pre-existing belief in the benefits of prone positioning (P=0.030), 
Higher pre-existing belief in the benefits of corticosteroids (P=0.0037). 
Complete details of the final multivariable model can be seen in Table 49. 
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Table 46. Univariable analysis of clinician-level factors and research experience 
Variable* Parameter 
Estimate 
SE  
parameter 
estimate 
P-value 
Q1. Gender – male referent 0.059 0.22 0.79 
Q2. Age in years 0.00053 0.0081 0.95 
Q3. Country of residence 
Compound dummy variable,  
overall P-value reported 
0.27 
Q4. Years practising 0.00021 0.0076 0.98 
Q5. Academic appointment 0.026 0.15 0.86 
Q6. Weekly CME hours 0.029 0.019 0.13 
Q7. Current position 
Compound dummy variable, 
overall P-value reported 
0.11 
Q8. Research training*    
   Research Fellowship* 0.18 0.20 0.37 
   Research Course* 0.075 0.17 0.65 
   Graduate Degree* 0.33 0.38 0.38 
   None 0.34 0.29 0.25 
Q9. EBM training
#
    
   Non-university based
# 
0.049 0.14 0.73 
   University
# 
-0.26 0.21 0.22 
   None  -0.087 0.14 0.53 
CME- continuing medical education; EBM – Evidence Based Medicine; SE – standard error 
*respondents able to select more than one level of training or qualification in research 
#
respondents able to select more than one level of training or qualification in EBM 
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Table 47. Univariable analysis of research use 
Variable  
 
Parameter 
Estimate 
SE parameter 
estimate P-value 
Q10. How often do you use 
EBM?  
-0.026 0.088 0.77 
Q11: How often do you read the following:  
 Published RCTs -0.10 0.091 0.27 
 Information in Cochrane   
 Library  
-0.13 0.078 0.094 
 Textbooks -0.013 0.066 0.84 
 Published EBGs -0.018 0.079 0.82 
 Published Meta-analyses -0.16 0.088 0.070 
 Evidence summaries -0.13 0.073 0.078 
Q12: How often do you use the following to guide clinical decisions:  
 Evidence summary journals -0.16 0.063 0.015 
 Advice given by colleague 0.084 0.079 0.29 
 Textbook information -0.091   0.068 0.19 
 Results of a Cochrane review -0.10    0.074 0.18 
 Results of an RCT -0.067 0.086 0.44 
 Published EBGs 0.018 0.085 0.83 
 Information from Google -0.089 0.066 0.18 
 Results of a Meta-analysis -0.094 0.069 0.18 
EBM – Evidence Based Medicine; RCT's – Randomised Controlled Trials; EBGs – Evidence 
Based Guidelines; SE – standard error 
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Table 48. Univariable analysis of research attitudes 
Variable  
 
Parameter 
Estimate 
SE parameter 
estimate P-value 
Pre-existing belief in benefits of specific clinical interventions for the patient-case 
described in the clinical scenario. 
Q13: High frequency 
oscillatory ventilation 
0.055 0.071 0.44 
Q14: Prone positioning  -0.51 0.061 <0.0001 
Q15: Non-invasive BiPAP  0.0059 0.073 0.94 
Q16: Corticosteroids 0.12 0.063 0.061 
Q17: Increased PEEP 0.051 0.071 0.47 
Q18: ECMO 0.013 0.082 0.87 
Q25. Positive feelings 
towards using the results of 
an RCT to guide my clinical 
practice  
-0.34 0.10 0.0015 
Q26. Positive feelings 
towards using the results of a 
systematic review/meta-
analysis to guide my clinical 
practice  
-0.15 0.092 0.11 
BiPAP - Bi-Level Positive Airway Pressure; PEEP - Positive End Expiratory Pressure; ECMO 
– Extra-Corporeal Membrane Oxygenation; RCT – Randomised Controlled Trial; EST – 
evidence summary tool; SE – standard error 
 
 
 
 
 
 195 
Table 49. Final Multivariable Model: Outcome is increase in the belief of the benefit of 
prone positioning 
Variable  
 
 
Parameter 
Estimate 
SE parameter 
estimate 
P-value 
Q14: Strength of pre-existing 
belief in benefits of prone 
positioning 
-0.52 0.058 0.030 
Q16: Strength of pre-existing 
belief in benefits of  
corticosteroids 
0.14 0.046 0.0037 
Q14 - I believe that this patient may benefit from the use of prone positioning, before reading 
the evidence summary tool; Q16- I believe that this patient may benefit from the use of 
corticosteroids, before reading the evidence summary tool; SE – standard error 
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DISCUSSION 
Attitudes towards research amongst intensive care specialists from Australia and New 
Zealand.  
Quantitative mail-out questionnaire survey design   
Consideration was given to the advantages and disadvantages of using a mail out self-
administered survey. The use of this type of instrument enabled a geographically widespread 
population to be surveyed in a cost effective manner.
107
 Mail out questionnaires offer a lower 
cost option when compared to other methods such as telephone or face-to face interviews
108
 
and this was considered an important advantage to the limited budget of our study. 
The success of self-administered surveys can be restricted if literacy levels are of 
concern in the intended survey population.
107
 This was deemed unlikely to impact on 
completion rates in our study. The intended study population were registered medical 
professionals with assumed acceptable levels of literacy. 
Formal validity studies for the McColl
34
 questionnaire instrument could not be found, 
however this questionnaire has been used to guide the development of  numerous other 
studies,
35, 40, 42-45, 51
 with consistent and similar results between studies demonstrating 
reliability. To ensure content validity of our instrument, we reviewed published questionnaires 
retrieved from the literature search, with a list of recurrent themes, topic areas and common 
questions collated. Selection and wording of our questions was based around the findings of 
the review of existing questionnaires to maintain construct validity.  
The Dillman Total Design Method advocates mail and telephone survey techniques that 
focus on social etiquette and personal attention in order to maximise response rates.
93, 98
 In 
general, the Dillman Total Design Method consists of two steps. In the first step, the 
investigator identifies aspects of the survey that are likely to influence the overall quality or 
quantity of responses and ensures each aspect of the survey is viewed by the potential recipient 
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as interesting, useful and easy to answer. The Dillman method also places an emphasis on 
establishing the legitimacy of the survey and creating trust.   
Utilising the framework provided by Dillman’s Total Design Method, careful attention 
was given to the wording of the cover letter to convey the importance of the project and to 
ensure that the study investigators’ appreciation of the time and effort of respondents was 
clearly communicated. Support of the local intensive care professional college (CICM) was 
gained, thus increasing legitimacy and trust.  
In addition to the initial time and effort placed on the design and wording of each 
question, pilot testing provided a formal process that allowed us to alter the questionnaire’s 
design and wording one last time, in response to feedback from actual potential recipients. 
Survey response rate 
In line with the Dillman Total Design Method,
109
 following the initial mail out of the 
survey packages in January 2011, we conducted a total of three mail outs. Dillman and 
colleagues proposed the use of three follow-up ‘waves’ to increase response rates to mail out 
questionnaires,
109
 with suggestions in the literature that each additional mail reminder yields 
about 30-50% of the initial responses.
110
 Persistence in the conduct of follow-up mail outs 
allowed us to improve our response rate from 30% after the first mail out to a final overall 
response rate of 56%.  
Another effective method proposed to increase response rates to postal questionnaires 
documented in the literature is the use of financial incentives, with a Cochrane review 
suggesting response can be doubled with the use of financial incentives.
95
 Due to funding 
limitations, we were unable to consider the use of financial incentives and it is unclear if this 
may have had an effect on our response rate.
111
  
Despite optimal survey methodology we did not reach our desired response rate of 
70%. However, our response rate is similar to rates achieved in other contemporaneous 
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physician surveys with similar design.
112, 113
 Physicians appear to be a particularly difficult 
group to survey, with a review by Asch et al. finding that compared to other groups, physicians 
are the poorest responders to surveys.
112
 In their review, response by group was evaluated 
within 321 surveys that included groups such as physicians, dentists, nurses, patients, other 
health care workers and administrators. Within 68 surveys that involved only physicians, the 
mean response rate was 54%, which was significantly lower than all other professional groups 
(p=0.001). This is consistent with our response rate and serves to reinforce the commonality of 
the difficulties we faced in maximising response rates within our survey.  
Item response rates 
The item response rate for individual questions was generally very good, with the 
majority of questions achieving response rates greater than ninety-five percent. We would 
suggest this further supports the value of the Dillman Total Design Method,
109
 and the 
emphasis it places on design, wording and pilot testing to make each individual question easy 
to understand and answer.  
Sampling frame and characteristics of non-responders 
The CICM is a medical specialty college with statutory responsibilities for specialist 
training and education in the field of intensive care medicine in Australia and New Zealand. 
The CICM maintains a complete list of accredited practicing intensive care specialists in 
Australia and New Zealand. Direct use of this registration list minimises non-coverage error by 
ensuring all members of the population to be studied had a chance of being selected into the 
study sample.
93, 108
 
A comparison of responders and non-responders was not conducted. We were unable to 
access any identifying details of CICM members and therefore we could not determine if our 
sample was truly representative of all members. Our sample was similar in regards to mean age 
and gender composition seen in similar surveys of physicians practicing in this field.
39, 42, 43, 51
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However, it is possible that intensive care specialists with an interest in academia and research 
may have been more inclined to respond to our survey mail out, and this could be a potential 
source of non-response bias if this group was over-represented in responders.
108
 We interpreted 
our results with caution based upon an understanding of this potential source of bias. 
Technical knowledge 
We are unaware of any previous surveys that have documented technical knowledge of 
research use amongst groups of intensive care practitioners. Thus we are unable to make 
comparisons to intensive care clinicians from different geographic locations or practice 
settings, however, it may still be useful to briefly compare and contrast key aspects of our 
survey against different surveys conducted amongst specialist groups within other fields of 
medicine.   
Consistent with the positive attitudes and acceptable levels of knowledge expressed by 
respondents to our survey, the majority of published studies show generally positive attitudes 
towards the use of research evidence to guide clinical practice. 
Previously published surveys have often assessed knowledge based upon a self-
reported understanding of terms.
34, 45
 Self-reported understanding is elicited by asking a 
question such as “Could you explain the term Odds Ratio to a colleague? – Yes or No.” 
Relying on self-reported understanding can be an unreliable measure of actual knowledge, as 
demonstrated by Young et al.
114
  
In 2002 Young et al. conducted a study of Australian general practitioners and 
compared self-reported understanding to actual knowledge.
35, 114
 In this study, self-reported 
understanding of seven research related terms was assessed and then the investigators 
conducted structured interviews with all participants and asked them to explain the seven terms 
out loud. For all seven terms, self-reported understanding was found to be significantly higher 
than actual knowledge. 
 200 
In consideration of the results of Young et al.’s validation study,114 we chose to assess 
actual knowledge in our study. Despite this technical aspect of our knowledge assessment, 
respondents demonstrated levels of actual knowledge consistent with previous studies across 
many different specialist groups within other fields of medicine.
34, 35, 39, 44, 45, 115-117
 
Structured hierarchies of research evidence vs. clinician preferences 
There appears to be a gap between the type of research evidence that authoritative 
bodies are recommending that clinicians should use to support clinical decisions and the type 
of research evidence that clinicians prefer to use. Key authoritative bodies have proposed 
structured hierarchies of research evidence that consistently promote systematic reviews and 
meta-analysis as the ‘most reliable’ source of evidence to support clinical decision making.52, 53 
Interestingly, respondents to our survey consistently ranked RCTs as their most preferred 
source of evidence to support clinical decision making, whilst systematic reviews and meta-
analysis from the Cochrane library ranked as the least frequently read and the least frequently 
used type of evidence.  
A preference for RCTs over systematic reviews and meta-analyses is consistent with 
other published studies, with clinicians from many different specialist groups within other 
fields of medicine expressing higher levels of trust in RCTs.
35, 36, 44
 Indeed, in some studies half 
of the respondents reported not even being aware of the existence of the Cochrane library
34, 43, 
44
 whilst in other studies almost all respondents reported that they never used information from 
the Cochrane library to help in clinical decision making.
39, 51
 
Clearly, research is needed to determine whether this divergence between the type of 
research evidence that is being promoted by authoritative bodies (systematic reviews and meta-
analyses) and the type of research evidence that is preferred by clinicians (RCTs) contributes 
towards creating evidence-practice gaps.  
 201 
Strengths and limitations  
We utilised a simple random sampling technique to obtain our study sample. The 
CICM registration list was the most comprehensive list available of practising intensive care 
specialists and utilisation of this list maximised the chance of ensuring all the target population 
had a chance of selection in our study. These techniques serve to increase the ability to 
generalise our results to other intensive care specialists. However, it is possible intensive care 
specialists with positive attitudes towards published research evidence, such as those with 
academic affiliations, would be more likely to respond to a survey regarding research evidence. 
We cannot exclude that this may have biased our survey and impacted on external validity.  
Demographic data regarding non-responders was not available when evaluating our 
response rate, as such we were unable to compare non-responders to responders. It was not 
possible to assess or address any potential non-responder bias and determine impact on the 
external validity of our findings. The results of our survey may therefore not be representative 
and generalisable to all intensive care specialists. Thus we have been conservative in the 
interpretation of our results. 
We conducted a rigorous and methodologically sound mail out survey. Whilst all 
attempts were made to minimise bias through use of The Dillman Total Design Method
109
 it is 
possible that bias is present based upon the order, wording and framing of the questions 
contained in our questionnaire.  
Appropriate use of research evidence amongst intensive care specialists from Australia 
and New Zealand. 
There are few repeatable objective definitions published regarding appropriate use of 
published research evidence in clinical practice. A survey conducted in Italian physicians by 
De Vito et al. provides a working template of appropriate use, defined as to read sometimes, 
often or very often RCT's and meta-analyses, and use the results of RCT's and meta-analyses in 
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clinical practice.
45
 We found no other surveys that utilised such a metric or attempted to 
quantify appropriate use.
34-36, 39-44, 51, 68, 94
 
The face validity of De Vito et al.’s definition of appropriate use hinges on the measure 
of frequency. With the defined frequency set at sometimes read and sometimes use, a 
conservative threshold is set. Given the current rapid increase in new publications of primary 
research evidence in all fields of medicine,
50
 it would be difficult to argue for a lower 
frequency such as rarely read and rarely use, however, we acknowledge that validation studies 
are needed to demonstrate whether a higher frequency may be more appropriate (e.g. often read 
and often use). Thus, if any bias is present in this metric, because of the low frequency set by 
the term sometimes, we would acknowledge the metric may over-estimate appropriate use 
rates.   
Compared to the original survey conducted by De Vito et al.
45
, we found that 
significantly more Australian and New Zealand intensive care specialists responding to our 
survey met the definition of appropriate users of published research evidence compared to the 
Italian general physicians (88/129 vs. 209/654, P<0.0001). It is possible that this difference 
may be related to a shift over time in patterns of use as our survey was more recent, or perhaps 
this finding is explained by practice within a highly specialised area. Setting this significant 
difference between groups aside, we do find it somewhat concerning that 31.8 percent of 
responding intensive care specialists do not even read or use research evidence sometimes.   
The intensive care unit is a complex and costly area of the hospital in which the most 
critically ill patients with the highest risk of death are cared for.
20
 With an exponentially 
expanding research-base demonstrating the desire of the field of intensive care to learn and 
improve outcomes for patients,
4
 we propose it would not be unreasonable to expect all 
intensive care clinicians to read and use research evidence at least sometimes. Given the metric 
we used to estimate appropriate use rates may be biased towards over-estimation, future 
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research is needed to identify ways to improve the appropriate use of research evidence by 
intensive care specialists.  
 Strengths and Limitations 
The level of appropriate use of published research evidence in clinical practice was 
assessed based on the construct previously published in De Vito et al.’s large well conducted 
survey of physicians in Italy.
45
 Whilst the components of the tool were not comprehensive, 
they were easily repeatable and thus enabled us to make a comparison of the levels of self-
reported appropriate use found in our population. It must be noted that all measures of 
appropriate use obtained in this survey were based solely on self-reporting and may therefore 
not reflect true rates of appropriate use. The measure of appropriate use utilised is an arbitrary 
metric and it is unknown whether it is the most suitable way to measure appropriate use. 
However, we found no other studies that attempted to quantify or measure rates of appropriate 
use and therefore this metric is the most reasonable strategy to have used. 
De Vito et al.’s definition of what constitutes appropriate use appears to be reasonable 
on face value. By definition, it only requires that you sometimes read and use. Clearly, the only 
other options are never, which is certainly inappropriate, and rarely. With suggestions that only 
30 to 40 percent of practice is based on evidence
10
 despite a dramatically expanding evidence 
base with increasing numbers of studies being published
4
 it can certainly be argued that to 
rarely use evidence is just not good enough.  
As previously noted, there may be an over-representation of responders with an interest 
in research in our study, with a seemingly high level of academic affiliations. The level of 
appropriate use found in our population could potentially over-estimate appropriate use rates in 
the general population of intensive care specialists in Australia and New Zealand and thus has 
been interpreted with caution.  
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Future directions 
Although self-reported appropriate use as ascertained by the tool developed by De Vito 
et al.
45
 in Australian and New Zealand intensive care specialists was significantly higher than 
that found in Italian physicians, a moderate level of appropriate use indicates further room for 
improvement. However, as acceptable levels of appropriate use have not specifically been 
defined, further research is needed to enable evaluation and establishment of true rates of 
appropriate use. A clearer definition of what is an acceptable rate of appropriate use is 
required. More research is needed to assess the depth, reliability and validity of these measures 
of appropriate use.  
Whilst the results of our survey have reinforced ideas from prominent change theorists 
that promote attitudes and understanding as important components of a successful change 
management process,
38, 118
 there are few studies that actually attempt to measure and quantify 
these factors in relation to rates of appropriate use of published research evidence. Improving 
knowledge may lead to a greater understanding of the need to change practice based upon the 
results of published research evidence. Strategies to improve knowledge such as participation 
in research training and evidence based medicine courses may be of potential benefit. We 
recommend that when future research is conducted on measures of appropriate use, measures 
of the influence and association between attitudes, knowledge and appropriate use be included. 
This will enable us to gain a better understanding of how these attributes influence the use of 
published research evidence in clinical practice. 
Characteristics associated with the appropriate use of published research evidence.  
Univariable analysis identified several clinician-level factors that were strongly 
associated with being an appropriate user of published research evidence in clinical practice. 
These factors included formal training in evidence-based medicine, experiences related to 
actively running a clinical research project (published as a named primary author, experience 
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running a funded clinical trial, and having consented a patient for a clinical trial), higher than 
average CME hours per week, a higher mean knowledge score and more frequent use of a 
computer to conduct database searches. 
One of the founders of the evidence-based medicine movement, David Sackett, defines 
evidence-based medicine as the “conscientious, explicit, and judicious use of current best 
evidence in making decisions about the care of individual patients. The practice of evidence 
based medicine means integrating individual clinical expertise with the best available external 
clinical evidence from systematic research.”63 Clearly, he views evidence based medicine as an 
active applied science focussed specifically on identifying appropriate research evidence for 
the primary purpose of supporting individual patient-level clinical decision making. It is 
somewhat surprising that we fail to find any previous studies that attempt to determine whether 
training in evidence based medicine results in improved use of research evidence in clinical 
practice, or whether clinicians who are motivated to identify and use research evidence in 
practice seek training in evidence based medicine. Interventional studies are needed to evaluate 
whether providing more training in evidence based medicine to untrained clinicians will 
increase rates of appropriate use.  
It is not surprising to observe that increased CME hours and higher knowledge scores 
were associated with increased appropriate use rates. As with formal training in evidence based 
medicine, future interventional studies may be required to determine whether these observed 
associations are causal. 
It was interesting to note that the clinician-level characteristics of age, gender and years 
practising were not associated with appropriate use. This is consistent with the findings of De 
Vito et al. where Italian physicians’ age was not related to appropriate use.45  
In addition to the above clinician-level factors, univariable analysis identified eight key 
characteristics of research studies that were identified as being more highly valued by 
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appropriate users. Appropriate users expressed a preference for methodologically sound, larger 
multicentre studies conducted in their own health care system. They preferred papers that were 
clearly written, in a fashion consistent with CONSORT or QUOROM statements. Furthermore, 
appropriate users valued a paper more highly if it was the second publication on the topic to 
demonstrate a significant benefit and if the benefit was measured using patient-centred 
outcomes. Appropriate users also expected a paper to fully explore all possible benefits and 
harms and present a full economic analysis. It is possible that evidence-practice gaps are more 
likely to be closed if the supporting research evidence fulfils each of the above identified 
characteristics. Future interventional studies need to address this hypothesis.  
Univariable analysis also identified five potential inhibitory factors that were strongly 
associated with not being an appropriate user. Clinicians who were not appropriate users were 
more likely to report difficulties using MEDLINE and were less likely to be able to find useful 
papers using MEDLINE. Furthermore, they were more likely to judge known papers as not 
good enough to guide practice. Clinicians who were not appropriate users held a stronger 
belief that appraising published research papers is not part of their job role, a stronger belief 
that they do not have enough training in EBM and they had greater difficulty integrating 
individual clinical expertise with the best available external clinical evidence from systematic 
research because they held a stronger belief that individual patient variation is not accounted 
for in the results of published research. 
It is concerning to observe that any intensive care specialist in Australia and New 
Zealand currently believes that appraising published research papers is not part of the job 
role. However, because of the nature of the study we conducted, these observed associations 
may not be causal. This finding may be an artefact of the wording we chose or it may be 
simply correlated with another more important characteristic. To identify whether any of the 
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key associations identified above might remain on a potentially casual pathway after 
controlling for all other interrelationships, we conduced multivariable analysis. 
 Multivariable analysis 
Multivariable analysis of the clinician-level factors, research study characteristics and 
potentially inhibiting factors distilled the results to three factors that were independently and 
significantly associated with appropriate use: mean knowledge score; experience running 
funded clinical trials; and a preference for multicentre projects.  
For the two clinician-level factors: mean knowledge score and experience running 
funded clinical trials; it is difficult to determine the temporal relationship with appropriate use. 
For example, having better knowledge and more experience running clinical trials may lead to 
increased frequency of research use. Alternatively, being an appropriate user and as such, a 
more frequent user of research evidence may lead to a higher level of knowledge or a 
commitment to contribute to knowledge by running a funded clinical trial. Interventional or 
prospective cohort studies may help determine this relationship.  
Interestingly, the only research study characteristic that remained independently 
associated with appropriate use was that the project involved multiple study centres. This 
finding is consistent with the published opinions of experts in the field, who clearly express  a 
preference for multicentre trials.
119
 Indeed, in their 2009 opinion paper Bellomo et al. report 
multiple examples of single-centre studies with positive results that were contradicted by the 
conduct of subsequent multicentre definitive trials. Based on the results of our multi-variable 
regression analysis, conduct across multiple sites may be the single most important study 
characteristic to emphasise when presenting research evidence to influence practice change. 
Future studies should be undertaken to investigate the potential importance of this approach to 
presenting and describing research evidence. 
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Attitudes towards research amongst a multinational cohort of clinicians with a special 
interest in intensive care. 
Quantitative e-mail questionnaire survey design   
A self-administered e-mail questionnaire was selected for this study as it enabled us to 
survey a geographically widespread population in a cost-effective manner.
107
 Compared to 
postal mail out, e-mail administration greatly reduces costs associated with the conduct of a 
survey.
120
 
The success of self-administered surveys can be restricted due to literacy or language 
concerns in the intended survey population.
107
 Although we expected a significant proportion 
of respondents to have a primary language other than English, the sampling frame was 
composed of registered medical professionals who actively participated in an English-language 
e-mail discussion group (CCM-L: The Critical Care e-mail discussion List). Thus, we expected 
a good working knowledge of English amongst respondents to complete the questionnaire. 
Furthermore, the limited budget of the study did not enable us to consider utilising the services 
of a translator to provide options for completion of the questionnaire in any other language.  
To ensure content validity and maintain construct validity we utilised pre-existing 
questionnaires as the basis for development of the e-mail questionnaire survey for this study
34, 
45, 104
 and to maximise the quality and quantity of responses, we embraced the Dillman Total 
Design Method.
93, 98, 109, 111, 121
 We carefully constructed a cover letter to participants that 
conveyed the importance of the project and clearly communicated our appreciation of the time 
and effort given by respondents to participate. Our cover letter concluded with the statement 
“since the validity of the results depends on obtaining a high response rate, your participation 
is crucial to the success of this study.” Emphasising the importance of every recipient’s 
contribution being important to the success of the survey can directly influence participation.
120
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In order to maximise readability and encourage completion of the questionnaire we paid 
strong attention to recommendations in the Dillman method regarding formatting and design.
96, 
98, 107, 108, 120
 The length of the questionnaire was minimised and it was emphasised in the cover 
letter than the questionnaire should take no longer than five to ten minutes to complete. While 
the definition of what constitutes a long survey varies among studies, response rates generally 
increase with shorter questionnaires.
107
 To minimise the overall number of pages included in 
the questionnaire, a separate cover page was not added to the booklet. Other considerations to 
improve readability included creating a single sided document, minimal use of bulk capital 
letters, use of headings and sections, and a minimum font size of twelve points throughout the 
document.  
It has been suggested that placing demographics at the beginning of a questionnaire can 
put respondents off, however a Cochrane review demonstrated that there was no difference in 
response rates when comparing questionnaires with demographic items first and questionnaires 
with demographic items last.
95
 We chose to place simple demographic questions at the 
beginning of our document to ease respondents into questionnaire completion. Careful 
consideration was given to the amount of information collected in demographics in order to 
minimise reduced response rates from perceived threats to anonymity being maintained.
95
 
In addition to the initial time and effort placed on the design and wording of each 
question, pilot testing provided a formal process that allowed us to alter the questionnaire’s 
design and wording one last time, in response to feedback from actual potential recipients. 
 Survey response rate 
The administration of surveys via e-mail may appear to offer promising advantages 
such as reduced response time, higher completeness of data, and large cost savings compared 
to other methods of survey administration.
122, 123
 Unfortunately, e-mail surveys of medical 
professionals are known to be problematic, with low completeness rates and low response 
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rates.
122, 124, 125
 At approximately ten percent, our response rate for this e-mail survey of 
intensive care clinicians was similar to other e-mail surveys of clinicians in other fields of 
medicine. 
We used design-based approaches to maximise response rates in our study, such as 
personalised mailings, design-friendly questionnaires, and university sponsorship.
95, 109, 126, 127
 
Token monetary incentives are known to increase physician response to surveys
113, 128
 however 
the funding limitations of this study meant we were unable to consider offering any financial 
reward for participation. Instead we appealed to potential participants’ professionalism and 
collegiality in the initial recruitment e-mail.  
The repeated encouragement of participation through ongoing follow-up reminders is a 
well established strategy to maximise response rates.
98, 121
 We sent monthly reminder 
recruitment e-mails to the CCM-L list, with a carefully worded cover letter that outlined the 
purpose of the study and the importance of each individual’s participation. Despite extending 
our study to a total recruitment period of one year, and maximising the use of strategies to 
enhance response, we were unable to achieve our desired response rate.  
Due to the low response rate of ten percent of the total sampling frame, we exercise 
caution generalising our results.  
 Item response rates 
Six of the 93 questionnaires were returned to our secure dropbox completely blank. We 
believe this may have been a technical issue related to the live PDF format of the survey. 
Although we had undertaken beta-testing with many different hardware platforms and PDF 
readers, it is possible some respondents used unexpected computing platforms (any flavour of 
UNIX) with a generic PDF reader. In such a situation, it is possible the completed form failed 
to save properly, and the unaware respondent submitted the blank form assuming it was 
completed. 
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Because of the anonymous process used for secure dropbox submission, we were 
unable to trace the blank forms back to respondents to obtain complete data. When working 
with new technology, such as an editable Adobe
o
 PDF form, it is difficult to predict technical 
issues that may arise even after extensive beta-testing. Perhaps this technical difficulty could 
have been overcome through the use of a paper-based survey. However, since we did receive 
one blank survey form during the conduct of our paper-based survey
104
 with a ‘protest note’ 
attached, we must also consider the possibility that these six blank PDF responses were also 
‘protest votes’. 
Sampling frame and characteristics of non-responders 
The Critical Care Medicine e-mail list (CCM-L) is a free, multidisciplinary electronic-
mail discussion group serving multinational subscribers, which has been actively running since 
1994. It has over 1,000 voluntary members from more than 50 different countries.
105
 Selection 
of the CCM-L as the sampling frame was based on convenience, as it provided access to 
clinicians with an interest in intensive care from throughout the world. 
A comparison of the basic characteristics of responders and non-responders could not 
be conducted. We were unable to access any identifying details of CCM-L members and 
therefore we could not determine if our sample was truly representative of all members. Our 
sample was similar in regards to mean age and gender composition seen in similar surveys of 
physicians practicing in this field.
39, 42, 43, 51
 Furthermore, the basic demographics of responders 
to this survey were similar to the basic demographics of responders to our mail survey of 
intensive care clinicians from Australia and New Zealand.
104
 
However, it is possible that intensive care specialists with an interest in academia and 
research may have been more inclined to respond to our e-mail survey, and this could be a 
potential source of non-response bias if this group was over-represented in responders.
108
 We 
                                                 
o
 Adobe Systems, San Jose, CA, USA. 
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interpreted our results with caution based upon an understanding of this potential source of 
bias. 
Structured hierarchies of research evidence vs. clinician preferences 
Like the Australian and New Zealand intensive care specialists who responded to our 
mail survey,
104
 respondents from this international cohort of clinicians with an interest in 
intensive care consistently ranked RCTs as their most preferred source of evidence to guide 
clinical decision making. This preference for RCTs over systematic reviews appears to be 
consistently expressed by clinicians,
35, 36, 44
 yet all theoretical research hierarchies rank RCTs 
below systematic reviews as a trusted source of evidence. 
52, 53, 57
 
Despite the methodological rigour offered within Cochrane reviews, information from 
the Cochrane library ranked as one of the most underutilised resources, with only textbooks 
ranking lower from a list of six information sources read by the respondents to our e-mail 
survey.  Again, this is consistent with the underutilisation of the Cochrane library reported by 
surveys conduct amongst many specialist groups within other fields of medicine.
34, 43, 44
 
This clear discordance between hierarchies of evidence and clinicians preferences 
highlights the need for further research to evaluate the effectiveness of influencing change 
using RCTs compared to systematic reviews and meta-analyses. 
Appropriate use of research evidence amongst a multinational cohort of clinicians with a 
special interest in intensive care. 
We found an appropriate use rate of 83.9% (95% CI, 76.2 to 90.9%) according to the 
metric set out by De Vito et al.
45
 Based on a direct comparison of 95% confidence intervals, 
appropriate use was significantly higher in responders from this multinational cohort compared 
to responders to our survey conducted amongst Australian and New Zealand intensive care 
specialists 68.2% (95% CI, 59.4 to 76.1%).
104
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The CCM-L provides an online e-mail discussion forum for clinicians with a special 
interest in intensive care. Participants self-select for membership in this group. Although the 
main focus of CCM-L is to enable clinical consultation with peers to solve current bedside 
patient problems, CCM-L also provides a forum to discuss the clinical relevance of the latest 
breaking research.  Our mail survey of intensive care specialists in Australia and New Zealand 
identified that higher CME time was associated with respondents being identified as an 
appropriate user of research evidence.
104
 Although formal CME credits are not offered, 
participation in CCM-L could be regarded as a CME related activity. Thus, using a CME 
related special interest group such as CCM-L as the sampling frame could be expected to result 
in a population of responders who were more prone to being classified as appropriate users of 
research. 
Strengths and limitations 
With blanket e-mails to all member of CCM-L, we attempted a census style approach to 
sampling that had the potential to include all members of our sampling frame. Although our 
overall response rate was low, it was consistent with previous e-mail based surveys of medical 
professionals. Our questionnaire design was based on well-established methodology known to 
improve the quality and quantity of responses.
109
 Given our final response rate, we were 
conservative in the generalisation of our results. Nevertheless, based on our robust and sound 
methodological design, internal validity was preserved.   
A reporting bias occurs when there is selective revelation of information by study 
participants.
49
 For example, physicians consistently state they value practice recommendations 
made by credible clinical practice guidelines
94,35,41,43
 and self-report their provision of care 
complies with practice recommendations made by credible clinical practice guidelines.
44,35,114
  
However, audits of actual clinical practice demonstrate that clinicians’ behaviours are not 
consistent with practice recommendations made by credible clinical practice guidelines.
6
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Underuse evidence-practice gaps arising from the difference between what clinicians say they 
do and what they actually do have been documented by numerous studies.
13,15,18
  
Because our survey relies on self-reporting of attitudes towards practice, we caution the 
reader that our results may over-estimate the actual change in practice that could be achieved 
through the use of an evidence summary tool. We strongly recommend that future research 
evaluates the influence of an evidence summary tool on actual practice in the clinical 
environment in order to remove the potential for a reporting, or say-do, bias. 
Using an evidence summary tool to improve research use. 
We developed a case-based scenario that presented a realistic patient in order to create 
an experiential learning situation. Theories of adult learning promote experiential learning 
situations as an effective method of transferring information.
129
  
The novel information identified for inclusion in the evidence summary tool was based 
on a thorough review of the literature in the field of intensive care medicine. At the time of 
commencement of our study in August 2015, current best evidence to support prone 
positioning of patients with severe ARDS was based on a multicentre RCT that clearly 
demonstrated a statistically significant and clinically meaningful reduction in mortality.
5
 
 The results of this multicentre RCT, published two years prior to our study, had not yet 
been incorporated into the one major clinical practice guideline that recommended prone 
positioning for patients with severe ARDS. In 2015, the most recent version of the Surviving 
Sepsis Campaign guideline was the ‘2012 update.’24 When published in 2013, the authors of 
the ‘2012 update’ made a weak recommendation using the wording “We suggest prone 
positioning in sepsis-induced ARDS patients with a PaO2/FiO2 ratio ≤ 100 mm Hg in facilities 
that have experience with such practices.” This recommendation is formally recognised as 
weak, as it was only supported by Grade 2B evidence at the time (‘2’ indicates a weak 
recommendation and ‘B’ indicates moderate evidence).24  
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In the ‘2016 update’ of the Surviving Sepsis Campaign guideline, when published in 
2017, the recommendation for prone positioning was upgraded to strong using the wording 
“We recommend using prone over supine position in adult patients with sepsis-induced ARDS 
and a PaO2/FiO2 ratio <150 (strong recommendation, moderate quality of evidence).”
26
 The 
upgrading to a strong recommendation and the explicit change in the PaO2/FiO2 ratio threshold 
to < 150 mm Hg based on the results of Guerin et al.’s 2013 multicentre RCT5 demonstrate 
that acceptance of the evidence supporting this clinical recommendation was in dynamic 
transition during the conduct of our study. Prone positioning was therefore a highly appropriate 
novel clinical intervention to use for testing the utility of an evidence summary tool.   
Change in the belief in the benefits of prone positioning 
Reviewing an evidence summary tool that concisely presented objective research 
evidence supporting the benefits of prone positioning for critically ill patients with severe 
ARDS resulted in a significant increase in the belief that prone positioning would benefit the 
realistic patient described in our case-based scenario. Interestingly, reviewing the evidence 
summary tool that concisely presented objective research evidence supporting the benefits of 
prone positioning also led to a significant decrease in the belief that corticosteroids would 
benefit the realistic patient described in our case-based scenario. Although the evidence 
summary tool did not even mention corticosteroids, we believe this decrease in belief is 
entirely consistent with a real change in the acceptance of prone positioning as an appropriate 
real-world treatment option. 
The practice of using corticosteroids to treat patients with sepsis-induced ARDS was 
commonplace in the early 21
st
 century, and was supported by numerous small RCTs.
130, 131
 
However, ten years ago the ARDSNet investigators published a large multicentre RCT in the 
New England Journal of Medicine that failed to demonstrate any benefits of corticosteroids for 
the treatment of ARDS.
132
 The most recent ‘2016 update’ of the Surviving Sepsis Campaign 
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guidelines, published in 2017, makes no recommendation for the use of steroids in patients 
with sepsis-induced ARDS.
26
 Corticosteroids are cheap and have been used clinically for a 
long time. Currently, they are most likely to be used by clinicians in patients who have 
developed ARDS and are very difficult to ventilate, most likely because the clinicians are 
unaware of, or do not believe in, other proven treatment options. We suggest that our evidence 
summary tool, which was clearly effective at communicating the appropriateness of prone 
positioning for the realistic patient described in our clinical scenario, also resulted in prone 
positioning replacing corticosteroids as a competing treatment option and thus significantly 
reduced the clinicians belief in the possible benefits of corticosteroids for the realistic patient 
described in the clinical scenario.  
We have demonstrated that reviewing an evidence summary tool that concisely 
describes the research evidence supporting a treatment option can change a clinician’s belief in 
the potential benefits of that treatment. The seminal transtheoretical model of health behaviour 
change proposed by Prochaska and Velicer posits that before health-related behaviour is 
changed, the individual must be aware of the need for change and the positive benefits of 
change.
38
 Belief in the positive benefits of change achieved by our evidence summary tool 
therefore may represent the required first steps necessary to achieve actual behaviour change. 
We strongly recommend additional research to determine whether a change in belief achieved 
by use of an evidence summary tool can translate into a change in clinical practice behaviours. 
Although we achieved a change in belief using our evidence summary tool, achieving a change 
in clinical practice behaviours is considered complex and usually requires a multifaceted 
intervention.
133
 Undertaking such a project was beyond the scope of this current thesis, but our 
promising results clearly indicate that the use of evidence summary tools requires further 
evaluation. 
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Should evidence summary tools promote RCTs or systematic reviews? 
By placing systematic reviews and meta-analyses at the top of evidence hierarchies, 
experts are clearly recommending that clinicians should prefer this type of evidence to support 
clinical decision making.
52, 53
 However, clinicians clearly express a preference for RCTs to 
inform their decisions.
35, 36, 44, 45, 104
 To test whether clinicians are influenced differently by 
different primary sources of evidence, we developed two subtly different versions of the 
evidence summary tool. Although both versions of the tool concisely summarised the evidence 
supporting the benefits of prone positioning, one version emphasised the evidence source as 
being a multicentre RCT plus additional smaller RCTs whilst the other version emphasised the 
evidence source as being a multi-trial meta-analysis. Members of CCM-L who volunteered to 
respond to our survey on attitudes towards research evidence were randomly assigned to 
receive one of the two competing versions of the evidence summary tool.  
Whilst both evidence summary tools increased clinicians’ belief in the benefit of prone 
positioning, we failed to find any differences between the two tools. Even after accounting for 
potential confounding arising because of imbalance in baseline variables, we failed to find a 
difference between the competing evidence summary tools.   
It is possible that we were unable to detect a difference between groups due to the small 
size of our study. It is also possible that the evidence summary tools were so subtle in the way 
the evidence-source was emphasised, that no differences exist. Based on our results, the best 
estimate of a possible difference in effect achieved by the competing evidence summary tools 
was 0.07 units. The mean magnitude of belief change achieved by both tools was +0.32 units. 
Although we are unable to comment on whether a value of 0.07 units would be clinically 
meaningful, we do recommend more research on this issue with larger sample sizes. Data 
presented in our Results section can serve to guide appropriate sample size calculations for 
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future research. In addition, we recognise that additional research should determine whether 
other factors of the evidence summary tool can be optimised to maximise effectiveness.  
Who did the evidence summary tool influence? 
On univariable analysis, clinician-level factors and research experience were not found 
to be predictors of the likelihood of change in response to our evidence summary tool. For 
example there was no relationship between age, gender, number of years practising in intensive 
care, or weekly CME hours and change in belief of benefit. Likewise research training and 
EBM training did not predict a change in belief of benefit. 
Interestingly, frequency of reading and positive attitudes towards using different types 
of evidence were found to influence the magnitude of the change in the belief in benefit. A 
lower frequency of reading information from the Cochrane library, meta-analyses and evidence 
summary journals predicted a greater increase in the belief of benefit of prone positioning after 
reading the evidence summary tool. Furthermore, less positive feelings towards using RCTs 
and systematic reviews to guide clinical practice also predicted a greater increase in the belief 
of benefit of prone positioning after reading the evidence summary tool.  
These findings are interesting and potentially very important. A lower frequency of 
reading and a less positive attitude towards using RCTs and systematic reviews to guide 
practice change could describe a clinical population who is less up to date.  In his seminal text 
book on change management theory, Diffusion of Innovations, Everett Rogers proposed that 
when any population of individuals is presented with a new technology, their initial responses 
can be broken down into five classes: Innovators; Early adopters; Early majority; Late 
majority; and Laggards.
118
  The term Laggards is used to describe the group that is last to 
change. Typically, they are described as having an outlook that focuses on the past and how 
things were done, rather than looking to the future. They are described as being slow to become 
aware of new innovations and they delay changing until they are absolutely certain that a new 
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idea or practice will not fail. It is extremely promising that our tool seemed to capture the 
attention of this group of people, who are typically the last and most difficult in a group to 
change.  
On multivariable analysis, accounting for potential confounding arising from all of the 
potential predictors identified during univariable analysis, two variables remained statistically 
significant independent predictors of a change in the belief of benefit of prone positioning. 
These variables were a higher pre-existing belief in the benefit of corticosteroids and a lower 
pre-existing belief in the benefit of prone positioning. Again, we would suggest that these two 
characteristics identify clinicians who are less up to date.  
With regards to the clinical options identified for the realistic patient described in our 
case-based scenario, we would suggest that treatment with corticosteroids would represent an 
‘outdated’ approach proven to have no effect over ten years ago,132 whilst prone positioning 
would represent the approach most recently proven effective in a multicentre RCT.
5
 Once 
again, this fits the profile of a change Laggard: Lack of awareness of new technology and a 
fixation on past technology.  
Context 
Despite an awareness that current best research evidence should be used to guide 
clinical decision making, it is well documented that there is a continuing failure of health care 
professionals to provide medical care in line with good quality evidence.
10
 Situations where 
good quality evidence is not translated into clinical practice cause significant harm to patients. 
The overwhelming loss of life attributable to the failure to implement a simple and effective 
treatment for scurvy in the 18
th
 century is one such astounding example. Despite James Lind 
successfully demonstrating citrus fruit was an effective intervention to treat scurvy, the use of 
this simple treatment did not become common practice until 42 years after publication of his 
results.
7, 8
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Unfortunately modern medicine fares no better, with irrefutable evidence demonstrating 
that clinical practice is not always guided by the best available evidence. In the United States, 
in a large study involving over 6,000 patients with a wide range of medical conditions, 45% 
failed to receive care supported by research evidence.
13
 A similar study conducted in Australia 
produced similar findings: care was based on best evidence recommendations in only 43% of 
patient encounters.
15
 These situations serve to highlight that evidence-practice gaps warrant 
attention in all fields of medicine.   
In the ICU, where patients have a high risk of death
20
 and the cost of providing medical 
care is three times that of the standard hospital patient,
3
 evidence-practice gaps have the 
potential to cause significant patient harm. The number of clinical trials being produced in the 
field of intensive care medicine is increasing exponentially,
4
 yet despite numerous trials 
demonstrating the effectiveness of life saving clinical interventions, evidence-practice gaps 
exist.  
The landmark ARDSNet low-tidal-volume ventilation trial provides clear evidence 
supporting a simple life saving intervention for ventilatory management of patients with Acute 
Respiratory Distress Syndrome in the ICU.
23
 The ARDSNet low-tidal-volume ventilation 
strategy evaluated in this trial significantly reduced mortality rates by 8.8% (31.0% vs. 39.8%, 
P=0.007) compared to traditional tidal volumes.  
Incorporation of the ARDSNet low-tidal-volume ventilation strategy into major 
international clinical practice guidelines confirms the acceptance of the importance of the 
results of this trial,
24-26, 30
 yet studies evaluating delivery of care clearly demonstrate an 
evidence-practice gap. Published in 2016, Bellani et al. measured the adherence to the 
ARDSNet low-tidal-volume ventilation strategy in patients with the Acute Respiratory Distress 
Syndrome.
6
 In the 915 critically ill patients objectively diagnosed with the Acute Respiratory 
Distress Syndrome, 36.3% (332/915) of eligible patients did not receive the ARDSNet low-
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tidal-volume ventilation strategy. Despite the results of the ARDSNet low-tidal-volume 
ventilation trial demonstrating that we can save one life by treating just eleven patients with 
this simple effective life saving intervention, clinicians fail to provide medical care in line with 
this high quality evidence.   
The use of prone positioning in the ICU provides another example of a clear evidence-
practice gap where an intervention has proven benefit from a high quality clinical trial. 
Although Guerin et al.’s landmark trial was published in 2013,5  Bellani et al. reported that by 
2016, only 16.3% (119/729) of eligible patients actually received prone positioning.
6
  
Evidence-practice gaps exist today. Failure to receive beneficial treatment according to 
the best available evidence results in harm to patients. Despite the known existence of 
evidence-practice gaps and the associated harms, objective evidence for techniques proven 
effective at closing evidence-practice gaps is sparse.
61, 134-138
 The findings of this thesis take an 
important first step in the identification of a method that may hold great promise for addressing 
evidence-practice gaps: the evidence summary tool.  
With clinicians consistently reporting a preference for RCTs
35, 36, 44, 45, 104
 and research 
demonstrating widespread underuse of systematic reviews and meta-analyses
39, 42, 51, 68, 94, 104
 
the development and promotion of a structured, succinct and concise evidence summary tool 
offers a promising strategy to increase awareness and acceptance of novel research evidence. 
Logically, this increased awareness may lead to appropriate practice changes. Thus, evidence 
summary tools may play an important role in reducing evidence-practice gaps.  
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 Provision of an annual report on this research to the Human Research Ethics Committee from 
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withdrawal of ethics approval for the project.  
 
 All serious and unexpected adverse events should be reported to the HREC within 72 hours. 
 
 All unforeseen events that might affect continued ethical acceptability of the project should be 
reported to the HREC as soon as possible. 
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 Any changes to the project including changes to research personnel must be approved by the 
HREC before the research project can proceed.  
 
 Note that for student research projects, a copy of this letter must be included in the 
candidate’s thesis. 
 
Chief Investigator / Supervisor’s responsibilities: 
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Northern Clinical School 
Intensive Care Research Unit 
University of Sydney 
 
 
COVER LETTER AND PARTICIPANT INFORMATION FOR THE SURVEY TITLED: 
Use of published research evidence in Intensive Care 
 
 
Thursday, 18 November 2010 
 
 
Dear Fellow of the College of Intensive Care Medicine, 
 
 
This survey has been mailed to you with the full support and cooperation of the College 
of Intensive Care Medicine. This survey seeks to gain insights into how and when 
Intensive Care Specialists use published research evidence to support clinical practice. 
It is being conducted by A/Prof Gordon Doig and Philippa Heighes from the Northern 
Clinical School Intensive Care Research Unit at the University of Sydney. 
 
We appreciate that your time is valuable. It should only take 5 to 10 minutes to complete 
the questionnaire. We would be grateful for your completion of the questionnaire at your 
earliest convenience. 
 
Your participation in this survey is completely voluntary and your responses will be 
anonymous and confidential. You are under no obligation to complete the questionnaire. 
Submission of a completed questionnaire will be taken as an indication of your consent 
to participate in the study. You can withdraw any time prior to submitting your completed 
questionnaire. Because there are no identifiable markings on the questionnaire, once 
you have submitted your completed questionnaire your responses will be anonymous 
and cannot be traced or withdrawn. 
 
Postage-paid return envelopes have been marked with a unique identification code to 
enable the registration of responders. The return envelope will be separated from the 
anonymous questionnaire upon receipt. Data will be processed blinded to identity to 
maintain your anonymity. All source data will be stored for 7 years, as required by 
University of Sydney Ethics Committee policy. Only the named researchers will have 
access to participant-level information.  
 
Aggregate level-summary information that cannot result in the identification of 
respondents, may be shared with the College of Intensive Care Medicine and will be 
published and presented at academic meetings. However aggregate level-summary 
information will be presented in such a way that individuals cannot be identified. 
 
This study has been reviewed and approved by The University of Sydney Human 
Research Ethics Committee. The Human Research Ethics Committee has determined 
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that this study meets the ethical obligations required by law and University policies.  If 
you have further questions or concerns regarding this study please contact the 
Investigators:  
 
A/Prof Gordon S. Doig 
Royal North Shore Hospital, 
Intensive Care Unit, 
St Leonards, NSW 
Australia 2065 
 
02 9926 8656 
gdoig@med.usyd.edu.au 
Philippa Heighes  
Royal North Shore Hospital, 
Intensive Care Unit, 
St Leonards, NSW 
Australia 2065 
 
02 9926 8656 
pheighes@med.usyd.edu.au 
 
 
We would sincerely appreciate your completion and return of the attached questionnaire 
in the enclosed stamped, self-addressed envelope. Since the validity of the results 
depend on obtaining a high response rate, your participation is crucial to the success of 
this study. 
 
We thank you in advance for your participation. 
 
 
Yours Sincerely, 
 
 
Gordon Doig  
 
 
Philippa Heighes  
 
 
 
 
 
 
 
 
 
Any persons with concerns or complaints about the conduct of this research project can contact: 
The Manager, Human Ethics Administration, University of Sydney, NSW 2006  
+61 2 8627 8176 (Telephone);  
+61 2 8627 8177 (Facsimile) or 
ro.humanethics@sydney.edu.au (Email) 
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Please answer all of the following questions to the best of your ability:
Demographics:
1. What year did you first become registered with the
Joint Faculty Of Intensive Care Medicine (JFICM)/
College of Intensive Care Medicine (CICM)?
  (please insert year here)
Female2. Are you:
Male
3. What year were you born?
  (please insert year here)
4. Please indicate your level of training or qualification in research: (select all that apply)
a: Research fellowship
b: Formal research methodology course (eg short course at university)
d: Certificate, Diploma or Degree in research methodology
(I)  Graduate Certificate level
(II) Graduate Diploma level
(III) Masters level
(IV) PhD level
e: No formal research qualification
5. Please indicate your level of training in Evidence Based Medicine
(EBM): (select all that apply)
a: Have attended an EBM course/workshop
(eg offered at a hospital, a conference or by a for-profit organisation)    
b: Have attended an EBM course/workshop offered by a University
c: Have attended an EBM course/workshop at McMaster University
d: No formal training in EBM
Research Experience:
6. Do you hold an academic appointment within a
university? YES NO
7. Have you published any research papers as a named
contributing or primary author? YES NO
8. Are you involved in the running of any funded clinical
trials? YES NO
9. Have you ever consented a patient for a clinical trial? YES NO
10. Are you or have you been named as an investigator
on an ethics submission for a funded clinical trial? YES NO
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11. How many hours a week do you devote to your own
continuing medical education?
(eg journal club, grand rounds, self study)
 (please insert hours here)
12. How often do you use the Internet?
    (select only one)
a: Daily b: At least weekly c: Less than weekly d: Never
13. For what purposes do you use a computer?
    (select all that apply)
a:  For word processing
b:  For data analysis
c:  To search databases for published research papers
d:  Other
Research Knowledge:
In
co
rr
ec
t
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rr
ec
t
(select only one for each statement)
14. The CONSORT Statement is an international guidance document
intended to improve the reporting of Randomised Controlled Trials
(RCT).
15. Allocation concealment refers to the act of masking which
treatment a patient enrolled in a clinical trial is currently receiving
from the treating clinician.
16. The PRISMA Statement is an international guidance document
intended to address the suboptimal reporting of systematic reviews
and meta-analyses of RCTs.
17. Conventionally, results in a clinical trial are considered to be
statistically significant (ie unlikely to have arisen by chance) if the
p value is less than 0.05 (p<0.05).
18. In a meta-analysis, the I2 metric is a measure of heterogeneity that
is dependant on the number of patients included in a trial.
19. The forest plot is a graph used in a meta-analysis to detect
publication bias in which the estimate of risk is plotted against
sample size.
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Research attitudes:
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(select only one for each statement)
20. My feelings towards EBM are positive.
21. My colleagues’ feelings towards EBM are positive.
22. My feelings towards using the results of an RCT to guide
my clinical practice are positive .
23. My feelings towards using the results of a systematic
review / meta-analysis to guide my clinical practice are
positive.
24. Time limitations are a factor that restrict the incorporation
of EBM into my clinical practice in Intensive Care.
25. The use of published research evidence has not made a
difference to my clinical practice.
Research use:
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(select only one for each statement)
26. How often do you use the concepts of EBM in your
clinical practice?
27. How often do you read the following?
a Published RCT’s
b Information obtained from The Cochrane Library
c Textbooks
d Published evidence based guidelines
e Published meta-analyses
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28. How often do you use the following information sources to guide decisions in your
clinical practice?
a Information provided in evidence summary journals
(Intensive Care Monitor etc).
b Advice given to me by a colleague.
c Information I have read in a textbook.
d The results of a Cochrane review.
e The results of an RCT.
f Conference presentations.
g Published evidence based guidelines.
h Information I found through a Google search.
i The results of a meta-analysis.
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(select only one for each statement)
29. How often do you use published research evidence in the following situations:
a Preparing a teaching session for trainees.
b Making individual patient care decisions.
c Developing guidelines or protocols.
d Settling a clinical dispute regarding patient management.
e Reviewing management of a past patient (eg M&Ms).
f Improving my knowledge.
g Preparing a presentation for colleagues.
h Preparing to provide information to a patient or next of kin.
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30. How often are the following factors likely to help your decision to use the results of
published research evidence to change practice:
a The project was conducted in my own health care system.
b The project included a lot of patients.
c The paper was clearly written
(ie concise, coherent, to the point, logical).
e The paper fully explored all possible benefits and harms.
f The project was methodologically sound, with no major flaws.
g Other Intensivists have changed practice based on this paper.
h The results will reduce costs but patient outcomes will not be
compromised.
i The CONSORT or QUOROM statements were followed.
j I have seen the author present the findings of the project at a
conference.
k I understand the pathophysiological rationale of the
intervention.
l The results have clear benefit to my patients.
m The intervention is described in enough detail so that I could
implement it in my clinical practice.
n The project involved multiple study centres.
o The paper was written by a recognised expert in the field.
p The paper is the second publication on this topic to
demonstrate a significant benefit to patients.
q The paper presents a full economic analysis.
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31. The following factors inhibit my use of published research evidence in clinical practice:
a I have difficulty finding the time to read.
b I have difficulties using MEDLINE.
c I can find papers using MEDLINE, but it is difficult to find key
papers that are good enough to guide my practice.
d I have difficulties critically appraising papers.
e I have difficulties convincing my hospital to stock new drugs.
f I believe there is a lack of good evidence providing
meaningful answers to my clinical problems.
g My colleagues do not support me when I am the first to
change my own practice using new research evidence.
h I have insufficient authority to introduce some new practices
into my hospital.
i Appraising published research papers is not part of my role.
j I do not have enough training in EBM.
k Individual patient variation is not accounted for in the results
of published research.
l I do not trust observational studies enough to use them to
guide my practice.
m Studies conducted in Europe and the USA do not apply to my
patients.
You have now reached the end of the questionnaire.
Thank you for taking the time to participate in our study.
Please return the questionnaire in the enclosed return envelope at your convenience.
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Northern Clinical School 
Intensive Care Research Unit 
University of Sydney 
 
 
COVER LETTER AND PARTICIPANT INFORMATION FOR THE SURVEY TITLED:  
 
Facilitating practice change using an evidence summary tool: A survey of clinicians attitudes. 
 
 
Thursday, 23 July 2015 
 
 
Dear Member of the CCM-L Mailing list, 
 
 
We are conducting a study to gain insights into the attitudes of Intensive Care Clinicians 
towards the use of Evidence Summary Tools to support clinical practice. With the support of 
Prof David Crippen, the convenor of the Critical Care Mailing List (CCM-L), we would like to 
invite you, as a subscribing member of CCM-L, to participate in this study. The study is being 
conducted by A/Prof. Gordon Doig and Philippa Heighes from the Northern Clinical School 
Intensive Care Research Unit at the University of Sydney, Australia.  
 
Since the validity of the results depends on obtaining a high response rate, your participation is 
crucial to the success of this study. We therefore thank you in advance for your important 
contribution to our study. If you would like to participate in this study, we would appreciate you 
responding via email to pheighes@med.usyd.edu.au to indicate your interest at your earliest 
convenience.  
 
On receipt of your email, we will send you a survey package containing one of two possible 
evidence summary tools selected by a random number generator, and a self-administered 
anonymous questionnaire. We appreciate that your time is valuable, and as such, it should only 
take 10 to 15 minutes to complete the questionnaire. 
 
Your participation in this study is completely voluntary, you are under no obligation to 
complete the questionnaire and can withdraw any time prior to submitting your completed 
questionnaire with no consequences. Submission of a completed questionnaire will be taken to 
indicate your consent to participate in the study. Because there are no identifiable markings on 
the questionnaire, once you have submitted your completed questionnaire your responses will 
remain anonymous and cannot be withdrawn. 
 
An anonymous drop box has been created at https://research.evidencebased.net/dropbox to 
enable you to easily return the completed questionnaire. Simply visit the web address provided 
and follow the links to upload your questionnaire. Your responses will be anonymous and 
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confidential, with data processed in de-identified form. All source data will be stored securely 
for 5 years, as required by University of Sydney Ethics Committee policy.  
 
Anonymous aggregate level-summary information that cannot result in the identification of 
respondents may be shared with the Critical Care Mailing List (CCM-L), will be published and 
presented at academic meetings, and will be included in the PhD theses for Philippa Heighes.  
 
This study has been reviewed and approved by the Human Research Ethics Committee (HREC) 
of the University of Sydney (protocol project number 2015/634) who have determined that the 
study meets the ethical obligations required by law and University policies.  If you have further 
questions or would like to know more at any stage during the study please contact the 
Investigators:  
 
A/Prof Gordon S. Doig 
c/- Royal North Shore Hospital, 
Intensive Care Unit, 
St Leonards, NSW 
Australia 2065 
 
02 9463 2633 
gdoig@med.usyd.edu.au 
Philippa Heighes  
c/- Royal North Shore Hospital, 
Intensive Care Unit, 
St Leonards, NSW 
Australia 2065 
 
02 9463 2633 
pheighes@med.usyd.edu.au 
 
 
Thank you in advance for taking the time to participate and for your important contribution to 
our study. 
 
 
Yours Sincerely, 
 
  
  
 Gordon Doig  
 
 
 
 
 
 Philippa Heighes  
 
 
 
 
 
 
 
If you are concerned about the way this study is being conducted or you wish to make a complaint to 
someone independent from the study, please contact the university using the details outlined below. 
Please quote the study title and protocol number.  
 
The Manager, Ethics Administration, University of Sydney: 
• Telephone: +61 2 8627 8176 
• Email: ro.humanethics@sydney.edu.au 
• Fax: +61 2 8627 8177 (Facsimile) 
 
 
Use of an Evidence Summary Tool in Intensive Care.  
Return to: https://research.evidencebased.net/dropbox 
OR print and mail to Philippa Heighes 
c/- ICU Office Level 6 RNSH, Pacific Highway 
St Leonards 2065 NSW Australia 
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SECTION 1 - DEMOGRAPHICS AND RESEARCH USE 
General Instructions: Please answer all questions to the best of your ability in the order that they appear. 
Directions for completing individual questions are given throughout the questionnaire where necessary. 
When you have completed the questionnaire please save and return at your earliest convenience.  
 
DEMOGRAPHICS: 
 
  
  
1. Are you:   Male  Female  
 
 (select appropriate box) 
  
      
2. What is your current age?      
 (please insert age here)  
   
       
3. What country do you live in?    
 (please insert country here) 
  
  
4. What year did you first start working in Intensive Care?    
 (please insert year here) 
  
    
 
5. Do you currently hold an academic appointment 
within a university? Yes  No  
  (select appropriate box) 
   
   
6. How many hours a week are you able to devote to 
your own continuing medical education?  
      
      (eg journal club, grand rounds, self study)   (please insert hours here) 
 
 
 
Continues next page....... 
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   7. What is your current position? Please select the category that 
most accurately describes your daily role:  (select only one) 
 a: Part time in Intensive Care, primary speciality in other field   
 b: Full time Intensive Care Specialist   
 c: ICU trainee     
 d: Nurse    
 e: Dietician    
 f:  Physiotherapist    
 g: Occupational therapist     
 h: Respiratory therapist    
 i:  Pharmacist    
 j:  Other     
 
 
  
 
  
8. Please indicate your level of training or qualification in research: (select all that apply) 
 a: Research fellowship  
 b: Formal research methodology course (eg short course at university)  
 c: Certificate, Diploma or Degree in research methodology  
   (I)  Graduate Certificate level  
   (II) Graduate Diploma level  
   (III) Masters level  
   (IV) PhD level  
 d: No formal research qualification   
 
9. Please indicate your level of training in Evidence Based Medicine (EBM):   
 (select all that apply) 
 a: Have attended a short EBM course/workshop  (eg offered at a hospital, a conference or by a for-profit organisation)     
 b: Have attended an EBM course/workshop at McMaster University   
 c: Have attended an EBM course/workshop at another University  
 d: No formal training in EBM  
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RESEARCH USE: 
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  (select only one for each statement) 
        
10.  
 
How often do you use the concepts of EBM in your 
clinical practice? 
 
     
                        
11.  How often do you read the following? 
      
        
 a Published Randomised Controlled Trials (RCTs)       
 b Information obtained from The Cochrane Library       
 c Textbooks       
 d Published evidence based guidelines       
 e Published systematic reviews/ meta-analyses       
 f Evidence summaries       
         
12.  
 
How often do you use the following information sources  
to guide decisions in your clinical practice? 
  
 
a 
 
Information provided in evidence summary journals  
(eg Intensive Care Monitor etc) 
      
 b Advice given to me by a colleague       
 c Information I have read in a textbook       
 d The results of a Cochrane review       
 e The results of an RCT       
 f Published evidence based guidelines       
 g Information I found through a Google search.       
 h The results of a systematic review/ meta-analysis.       
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SECTION TWO – CLINICAL SCENARIO 
General Instructions: Please carefully read the clinical scenario presented to you following these 
instructions. When you have finished reading the scenario you will be asked some questions regarding the 
ongoing management of the patient presented.  
 
Mr Mathews, a 68 year old male who weighs 89kg (196lb) and is 178cm (5'10") in height was admitted 
to your ICU 30 hours ago with community acquired pneumonia and sepsis. Chest x-ray showed diffuse 
bilateral opacities and a BiPAP trial for worsening respiratory function failed. He was intubated 26 
hours ago and commenced on mechanical ventilation for the management of severe ARDS.  
This morning, Tidal Volume is 450mls, PEEP is set at 14cmH2O with an FiO2 of 0.8 and a PaO2:FiO2 ratio 
of 73. You have attempted multiple lung recruitment manoeuvres with no visible improvement and 
remain concerned with his respiratory status. 
 
Please indicate your level of agreement with the following 
statements: 
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 (select only one for each statement) 
13.  I believe that this patient may benefit from High Frequency Oscillatory Ventilation       
        
14.  I believe that this patient may benefit from Prone Positioning        
        
15.  I believe that this patient may benefit from Non-Invasive Bi-Level positive airway pressure (BiPAP) ventilation       
        
16.  I believe that this patient may benefit from the use of corticosteroids         
        
17.  I believe that this patient may benefit from the use of increased levels of PEEP         
                
18.  I believe that this patient may benefit from Extra-Corporeal Membrane Oxygenation (ECMO)         
        
SECTION THREE – EVIDENCE SUMMARY TOOL 
On the next page you will find an Evidence Summary Tool that presents recent evidence from published 
literature regarding the management of patients with severe ARDS. Please carefully read the Tool and 
consider the evidence presented before moving onto Section Four 
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Prone Positioning in ARDS saves lives 
To save 1 life you need to prone 6 patients with severe ARDS on low-tidal volume ventilation.  
This is supported by a significant mortality reduction in a well conducted RCT analysing 466 
patients from 27-hospitals and 5 smaller RCTs enrolling an additional 542 patients. 
Other patient benefits 
For every 15 patients proned, 1 cardiac arrest is prevented.1 
For every 7 patients proned, 1 additional patient is successfully extubated before Day 90. 1 
Potential harms 
For every 25 patients proned, 1 transient endotracheal tube obstruction occurs.2 
For every 77 patients proned, 1 thoracotomy tube is dislodged.2 
For every 10 patients proned, 1 additional pressure ulcer occurs.2  
There is no documented increase in additional accidental extubations.1,2,3 
Identifying patients that will benefit from prone positioning 
1) Identify severe ARDS patients early  
Intubated and ventilated < 36 hours AND PaO2:FiO2 ratio < 150mmHg. 
2) Implement low-tidal volume ventilation for a period of 12 to 24 hours 
Ensure PEEP is at least 5cmH2O and FiO2 ≥ 0.6. 
3) If PaO2:FiO2 ratio remains < 150 mmHg, consider proning. 
Implementing prone positioning in suitable patients 
1) Maintain prone position for at least 16 consecutive hours. 
2) Following return to supine position reassess PaO2:FiO2 ratio and continue to use prone 
positioning each day if PaO2:FiO2 ratio < 150mmHg. 
3) If PaO2:FiO2 ratio ≥ 150mmHg and PEEP ≤ 10cmH2O and FiO2 ≤ 0.6 cease prone positioning. 
Useful educational resources regarding prone positioning 
The successful management of the patient in prone position relies on the skill of the staff 
performing the procedure. Adequate training and experience of staff is key to maintaining 
patient safety and minimising potential harms.  
Guidelines for standardising prone positioning and a useful 5 minute training video demonstrating 
prone positioning procedure available at http://www.nejm.org/ 
A complete list of eligibility criteria and contraindications can be found at 
http://www.nejm.org/suppl 
Physiological rationale of why prone position is beneficial 
Prone positioning leads to more equal ventilation perfusion match; more uniform alveolar 
recruitment and expansion; and more even distribution of pleural pressure within the lungs 
Brief summary of Evidence Reviewed 
466 patient RCT1 published in NEJM in 2013. There were no major flaws in this paper. 
Five additional RCTs enrolled 22 - 344 patients each. Four of these additional RCTs were free from 
major flaws, whilst 1 RCT had a high risk of bias due to failure to conceal allocation.2,3  
References – click journal title for PubMed link 
1.  Guerin C et al. Prone positioning in severe acute respiratory distress syndrome. NEJM 2013;368:2159-68. 
2. Sud S et al. Effect of prone positioning during mechanical ventilation on mortality among patients with 
acute respiratory distress syndrome:  a systematic review and meta-analysis. CMAJ 2014; 186:E381-E390.  
3. Beitler J et al. Prone positioning reduces mortality from acute respiratory distress syndrome in the low 
tidal volume era: a meta analysis. ICM 2014; 40:332-341. 
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SECTION FOUR – CLINICAL SCENARIO 
Now that you have read through the Evidence Summary Tool, please once again consider the clinical 
scenario presented earlier and answer the questions that follow: 
 
Mr Mathews, a 68 year old male who weighs 89kg (196lb) and is 178cm (5'10") in height was admitted 
to your ICU 30 hours ago with community acquired pneumonia and sepsis. Chest x-ray showed diffuse 
bilateral opacities and a BiPAP trial for worsening respiratory function failed. He was intubated 26 
hours ago and commenced on mechanical ventilation for the management of severe ARDS.  
This morning, Tidal Volume is 450mls, PEEP is set at 14cmH2O with an FiO2 of 0.8 and a PaO2:FiO2 ratio 
of 73. You have attempted multiple lung recruitment manoeuvres with no visible improvement and 
remain concerned with his respiratory status.  
Please indicate your level of agreement with the following 
statements: 
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  (select only one for each statement) 
19.  I believe that this patient may benefit from High Frequency Oscillatory Ventilation       
        
20.  I believe that this patient may benefit from Prone Positioning        
        
21.  I believe that this patient may benefit from Non-Invasive Bi-Level positive airway pressure (BiPAP) ventilation       
        
22.  I believe that this patient may benefit from the use of corticosteroids         
        
23.  I believe that this patient may benefit from the use of increased levels of PEEP         
        
24.  I believe that this patient may benefit from Extra-Corporeal Membrane Oxygenation (ECMO)         
        
25.  My feelings towards using the results of an RCT to guide my clinical practice are positive.       
        26.  
 
 
My feelings towards using the results of a systematic 
review/ meta-analysis to guide my clinical practice are 
positive.  
      
         
You have now reached the end of the questionnaire. 
Thank you for taking the time to participate in our study.  
 
Please save and return the questionnaire at your earliest convenience to Philippa Heighes  
Upload to - https://research.evidencebased.net/dropbox 
or mail c/- ICU Office Level 6 RNSH, Pacific Highway, St Leonards 2065 NSW Australia 
Use of an Evidence Summary Tool in Intensive Care.  
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SECTION 1 - DEMOGRAPHICS AND RESEARCH USE 
General Instructions: Please answer all questions to the best of your ability in the order that they appear. 
Directions for completing individual questions are given throughout the questionnaire where necessary. 
When you have completed the questionnaire please save and return at your earliest convenience.  
 
DEMOGRAPHICS: 
 
  
  
1. Are you:   Male  Female  
 
 (select appropriate box) 
  
      
2. What is your current age?      
 (please insert age here)  
   
       
3. What country do you live in?    
 (please insert country here) 
  
  
4. What year did you first start working in Intensive Care?    
 (please insert year here) 
  
    
 
5. Do you currently hold an academic appointment 
within a university? Yes  No  
  (select appropriate box) 
   
   
6. How many hours a week are you able to devote to 
your own continuing medical education?  
      
      (eg journal club, grand rounds, self study)   (please insert hours here) 
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   7. What is your current position? Please select the category that 
most accurately describes your daily role:  (select only one) 
 a: Part time in Intensive Care, primary speciality in other field   
 b: Full time Intensive Care Specialist   
 c: ICU trainee     
 d: Nurse    
 e: Dietician    
 f:  Physiotherapist    
 g: Occupational therapist     
 h: Respiratory therapist    
 i:  Pharmacist    
 j:  Other     
 
 
  
 
  
8. Please indicate your level of training or qualification in research: (select all that apply) 
 a: Research fellowship  
 b: Formal research methodology course (eg short course at university)  
 c: Certificate, Diploma or Degree in research methodology  
   (I)  Graduate Certificate level  
   (II) Graduate Diploma level  
   (III) Masters level  
   (IV) PhD level  
 d: No formal research qualification   
 
9. Please indicate your level of training in Evidence Based Medicine (EBM):   
 (select all that apply) 
 a: Have attended a short EBM course/workshop  (eg offered at a hospital, a conference or by a for-profit organisation)     
 b: Have attended an EBM course/workshop at McMaster University   
 c: Have attended an EBM course/workshop at another University  
 d: No formal training in EBM  
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RESEARCH USE: 
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  (select only one for each statement) 
        
10.  
 
How often do you use the concepts of EBM in your 
clinical practice? 
 
     
                        
11.  How often do you read the following? 
      
        
 a Published Randomised Controlled Trials (RCTs)       
 b Information obtained from The Cochrane Library       
 c Textbooks       
 d Published evidence based guidelines       
 e Published systematic reviews/ meta-analyses       
 f Evidence summaries       
         
12.  
 
How often do you use the following information sources  
to guide decisions in your clinical practice? 
  
 
a 
 
Information provided in evidence summary journals  
(eg Intensive Care Monitor etc) 
      
 b Advice given to me by a colleague       
 c Information I have read in a textbook       
 d The results of a Cochrane review       
 e The results of an RCT       
 f Published evidence based guidelines       
 g Information I found through a Google search.       
 h The results of a systematic review/ meta-analysis.       
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SECTION TWO – CLINICAL SCENARIO 
General Instructions: Please carefully read the clinical scenario presented to you following these 
instructions. When you have finished reading the scenario you will be asked some questions regarding the 
ongoing management of the patient presented.  
 
Mr Mathews, a 68 year old male who weighs 89kg (196lb) and is 178cm (5'10") in height was admitted 
to your ICU 30 hours ago with community acquired pneumonia and sepsis. Chest x-ray showed diffuse 
bilateral opacities and a BiPAP trial for worsening respiratory function failed. He was intubated 26 
hours ago and commenced on mechanical ventilation for the management of severe ARDS.  
This morning, Tidal Volume is 450mls, PEEP is set at 14cmH2O with an FiO2 of 0.8 and a PaO2:FiO2 ratio 
of 73. You have attempted multiple lung recruitment manoeuvres with no visible improvement and 
remain concerned with his respiratory status. 
 
Please indicate your level of agreement with the following 
statements: 
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 (select only one for each statement) 
13.  I believe that this patient may benefit from High Frequency Oscillatory Ventilation       
        
14.  I believe that this patient may benefit from Prone Positioning        
        
15.  I believe that this patient may benefit from Non-Invasive Bi-Level positive airway pressure (BiPAP) ventilation       
        
16.  I believe that this patient may benefit from the use of corticosteroids         
        
17.  I believe that this patient may benefit from the use of increased levels of PEEP         
                
18.  I believe that this patient may benefit from Extra-Corporeal Membrane Oxygenation (ECMO)         
        
SECTION THREE – EVIDENCE SUMMARY TOOL 
On the next page you will find an Evidence Summary Tool that presents recent evidence from published 
literature regarding the management of patients with severe ARDS. Please carefully read the Tool and 
consider the evidence presented before moving onto Section Four 
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Prone Positioning in ARDS saves lives 
To save 1 life you need to prone 6 patients with severe ARDS on low-tidal volume ventilation.  
This is supported by a significant mortality reduction in two well conducted meta-analyses 
including 6 RCTs enrolling a total of 1,016 patients. 
Other patient benefits 
For every 15 patients proned, 1 cardiac arrest is prevented.1 
For every 7 patients proned, 1 additional patient is successfully extubated before Day 90. 1 
Potential harms 
For every 25 patients proned, 1 transient endotracheal tube obstruction occurs.2 
For every 77 patients proned, 1 thoracotomy tube is dislodged.2 
For every 10 patients proned, 1 additional pressure ulcer occurs.2  
There is no documented increase in additional accidental extubations.1,2,3 
Identifying patients that will benefit from prone positioning 
1) Identify severe ARDS patients early  
Intubated and ventilated < 36 hours AND PaO2:FiO2 ratio < 150mmHg. 
2) Implement low-tidal volume ventilation for a period of 12 to 24 hours 
Ensure PEEP is at least 5cmH2O and FiO2 ≥ 0.6. 
3) If PaO2:FiO2 ratio remains < 150 mmHg, consider proning. 
Implementing prone positioning in suitable patients 
1) Maintain prone position for at least 16 consecutive hours. 
2) Following return to supine position reassess PaO2:FiO2 ratio and continue to use prone 
positioning each day if PaO2:FiO2 ratio < 150mmHg. 
3) If PaO2:FiO2 ratio ≥ 150mmHg and PEEP ≤ 10cmH2O and FiO2 ≤ 0.6 cease prone positioning. 
Useful educational resources regarding prone positioning 
The successful management of the patient in prone position relies on the skill of the staff 
performing the procedure. Adequate training and experience of staff is key to maintaining 
patient safety and minimising potential harms.  
Guidelines for standardising prone positioning and a useful 5 minute training video demonstrating 
prone positioning procedure available at http://www.nejm.org/ 
A complete list of eligibility criteria and contraindications can be found at 
http://www.nejm.org/suppl 
Physiological rationale of why prone position is beneficial 
Prone positioning leads to more equal ventilation perfusion match; more uniform alveolar 
recruitment and expansion; and more even distribution of pleural pressure within the lungs 
Brief summary of Evidence Reviewed 
Meta-analyses published in CMAJ2 and ICM3 in 2014. The six included RCTs enrolled 22 - 474 
patients each. Five RCTs were free from major flaws, whilst 1 RCT had a high risk of bias due to 
failure to conceal allocation. One meta-analysis included all six trials2 whilst the second focused on 
adult patients, and included the four trials that were free from major flaws.3  
References– click journal title for PubMed link 
1.  Guerin C et al. Prone positioning in severe acute respiratory distress syndrome. NEJM 2013;368:2159-68. 
2. Sud S et al. Effect of prone positioning during mechanical ventilation on mortality among patients with 
acute respiratory distress syndrome:  a systematic review and meta-analysis. CMAJ 2014; 186:E381-E390.  
3. Beitler J et al. Prone positioning reduces mortality from acute respiratory distress syndrome in the low 
tidal volume era: a meta analysis. ICM 2014; 40:332-341. 
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SECTION FOUR – CLINICAL SCENARIO 
Now that you have read through the Evidence Summary Tool, please once again consider the clinical 
scenario presented earlier and answer the questions that follow: 
 
Mr Mathews, a 68 year old male who weighs 89kg (196lb) and is 178cm (5'10") in height was admitted 
to your ICU 30 hours ago with community acquired pneumonia and sepsis. Chest x-ray showed diffuse 
bilateral opacities and a BiPAP trial for worsening respiratory function failed. He was intubated 26 
hours ago and commenced on mechanical ventilation for the management of severe ARDS.  
This morning, Tidal Volume is 450mls, PEEP is set at 14cmH2O with an FiO2 of 0.8 and a PaO2:FiO2 ratio 
of 73. You have attempted multiple lung recruitment manoeuvres with no visible improvement and 
remain concerned with his respiratory status.  
Please indicate your level of agreement with the following 
statements: 
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  (select only one for each statement) 
19.  I believe that this patient may benefit from High Frequency Oscillatory Ventilation       
        
20.  I believe that this patient may benefit from Prone Positioning        
        
21.  I believe that this patient may benefit from Non-Invasive Bi-Level positive airway pressure (BiPAP) ventilation       
        
22.  I believe that this patient may benefit from the use of corticosteroids         
        
23.  I believe that this patient may benefit from the use of increased levels of PEEP         
        
24.  I believe that this patient may benefit from Extra-Corporeal Membrane Oxygenation (ECMO)         
        
25.  My feelings towards using the results of an RCT to guide my clinical practice are positive.       
        26.  
 
 
My feelings towards using the results of a systematic 
review/ meta-analysis to guide my clinical practice are 
positive.  
      
         
You have now reached the end of the questionnaire. 
Thank you for taking the time to participate in our study.  
 
Please save and return the questionnaire at your earliest convenience to Philippa Heighes  
Upload to - https://research.evidencebased.net/dropbox 
or mail c/- ICU Office Level 6 RNSH, Pacific Highway, St Leonards 2065 NSW Australia 
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 Author’s final version of: Heighes PT and Doig GS. Intensive care specialists' knowledge, attitudes, and 
professional use of published research evidence: a mail-out questionnaire survey of appropriate use of research 
evidence in clinical practice. J Crit Care 2014;29(1):116-122. doi: 10.1016/j.jcrc.2013.10.014. 
Abstract:          
Purpose 
This survey investigates the knowledge, attitudes and use of published research in clinical practice by 
Intensive Care Specialists.  
 
Materials and Methods 
A mail out questionnaire was sent to randomly selected Intensive Care Specialists registered with the 
Australian and New Zealand College of Intensive Care Medicine.  
 
Results 
The response rate was 55.9% (133/238). The average score for research knowledge was 2.9 out of 6. 
65.4% (85/130) of respondents reported positive feelings towards using published research evidence 
in clinical practice with 96.6% (126/130) reporting use of the concepts of evidence-based medicine at 
least sometimes. Randomised trials were rated as the most frequently read evidence (rank score 3.7 
out of 5) with 'Information obtained from the Cochrane Library' the least frequently read (rank score 2.8 
out of 5). The most inhibiting barrier to use of published research evidence in practice was 'a lack of 
good evidence providing meaningful answers to clinical problems' (rank score 3.5 out of 5). 67.7% 
(88/130) of respondents appropriately used published research evidence in clinical practice. 
 
Conclusions 
Respondents reported generally positive attitudes towards using published research evidence, in 
clinical practice, however, room for improvement in technical knowledge relating to published research 
evidence was noted.  
  
 Author’s final version of: Heighes PT and Doig GS. Intensive care specialists' knowledge, attitudes, and 
professional use of published research evidence: a mail-out questionnaire survey of appropriate use of research 
evidence in clinical practice. J Crit Care 2014;29(1):116-122. doi: 10.1016/j.jcrc.2013.10.014. 
(1) Introduction: 
Since its inception in the early 90's, evidence-based medicine (EBM) has been widely promoted in the 
medical literature as a paradigm in which patient care decisions are based on the best available 
evidence in conjunction with clinical expertise and patient preference.
1
 Despite this, studies suggest 
that 30-40% of patients do not receive care in line with the best available evidence.
2,3
 The provision of 
medical care unsupported by current evidence is costly, with estimates that the US health care system 
wastes in excess of $200 billion per year on unnecessary medical care.
4
 Situations where evidence-
practice gaps have been identified highlight the importance of ensuring appropriate uptake of research 
evidence as it may ultimately help save lives and reduce costs associated with inappropriate care.
5,6
 
 
Implementing a change in clinical practice based upon the results of published research evidence is a 
multifaceted and complex process. The results of published research evidence, pathophysiologic 
understanding, clinical experience and patient preferences all influence the decision making of 
clinicians.
7
 The 'Theory of Planned Behaviour' particularly highlights attitudes as one of three major 
characteristics that determine the likelihood of someone changing their behaviour, with positive 
attitudes being found in those more likely to adopt change early on.
8
    
 
In line with change management theories, there is an emerging interest in the literature in the 
exploration of attitudes towards published research evidence and its use in clinical practice. Surveys 
conducted in groups of general practitioners, oncologists and urologists showed generally positive 
attitudes towards research evidence and its use in clinical practice,9-12 however, a methodologically 
rigorous study of 933 Italian physicians revealed that whilst the physicians generally had positive 
attitudes towards research evidence, according to self-reported measures of use, 68% of respondents 
failed to appropriately use published research evidence to guide their clinical practice.13 It has been 
estimated that whilst the Intensive Care Unit (ICU) accounts for less than 10% of hospital beds, it is a 
particularly resource heavy area, consuming 22% of total hospital costs in the United States.
14
 As 
such, the application of the results of published research evidence in the ICU may be especially 
important in regards to saving lives and reducing costs, however we were unable to identify any 
publications addressing this question. 
 
 Author’s final version of: Heighes PT and Doig GS. Intensive care specialists' knowledge, attitudes, and 
professional use of published research evidence: a mail-out questionnaire survey of appropriate use of research 
evidence in clinical practice. J Crit Care 2014;29(1):116-122. doi: 10.1016/j.jcrc.2013.10.014. 
Therefore, the aim of this study was to conduct a methodologically rigorous survey to identify the 
attitudes, knowledge, and appropriate use of published research evidence in clinical practice by 
Intensive Care Specialists in Australia and New Zealand.  
 
(2) Methods: 
Approval to conduct the study was obtained from the University of Sydney Human Research Ethics 
Committee (Protocol number 13029; September 2010). 
 
Study design 
In order to evaluate the knowledge, attitudes and use of published research evidence in clinical 
practice a self-administered mail out survey of randomly selected Intensive Care Specialists was 
conducted, with repeat mail outs to non-responders and anonymous responses.
15
  
 
Sampling frame 
All qualified Australian and New Zealand Intensive Care Specialists registered with the College of 
Intensive Care Medicine (CICM) (current January 2011) were eligible for participation in the survey. 
The CICM is the regulatory body for Intensive Care Medicine specialist training and education in 
Australia and New Zealand, providing a six-year specialist preparation programme to trainees, and 
continuing medical education, professional development and support to fellows.  
 
Sample size 
An Italian survey of physicians’ knowledge, attitudes and professional use of randomised controlled 
trials and meta-analyses found that, according to self-reported measures of use, 32.1% of the 
population studied appropriately used evidence in their clinical practice.13 
 
Given a 32.1% (P) rate of expected self-reported appropriate use of evidence, and a total sampling 
frame (N) of 685 CICM registered Intensive Care Specialists, standard formulas for simple random 
samples calculated a survey of 238 (n*) Intensive Care Specialists would provide a precision (L) of 5% 
on the estimate of self-reported appropriate use, with adjustments for the sampling fraction (n/N) being 
greater than 10% of the total population.
16
 
 Author’s final version of: Heighes PT and Doig GS. Intensive care specialists' knowledge, attitudes, and 
professional use of published research evidence: a mail-out questionnaire survey of appropriate use of research 
evidence in clinical practice. J Crit Care 2014;29(1):116-122. doi: 10.1016/j.jcrc.2013.10.014. 
 
Survey Administration 
Pre-numbered survey packages were collated by the primary researchers and provided to the CICM 
along with a computer-generated list of random numbers. The CICM then handled the labelling and 
mail out of the survey packages to maintain the confidentiality and anonymity of the sample 
population. The survey was administered by direct mail out and a reply paid (stamped) response 
envelope was provided in the package.
17
 
 
A cover letter presented with the survey package outlined the purpose of the project, requested 
participation through completion and return of the accompanying questionnaire and assured 
respondents of confidentiality and anonymity.
18
  
 
When returned, member numbers were recorded and removed from the respondents list. Two repeat 
mail outs were conducted to member numbers not marked as returned, following the same procedures 
as the initial mail out.
15;19
 
 
Survey Instrument Design 
The survey instrument questionnaire comprising five sections (demographics; research experience; 
research knowledge; research attitudes and research use) was developed based upon a 
comprehensive review of the literature. Previously published surveys evaluating attitudes towards, and 
the use of, EBM were found by searching MEDLINE using the key search terms 'evidence based 
medicine' AND 'physician attitude' AND 'questionnaire.' To assure content and construct validity, 
articles were retrieved and reviewed for content, with a list of themes, topic areas and specific 
questions collated and included in our survey. Selection and wording of our questions was based on 
our review of topic related publications, with a major focus on the survey published by DeVito et al
13
, 
adapted to the Australian setting of intensive care medicine. The revised questionnaire was pilot 
tested on three individuals practicing in intensive care.  Pilot testers were asked to (a) review each 
individual question and make comments on what they thought it was asking, clarity of wording whilst 
(b) also completing the questionnaire in full. All responses and feedback from pilot testing were 
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reviewed by the two authors and questions were modified to incorporate feedback and ensure clarity. 
One iteration of pilot testing was undertaken.   
 
A copy of the survey is provided in appendix 1.  
 
Data Entry 
All data from returned survey questionnaires was entered into a Microsoft Excel™ database and re-
checked for accuracy following initial entry. An external researcher not directly involved with this 
project then audited accuracy of data transcription. Fifty percent of all records were audited.  
 
Statistical Analysis 
Descriptive statistics are presented. Results are reported as median with frequencies (percent); mean 
and standard deviation; or rates, with numerator and denominator. 
 
 (3) Results: 
Response rate 
The survey instrument questionnaire was sent to the sample population in three consecutive mail outs 
in January, February and March 2011. After the first mail out 72 out of 238 questionnaires were 
returned; an additional 17 surveys were returned after the second mail out; and 42 following the third 
mail out. Promotion by the CICM (at their annual conference and in their newsletter) resulted in receipt 
of a further two surveys. Of the original sample of 238 Intensive Care Specialists randomly selected 
from the CICM registration list, a total of 133 returned the questionnaire, giving an overall unit 
response rate of 55.88% (133/238). Item response rate for individual questions in the returned 
questionnaires was between 97% (129/133) and 99.25% (132/133). 
 
Data Entry 
Fifty percent of all records were audited, zero errors were found.  
 
Characteristics of Respondents 
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The average number of years practising as a Registered Intensive Care Specialist was 15 years (SD 
7.0 years) with a mean age of 51 (SD 8.57 years). Males made up 81.53% (106/130) of respondents. 
 
Some form of research training (research fellowship; formal research methodology course; or 
Certificate, Diploma or Degree in research methodology) had been completed by 31.06% (41/132) of 
respondents. Additionally, 40.77% (53/130) of respondents reported completion of some level of 
formal Evidence Based Medicine (EBM) training (attended an EBM course/workshop conducted at a 
hospital, conference, other organisation or university).  
 
Full details of characteristics of respondents can be found in Table 1.  
 
Research Knowledge 
To assess research knowledge, respondents were provided with six statements and asked to select 
correct, incorrect or not sure for each statement. See Table 2 for complete list of knowledge 
statements. Question 4, concerning the accepted level of statistical significance (p<0.05), received the 
most correct responses (96.15% (125/130)), whereas Question 5, addressing measures of 
heterogeneity (I
2
), received the least number of correct responses (14.73% (19/129)).  
 
The average score out of six for research knowledge was 2.92 (SD 1.59). The number of respondents 
correctly identifying all 6 correct responses was 2.30% (3/130). Full details of participants' responses 
to individual knowledge statements are summarised in Table 2.  
 
Research Attitudes 
Six statements concerning attitudes and feelings towards aspects of research were provided; with five 
options for response ranging from strongly disagree to strongly agree.  Positive feelings (agree or 
strongly agree) towards using published research evidence in clinical practice were reported by 
65.39% (85/130) of respondents, and 75.39% (98/130) of respondents also reported that their 
colleagues had positive feelings (agree or strongly agree) towards using published research evidence 
in clinical practice.  
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Responding Intensive Care Specialists reported the highest level of positive feelings (86.15% 
(112/130) agreed or strongly agreed) in regards to using the results of an RCT to guide their clinical 
practice, with less Intensive Care Specialists reporting positive feelings about using the results of a 
systematic review/ meta-analysis to guide their clinical practice (59.23% (77/130) agreed or strongly 
agreed).  
 
Frequency of Research Use 
When responding to a question that asked respondents to rate the frequency of use of the concepts of 
EBM in their own clinical practice, 96.62% (126/130) of Intensive Care Specialists reported that they 
use EBM at least sometimes, which was defined as 'every month or so'.  
 
Responding to a question regarding the frequency of reading different sources of evidence, Intensive 
Care Specialists rated RCT's to be the most frequently read evidence source, with a mean rank score 
of 3.73 (SD 0.67) and 97.69% (127/130) of respondents reporting they read RCTs at least sometimes. 
Information obtained from the Cochrane Library ranked lowest with a mean rank score of 2.81 (SD 
0.86) and 65.12% (84/129) of respondents reporting at least sometimes using this evidence source. 
Complete details regarding frequency of reading specific evidence sources are reported in Table 3.  
 
In a question regarding how often various information sources are used to guide decisions in clinical 
practice, Published Evidence Based Guidelines (EBG's) were ranked by respondents as the most 
often used information source to guide clinical decisions, with a mean rank score of 3.58 (SD 0.68) 
and 96.92% (126/130) of respondents reporting at least sometimes using this evidence source. The 
results of a Cochrane review were rated as the least often used information source with a mean rank 
score of 2.80 (SD 0.74) and at least sometimes use reported by 67.69% (88/130) of respondents. 
Complete details regarding frequency of use of specific evidence sources to guide clinical decision 
making are reported in Table 4. 
 
Table 5 provides details regarding the reported frequency of use of published research evidence in 
various situations other than clinical practice, such as teaching, talking to family or patients etc.  
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Factors that Influence and Inhibit Use of Published Research Evidence 
Respondents were given a list of potential influencing factors and asked whether the factors help their 
decision to use the results of published research evidence to change clinical practice. Respondents 
rated 'the results have clear benefit to my patients' as the most helpful factor with a mean rank score 
of 4.36 (SD 0.53), with 100% of respondents (129/129) selecting at least sometimes for this factor. 
The factor that was rated as the least helpful was that 'the paper presents a full economic analysis' 
with a mean rank score of 2.82 (SD 0.94), with 62.02% (80/129) of respondents selecting at least 
sometimes for this factor.  
 
The respondents were then asked to rate factors that inhibit the use of published research evidence in 
their clinical practice. The statement 'there is a lack of good evidence providing meaningful answers to 
clinical problems' was selected as the most inhibiting factor with a mean rank score of 3.54 (SD 0.90) 
and 87.6% (113/129) of respondents selecting at least sometimes. The least inhibiting factor was 
'appraising published research papers is not part of my role' with a mean rank score of 2.12 (SD 0.89), 
and at least agree selected by 10.08% (13/129) of respondents.   
 
When asked specifically to identify whether time limitations are a factor that restrict the incorporation of 
Evidence Based Medicine (EBM) into their clinical practice, the mean rank score was 2.68 (SD 1.02) 
and 26.92% (35/130) of respondents reporting at least agree. 
 
Level of Appropriate Use of Published Research Evidence in Practice 
As ascertained using the previously published tool by De Vito et al., 67.69% (88/130) of Intensive Care 
Specialists in Australia and New Zealand were rated as self reported appropriate users of published 
research evidence in clinical practice; that is 'they read sometimes, often or very often RCTs and 
meta-analyses and use the results of RCTs and meta-analyses in clinical practice'.
13
  
 
(4) Discussion: 
We conducted a mail out survey of qualified Intensive Care Specialists from Australia and New 
Zealand to explore their knowledge, attitudes and appropriate use of published research evidence in 
clinical practice. The responding Intensive Care Specialists reported overwhelmingly positive attitudes 
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towards published research evidence, with a moderate level of appropriate use in clinical practice; 
however, this survey highlighted room for improvement in technical knowledge relating to published 
research evidence.  
 
Attitudes towards published research evidence: 
Prochaska's seminal 'stages of change model' proposes that an awareness of the need for change 
and a positive attitude to the benefits of change are the necessary first steps to undertaking a 
successful change management process.
20
 The 'Theory of Planned Behaviour' further highlights the 
importance of attitudes, with a positive attitude defined as one of three major characteristics that 
determine the likelihood of someone changing their behaviour.
8
   It would appear that there has been a 
cultural shift in attitudes towards EBM since its inception in the early 90's, with the majority of recent 
studies now showing generally positive attitudes towards the concepts of EBM.
9,10,12,13,21-24
 However, 
there are varied attitudes towards specific aspects of the use of evidence in practice amongst some 
clinical specialties within medicine. For example, a survey of Australian surgeons reported ambivalent 
and contradictory attitudes towards the use of published research evidence in practice, with surgeons 
reporting high confidence in their own judgement compared with low confidence in clinical practice 
guidelines relative to other sources of evidence.
25
 In contrast to surgeons' attitudes, the majority of 
qualified Intensive Care Specialists within Australia and New Zealand responding to our survey 
reported positive attitudes towards the use of published research evidence along with an 
overwhelming perception that colleagues' attitudes towards published research evidence were 
positive. Having positive attitudes logically translates into being more likely to use published research 
evidence in clinical practice.
26
  
 
Appropriate Use: 
There are few repeatable objective definitions published regarding appropriate use of published 
research evidence in clinical practice. A survey conducted in Italian physicians by De Vito et al. 
provides a working template of appropriate use, defined as 'read sometimes, often or very often RCT's 
and meta-analyses, and use the results of RCT's and meta-analyses in clinical practice'.
13
 In order to 
be able to compare the levels of appropriate use of published research evidence in clinical practice by 
our respondents to those previously published, we asked the same questions as De Vito et al.
13
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Significantly more Australian and New Zealand Intensive Care Specialists reported fulfilling this self-
reported criteria of appropriate use of published research evidence in clinical practice than Italian 
physicians (67.69% (88/130) vs 32.1% (209/654), p<0.0001). Furthermore, respondents reported a 
preference towards RCTs over systematic reviews.  
 
In the '6S model', a hierarchical framework for accessing preappraised evidence, Haynes and 
colleagues propose that clinicians should seek systematic reviews in preference to RCTs when 
looking for evidence to support their clinical decision making.
27
 Major credible bodies, such as the 
Oxford Centre for Evidence Based Medicine, further advocate systematic reviews as representing the 
highest level of evidence on which to base clinical treatment decisions.
28,29
 Despite these 
recommendations, our survey showed Intensive Care Specialists place meta-analyses and Cochrane 
reviews lower than RCTs in their preferences of evidence sources used to guide clinical decision 
making. The number of large scale multi-centre clinical trials being conducted in Intensive Care Units 
within Australia and New Zealand is increasing rapidly each year
30
 which is reflected in the majority of 
respondents reporting participation in some form of clinical trial activity (93.13%), such as consenting 
patients for participation in clinical trials, acting as a site investigator, or publishing research papers. 
The experience gained through involvement and participation in large scale RCTs may have 
influenced the expressed preference amongst Australian and New Zealand Intensive Care Specialists 
for using the results of an RCT to guide clinical practice over a systematic review/meta-analysis.  
 
Knowledge: 
Although respondents reported a good level of knowledge of basic research evidence concepts, such 
as the accepted level of statistical significance in clinical trials (p<0.05 threshold), we found much 
lower levels of knowledge as questions were asked relating to more technical aspects of research 
evidence, such as measures of heterogeneity in meta-analyses (I
2
 metric). Good basic knowledge is 
consistent with the findings of De Vito et al. which showed Italian physicians level of knowledge also 
decreased as faced with more technical questions.
13
 Alongside positive attitudes, an awareness and 
understanding of the need for change is identified as important to the success of implementing a 
change in behaviour.
20
 Improved knowledge regarding research methods may lead to an increased 
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understanding of the need for change thus enhancing appropriate use of published research evidence 
in clinical practice.  
 
Barriers to use: 
The Intensive Care Specialists responding to our questionnaire ranked the belief that 'there is a lack of 
good evidence providing meaningful answers to my clinical problems' as the factor that most inhibits 
their use of published research evidence in clinical practice. Other studies consistently cite lack of time 
as the biggest barrier to the implementation of research evidence into practice.
9,10,21,23
 In our survey, 
having 'difficulties finding the time to read' ranked third in a list of 13 potential inhibiting factors, and 
when directly asked to identify whether 'time limitations were a factor that restricted the incorporation 
of research evidence into their clinical practice', only one quarter of respondents agreed or strongly 
agreed. This perhaps highlights that whilst finding the time to read published research evidence 
remains a potential barrier, reading research evidence is now more widely accepted as part of the 
medical role.  
 
Strengths and Limitations: 
Metric of Appropriate Use 
The level of appropriate use of published research evidence in clinical practice was assessed based 
on a construct previously published in a large well conducted survey of physicians in Italy.
13
 Whilst the 
components of the tool were not comprehensive, they were easily repeatable and thus enabled us to 
make a comparison of the levels of self-reported appropriate use found in our population. It must be 
noted that all measures of appropriate use obtained in this survey were based solely on self-reporting 
and may therefore not reflect true rates of appropriate use. The measure of appropriate use utilised is 
an arbitrary metric and it is unknown whether it is the most suitable way to measure appropriate use. It 
is also worth acknowledging that whilst the measure was defined in the Italian survey, the authors did 
not set a level of appropriate use that was deemed acceptable.  
 
Response Rates 
We achieved a response rate of 56% (133/238). We used optimal survey methodology from the 
Dillman Total Design Method,
15,31,32
  and gained the support of the local Intensive Care professional 
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college (CICM)
18
 to attempt to maximise response rates. Due to funding limitations, we were unable to 
consider the use of financial incentives and it is unclear if this may have had an effect on our response 
rate.
33
 Despite optimal survey methodology we did not reach our desired response rate of 70%, 
however our response rate is similar to average rates achieved in other contemporaneous physician 
surveys with similar design.
34,35
  
 
Generalisability 
It is possible Intensive Care Specialists with positive attitudes towards published research evidence, 
such as those with academic affiliations, would be more likely to respond to a survey regarding 
research. We cannot exclude that this may have biased the levels of self-reported appropriate use in 
our survey. Demographic data regarding non-responders was not available when evaluating our 
response rate, addressing any potential non-responder bias and assessing the external validity of our 
findings. We were therefore unable to compare non-responders to responders. The results of our 
survey may therefore not be generalisable to all Intensive Care Specialists and must be interpreted as 
such. 
 
Bias within survey design 
Whilst all attempts were made to minimise bias through use of The Dillman Total Design Method
15
 it is 
possible that bias is present based upon the order, wording and framing of the questions contained in 
our survey.  
 
Recommendations: 
Although self-reported appropriate use (as ascertained by the tool developed by De Vito et al)
13
 in 
Australian and New Zealand Intensive Care Specialists was better than that found in Italian 
physicians, a moderate level of appropriate use may indicate room for improvement. However, as 
acceptable levels of appropriate use have not specifically been defined, further research is needed 
using more direct methods, such as interpretation of clinical decision making scenarios or 
observations of use of research evidence in clinical practice to evaluate true rates of appropriate use 
and to define what is an acceptable rate of appropriate use. More research is also required to assess 
the depth, reliability and validity of these measures of appropriate use.  
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Whilst the results of our survey have reinforced ideas from prominent change theorists that promote 
attitudes and understanding as important components of a successful change management process, 
there are few studies that actually attempt to measure and quantify these factors in relation to rates of 
appropriate use of published research evidence. Improving knowledge may lead to a greater 
understanding of the need to change practice based upon the results of published research evidence. 
Strategies to improve knowledge such as participation in research training and Evidence Based 
Medicine courses may be of potential benefit. We recommend that when future research is conducted 
on measures of appropriate use, measures of the influence and association between attitudes and 
knowledge and appropriate use be included. This will enable us to gain a better understanding of how 
these attributes influence the use of published research evidence in clinical practice. 
 
Despite recommendations from key authoritive bodies that systematic reviews should be used over 
RCTs to guide clinical decision-making, the results of our survey show our population still prefer RCTs. 
This highlights an opportunity for researchers to increase awareness and understanding of the role of 
systematic reviews and meta-analyses and other types of evidence summaries. Further research may 
be required to investigate strategies for improving trust and confidence in these evidence sources.  
 
Concluding summary: 
Based on the responses to our survey, it is evident that Australian and New Zealand Intensive Care 
Specialists face similar research adoption challenges as those in other fields. Study respondents had 
positive attitudes towards using published research evidence in clinical practice and a moderate level 
of self-reported appropriate use despite lower than expected knowledge levels. Surveys in other fields 
report that ‘attitudes’ towards EBM are generally positive,
11,12,36,37
 however there is a high reliance 
upon traditional information sources, such as consulting colleagues or textbooks,
22,38-40
 with a lack of 
time and EBM skills emerging as the most frequently reported barriers.
9,21,36,37
 Further research is 
required to expand our understanding of the influence of knowledge and attitudes on use of published 
research evidence in clinical practice. 
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